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ABSTRACT
The ability of substituted A-hydroxyguanidines to act as nitric oxide donor drugs 
has heen previously established. To further investigate the potential of this class of 
compound as nitric donor drugs a number of new A-hydroxyguanidines were prepared. 
The compounds were synthesised and then subjected to a number of chemical and 
biological tests. A number of the examples prepared were indeed shown to be oxidised 
under chemical conditions to give nitric oxide. The nitric oxide was tested for using the 
Greiss test. One example, 1-benzyl-l-methyl-2-hydroxyguanidine showed biological 
activity and was found to be a vasodilator. In addition an X-ray crystal structure of this 
compound was obtained which gave a further insight into the conformation of this type 
compound and related analogues. A number of ureas were also prepared for use in the 
biological and chemical testing. Under chemical conditions the ureas were not oxidised 
thus indicating that the hydroxyguanidine functionality was required for nitric oxide 
generation.
0-Substituted A-hydroxyguanidines were also prepared in an effort to examine 
the possibility of selectively targeting the molecule to the site of action for nitric oxide 
release. These compounds were found to produce a small amount of nitric oxide under 
chemical oxidation, therefore confirming their potential as potential nitric oxide donor 
compounds. Acid catalysed decomposition of 0 -T H P -1 ,1 ,-d ibenzy 1-2- 
hydroxyguanidine was studied. The reaction was carried out at various pHs and was 
monitored using HPLC. It was found that the THP protecting group could be removed 
to give the free A-hydroxyguanidine. More easily removed 0-substituents are probably 
required to produce successful prodrugs. However the reaction only gave a reasonable 
rate at a very low pH (ti/2 = 122 s at pH 0). A number of O-substituted hydroxylamines 
were then prepared in an attempt to increase the range of O-substituted A- 
hydroxyguanidines that could be obtained.
Chapter One 
INTRODUCTION
1.0 NITRIC OXIDE
Nitric oxide is a colourless gas with b.p. -151.8 °C and m.p. -163.6 °C. Nitric 
oxide is a simple odd-electron species but its structure has been the subject of a lot of 
interest and debate. In valence bond terms it is best represented by the canonical forms 
given in Scheme 1.^
+•N——6 —^  N-----0  N“ +—O '  — N= = 0
Scheme 1
The presence of the unpaired electron effectively reduces the bond order to 
approximately 2.5 unlike NO^ where the bond order is 3. The geometrical location of the 
odd electron and also the virtually unchanged bond order in the dimer explains the 
reluctance of nitric oxide to dimerize. The odd electron leads to nitric oxide being 
paramagnetic and also explains its use as a free radical trap in gas-phase reactions. It is 
also an efficient quencher of excited singlet states.
Lab preparations involve the reduction of nitric acid, using copper or nitrous acid 
with either iodine or ascorbic acid. Industrially, nitric oxide can be prepared by the 
catalytic oxidation of ammonia with a palladium/ rhodium catalyst, however the majority 
of nitric oxide produced is further oxidised to nitrogen dioxide and then reacted with 
water to give nitric acid.i Thermodynamically the direct formation of nitric oxide from 
nitrogen and oxygen is unfavourable and for the reaction is 173 kJ mol“^ . However 
its production can be achieved to a small extent at high temperatures for example during 
lightning discharge and more importantly in the internal combustion engine. This nitric 
oxide, in the absence of a catalytic converter, is oxidised in the air to nitrogen dioxide 
which is an air pollutant (this is often ascribed to NOx) in the industrialised world. When 
nitric oxide is found in the atmosphere it can lead to major photochemical smog, for 
example in Los Angeles. There is also concern regarding the role of nitric oxide emitted 
from the engines of supersonic aircraft in the depletion of the ozone layer.^
1.1 BIOLOGICAL ACTIVITY OF NO
In 1980 Robert Furchgott and John Zawadzki of Down State Medical centre, 
New York reported strange findings.^ While studying the action of acetylcholine (1) on 
pre-contracted artery rings they found that, contrary to previous work, acetylcholine did 
not always induce muscle relaxation and thus artery dilation. This occurred when the 
endothelial cells had inadvertently been removed or damaged. This result lead them to 
report that acetylcholine does not act directly upon the muscle cells but on the 
endothelium, which then produces a secondary messenger. This messenger passes 
through the endothelium to the surrounding muscles to stimulate guanylate cyclase which 
is responsible for smooth muscle relaxation.
( 1 )
The chemical identity of the secondary messenger, which became known as the 
endothelium-derived relaxing factor (EDRF), was the subject of intense speculation. In 
1987 Moncada and co-workers,at the Wellcome research laboratories, and Ignano and 
co-workers^ published independent findings which identified nitric oxide as the EDRF. 
Both groups had found that in a bioassay the EDRF and nitric oxide behaved in an 
identical manner. The identification of NO as the EDRF explained two earlier results. 
Firstly, the lifetime of the EDRF was prolonged on addition of the enzyme superoxide 
dismutase (SOD). Superoxide reacts with nitric oxide and thus when SOD was added it 
destroys the superoxide leaving the nitric oxide unreacted. Secondly, if haemoglobin 
was added, the action of the EDRF was destroyed due to the strong binding of 
haemoglobin to nitric oxide.
The identification of nitric oxide as the EDRF has been questioned. Myers and 
co-workers, suggested that the EDRF was in fact S-nitrosocysteine.^ However, this is 
doubtful as it is impossible to obtain 5'-nitrosocysteine in pure form. The search for an 
alternative EDRF is motivated by the mistrust that a gas is the answer. However nitric 
oxide has all the necessary requirements; it is small and therefore mobile, it is soluble in 
both water and lipid, as a radical it is highly reactive but it is stable in isolation and finally 
another gas, ethene, is also effective as a messenger molecule. It has been reported that 
nitrosated thiol groups on proteins provide a vasodilator that is more stable than nitric 
oxide itself, so it may be possible that nitric oxide is stored in the form of an S- 
nitrosothiol.7
It has long been known that a number of NO-donating compounds act as 
vasodilators (substances that enlarge the blood vessels) and these are used in the 
treatment of diseases where increased blood flow will relieve the symptoms, for example 
angina pectoris. Treatments for these diseases include the use of glyceryl trinitrate (2) 
(GTN), amyl nitrite (3) and isosorbide dinitrate (4).
ONOg
ONOg
O  NO
- O N O g
(2) (3)
OgNO
Until it was discovered that nitric oxide was the EDRF the mode of action of these 
compounds was unknown. However, it now known that these compounds work by 
bypassing the NO-generating system in the endothelium and deliver nitric oxide directly 
to the muscle cells in the walls of the artery.
1.1.1 Platelet Aggregation and Adhesion
Nitric oxide is also involved in platelet aggregation and adhesion.^ This process 
prevents excessive bleeding when a blood vessel has been damaged. NO and 
prostacyclin act synergistically to inhibit platelet aggregation and to disaggregate platelets, 
but there is no parallel synergism in platelet adhesion. However myocardial infarction 
(heart attack) may be caused by an abnormal clotting in a coronary vessel coated with 
atherosclerotic plaque (a coating on the inside of a blood vessel containing quantities of 
cholesterol).
1.1.2 Immune Response
It was discovered that activated macrophages in culture produce nitrite and nitrate 
in the supernatant liquid.^ Macrophages are part of the body's immune response to 
invasion by foreign particles. They move around the body and upon encountering a 
foreign microbe are stimulated to engulf and kill it. It has been shown that the 
macrophage requires L-arginine for this destructive activity, which is also accompanied 
by the formation of citrulline and nitrite. Marietta suggested, taking into account these 
observations, that the arginine to nitric oxide pathway occurs in activated macrophages as 
well as endothelial cells (Section 1.2). It has also been suggested that the cytotoxic 
agent produced by the macrophages and responsible for foreign cell death is nitric oxide 
however, there is no direct evidence concerning the mechanism for NO involvement. It 
could be that as a radical species, nitric oxide is sufficiently destructive to the lipid cell 
membrane but there is no experimental evidence to either prove or disprove this theory. 
An alternative mechanism has been suggested (Scheme 2)M  Firstly NO reacts with 
superoxide to give peroxynitrite (ONOO ), which is a weak acid and will become 
protonated at normal physiological pH. This could then fragment to give nitrogen 
dioxide and a hydroxyl radical. Hydroxy radicals have already been shown to be more 
destructive towards lipid membranes and DNA,
NO + Ü2 --------------- ONOO"
ONOO" + i f ----------------► ONOOH
ONOOH ----------------► NO2 + HO
Scheme 2
A further alternative is that NO reacts with an enzyme iron-sulfur centre, which is 
required for metabolic activity and produces an iron-sulfur cluster nitrosyl and this 
dismpts the enzyme activity.
1.1.3 Septic Shock
There seems to be a rather curious and incompatible combination of beneficial 
effects and the cytotoxic effects of nitric oxide. This dual role does however explain a 
life threatening condition known as septic shock.^ Here when the body suffers from a 
massive infection there will be a lot of macrophage activity. In addition to having 
massive cytotoxicity towards the invading cells the nitric oxide produced will bring about 
massive hypotension and septic shock.
1.1.4 Nitric Oxide in the Brain
Nitric oxide is produced by the post synaptic neurone when the glutamate 
receptors are activated.^ The nitric oxide then appears to diffuse back to the presynaptic 
neurone thus acting as a feedback mechanism. It also diffuses to the surrounding 
neurones on reaching the presynaptic neurone. This could be one way in which memory 
is established although at the moment there is no direct evidence of this. It has been 
suggested that over production of nitric oxide could be involved with the process of
s e n i l i ty .2  This example contrasts the very different roles that nitric oxide does play 
within the body.
Nitric oxide is also partially responsible for brain damage occurring after a stroke. 
The enzyme nitric oxide synthase is involved in the biosynthesis of nitric oxide from 
arginine involving NADPH and dioxygen (Section 1.2). When the brain is starved of 
oxygen, for example during a stroke, nitric oxide synthase is deprived of one of its 
substrates. As a result the concentration of NOS becomes elevated to overcome the drop 
in activity. Then upon reoxygenation there is a sudden burst of nitric oxide production 
which is one of the causes of brain damage. If a drug could be designed that would 
inhibit the NOS then some of this reoxygenation injury could be avoided. Recent reports 
have shown that schizophrenia also involves a disturbance within the arginine-nitric oxide 
pathway in the brain.
1.1.5 Diabetes and other conditions
Nitric oxide appears in so many areas of human physiology that an abnormal 
nitric oxide metabolism is present in a number and variety of diseased states. Nitric oxide 
destroys the P-cells of the pancreas when macrophages invade the Islets of Langerhans to 
produce the condition known as i n s u l i t i s . ^ ^  when the P-cells of the sufferer can no 
longer produce insulin the patient suffers from diabetes. Arthritis and inflammation in 
general are associated with elevated production of NO.^4 The injury associated with 
paraquat poisoning appears also to arise from an over stimulation of nitric oxide 
synthase, resulting in high levels of nitrite in lung tissue. These three examples surely 
represent a more general phenomenon.
1.2 BIOSYNTHESIS
1.2.1 Introduction
NO is produced in vivo by the oxidation of the guanidine function of L-arginine 
(5) in a process that involves two monooxygenations and proceeds via the stable 
biosynthetic intermediate, A^®-hydroxy-L-arginine (NOHA) (6) (Scheme 3). The 
products of the reaction are L-citrulline (7) and nitric oxide. The family of enzymes 
involved in the process are nitric oxide synthases (NOS) of which there are 2 distinct 
classes.
(-1)NON(-3)NH
NH NHNH
NADPH, O2 (+2)
N = 0
0.5 NADPH, O2
NOS NOS
COGO CO
A-hydroxy-L-arginine (6)L-Arginine (5) Citrulline (7)
Scheme 3
The two monooxygenation steps probably involve the reductive activation of the 
dioxygen species at a heme centre in the enzyme with the required electrons coming from 
nicotinamide adenine dinucleotide phosphate (NADPH). Overall the reaction requires 1.5 
equivalents of NADPH and 2 equivalents of dioxygen and is a five electron oxidation of 
the terminal guanidino N atom. Each monooxygenation requires four electrons to reduce 
the dioxygen and these electrons are partially derived from both the substrate and the 
NADPH. In the first oxygenation two electrons come from NADPH and the other two
from the substrate. A two electron oxidation from N(-3)arg to N(-1)nqha occurs. In 
the second oxygenation NADPH contributes a single electron and the substrate undergoes 
a three electron oxidation from N(-1)noha to N(+2)no- The use of t^02  resulted in both 
the products, citrulline and nitric oxide, containing an tSQ label (Scheme 4).t6
NH
NHNH
COOHCOOH
Scheme 4
Since the initial discovery of NO biosynthesis it has become apparent just how 
widely the arginine-NO pathway is distributed in mammals and how many biological 
processes it regulates. This led to the proposal that there must be more than one isoform 
of the enzyme. There are now three NOS isoforms characterised which correspond 
to the different tissue/cell types in which the NO synthase was first discovered. The three 
isoforms are endothelial N O S  (eNOS),!^ neuronal N O S  ( n N O S ) , ^ 9 , 2 0  and inducible 
NOS (iNOS).^l Two, eNOS and nNOS, are constitutively expressed in cells where as 
iNOS is not normally present in resting cells but is produced in macrophages in response 
to bacterial products and immunoactive cytokines.
NOS isoforms in mammalian systems are the product of three distinct genes 
which are composed of 26 exons for iNOS,^^ and eNOS^^ or 29 exons for nNOS.^'^ 
The NOSs are cytosolic enzymes, with the exception of eNOS, which are active as 
homodimers, with each subunit containing one equivalent of heme.^^ The three isoforms 
have very similar biochemical properties and catalyse the same reaction but clearly show
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differences in the primary structure and molecular weight. However the main difference 
between the constitutive and inducible isoforms is in the method of regulation.
The regulation factor of NOS activity appears to be the presence of 
Ca^+/calmoduIin system. It appears that calmodulin binding is a switch that allows 
electron transfer from the reductase domain into the oxygenase domain of the enzyme, 
thus allowing enzyme activity. The two constitutive isoforms are Ca^+Zcalmodulin 
dependent and are therefore activated by hormones or neurotransmitters that cause a 
change in the intracellular concentration of Ca^+ ions. These isoforms produce a low 
concentration of NO as a signal for regulatoi-y purposes, mediated, for example by the 
interaction of NO with guanylate cyclase. It is interesting to note, however, that whereas 
nNOS shows a dependence on calcium ions guanylate cyclase is inhibited by free Ca^+. 
It has been suggested that this forms the basis of a control mechanism where the release 
of NO in a cell would affect guanylate cyclase in the neighbouring tai'get cells while at the 
same time minimising the activity of the enzyme in the cell producing the NO.^^ Recently 
it has been shown that there may be Ca^+Zcalmodulin independent mechanisms which 
regulate constitutive NOS activity .^6
In contrast the activity of iNOS is independent of the Ca^+ concentration, a 
characteristic that arises from its tight binding with calmodulin at normal physiological 
Ca^+ concentrations. Once it has been expressed it means in effect that this isoform is 
active all the time and provides NO at high concentrations as part of the 
cytotoxic/cytostatic immune response to invading pathogens and tumour cells. There are, 
however, regulation methods for this isoform and these include, regulation of the 
transcription that expresses the iNOS gene;^^ control of the availability of the substrate 
arginine via arginase a c t i v i t y a n d  control of the biosynthesis of the essential cofactors 
for example H4B.
The nitric oxide biosynthetic pathway is not restricted to mammalian systems and 
has been shown to be a fundamental process in birds,fish,^^ invertebrates,^^ plants, 
fungi33 and b a c t e r i a . ^ ^  is also known that some denitrifying bacteria can produce NO 
by reduction of nitrite and then further reduction to nitrous oxide by nitrite and nitric
11
oxide reducing enzymes^^ or by oxidative metabolism of ammonia.^6
1.2.2 Mechanism of transformations
There are two very different mechanisms proposed for the two 
monooxygenations, although both are assumed to be mediated by the activation of O2 at 
the heme centre of the enzyme. Several issues including the precise mechanistic role of 
the heme centre, the protonation state of both arginine and A-hydroxyarginine during the 
reaction and also the timing of the possible proton transfers are still unresolved.
1.2.2.1 Monooxygenation I
Monooxygenation I occurs mechanistically in the same manner as cytochrome 
P450 A-oxidations.^^'^8 It is probably, although it has not been proved beyond doubt, 
mediated by a transient, high-valent oxoiron porphyrin complex and may start by a single 
electron oxidation of the guanidine substrate followed by a recombination of this radical 
with the iron-bound oxygen. Although there is more known about this mechanism than 
the second monooxygenation, for which there actually appears to be no biological 
precedent, there are many unanswered questions about the fine mechanistic details. It 
maybe that substrate binding regulates the kinetics of the electron entry which facilitates 
the reductive activation of dioxygen. There is evidence to support this theory in particular 
the observation that substrate binding does not facilitate heme iron reduction but does 
influence the flux of electrons through the NOS redox centres.^^>‘^® The position of the 
substrate with respect to the active site perferryl oxygen and the protonation state of the 
guanidine will have a major impact with respect to the actual mechanistic detail but little is 
known about the active site as of yet. The other major matter to be resolved is the role of 
the H4B in catalysis. It is assumed that the hydroxylation step is catalysed by the action 
of heme without the biopterin being involved as a redox active cofactor and this is 
generally accepted.41
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1.2.2.2 Monooxygenation II
The mechanism of NOS monooxygenation II is not well understood and has been 
the subject of extensive speculation. As with monooxygenation I it has been suggested 
recently that the mechanism involves a heme-mediated monooxygenation rather than 
direct involvement of H4B as a redox active cofactor. Initially it was proposed that the 
A-hydroxyarginine (6) was oxidised to a C-nitroso derivative (8) (Scheme
NH NH -HOxidation,
NH HgNHgNHgN
OH
iV-Hydroxy-L-arginine
-H
NH
N = 0H2N
NHL-Citrulline (7)
Scheme 5
Various groups have attempted to try and probe the mechanism of the second 
oxidation. Fukuto and co-workers oxidised V-(V-hydroxyamidino)piperidine (NHAP) 
(9) using various chemical oxidation agents including Ag(I), Pb0 2  and Fe(III)/H202-'^  ^
Oxidation was observed, producing either NO or N2O. The N2O is formed from the
13
dimérisation of HNO to give hyponitrous acid which then decomposes to give water and 
N2O in aqueous solution.
Feldman also reported a chemical model for the oxidation of N-hydroxy-L- 
arginine (9) by nitric oxide s y n t h a s e . ^ 4  iV-Hydroxyguanidines were reacted with a range 
of oxidants; m-chloroperbenzoic acid (mCPBA), monoperoxyphthalic acid (magnesium 
salt, hexahydrate) and ozone. This confirmed the results of Fukuto and co-workers that 
suggested that either NO or HNO could be the oxidation product dependent on the 
oxidant. Both groups looked at the reaction of N-(N-hydroxyamidino)piperidine 
(NHAP) (9), but Feldman detected piperidinecarboxamide (PCA) (10) while Fukoto 
found no trace of PCA but detected large quantities of 1 -piperidinecarbonitrile (PCN) 
(11) (Scheme 6).
OH
CN
(10)(9) (11)
Scheme 6
Ishikawa and co-workers examined the photo-sensitised oxygenation of 
phenethylguanidoxime (phenethylhydroxyguanidine) (12) as a possible chemical model 
for the biological oxidation of iV-hydroxyarginine (6) to L-citrulline (7) (Scheme 3).^  ^
The singlet oxygen (IO2) ene reaction is a powerful method for the allylic oxidation of 
alkenes. The authors thought that the oxime bond (C=N-OH) would act as the ene to 
give a nitrosohydroperoxide which is structurally related to the peroxyheme complex 
(Scheme 7).
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(13) (14)(12)
Scheme 7
A solution of (12) in ethyl acetate was irradiated with a high pressure mercury 
lamp (400W) for 1 hour through a pyrex filter, while 0% was bubbled through the 
solution under water-cooling with rose bengal (RB) as the sensitiser. The rose bengal 
was removed from the mixture with decolourising charcoal and the products obtained by 
preparative tic which gave the expected phenethylurea (13) and phenethylcyanamide
(14) in 58% and 4% isolated yields respectively. When reactions were repeated omitting 
one or more of the components there was no reaction. The use of tetraphenylpoiphine as 
a sensitiser led to a very similar product distribution. Thus the C=N-OH of the 
hydroxy guanidine appears to be cleaved by IO2 to yield the expected urea.
The formation of the cyanamide would also suggest a second possible mechanism 
in which the amidino (N=C-NH) bond could act as the ene. However the authors 
observed no reaction with phenethylguanidine (15) with IO2 . This suggests that the 
whole hydroxyguanidine function [RNHC(NH2)=NOH] and not the limited function of 
either the amidino or oxime bond is essential for the photooxidative production of the 
urea and the cyanamide.
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HN NH2
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(15)
It is, therefore, reasonable to assume that a guanidoxime (16) would be 
oxygenated to yield a urea (17) and cyanamide (18) (Scheme 8 ). In the 
photooxygenation the C- and N- hydroperoxides (19) and (20) play a crucial role 
because they can spontaneously degrade into (17) and (18) with the loss of NO or its 
equivalent. Compounds (19) and (20) could be formed either by direct reaction of the 
ene (16) with ^0% (Routes 1 or 2) or by hydrogen transfer triggered by ring opening of 
the perepoxide (21), derived from a 1,2-cycloaddition of IO2 to (16) (Route 3). The 
fact that more of (17) is produced compaied to (18) suggests that there is more of the 
intermediate (19) than (20). The reason (18) could be produced preferentially is the 
potential zwitterionic character of a guanadoxime (16a), with the more nucleophilic 
carbon of the C=N-OH being attacked by the electrophilic 0^ 2 . In the route through to 
the cycloadduct (21), the facile transfer of the more acidic hydrogen on the hydroxy 
group rather than that on the amino group could also lead predominantly to the formation 
of (19) (Route 4).
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R
IN
(18)
These reactions produce either nitric oxide or nitrous acid. However, under the 
reaction conditions these must be oxidised to NO2, which is easily hydrolysable to NO2" 
or NO3-. Therefore analysis of the products, using the Griess test and other methods, led 
to both N0 2 '  and NOg- being found."^  ^ These results mean that it is possible to consider 
the oxygenation reaction as one possible chemical model for the NOS-catalysed oxidation 
of NOHA to citmlline and nitric oxide.
The reaction between nitric oxide and A-hydroxyguanidine (22) under anaerobic 
conditions was e x a m i n e d . ' ^ 7
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NH2IN NH2
(22)
A-Hydroxyguanidine (22) in buffer (pH 7.4) reacted with 2 equivalents of nitric 
oxide (in the reaction headspace) to give N2O as the only detectable gaseous product. 
Control experiments lacking either 7/-hydroxyguanidine or nitric oxide failed to produce 
N 2O. These results suggest that although slow under anaerobic conditions, N- 
hydroxyguanidine (22) does reduce nitric oxide to N2O. Further analysis of the reaction 
mixture showed that less than 0.01 moles of N0 2 " were formed per mole of N2O. 
Experiments under aerobic conditions showed an increase in the rate of N2O production. 
The authors then ran similar tests under both anaerobic and aerobic conditions and again 
found that the rate of reduction of nitric oxide in the system containing oxygen was 
quicker. The reaction was repeated with phenethylhydroxyguanidine (12). Reduction 
of nitric oxide to N2O proved that the reaction was general for substituted 
hydroxy guanidines. The products of the reaction were phenethylurea (PEU) (13) and 
phenethylcyanamide (PECA) (14). A typical 24 hour run would yield PEU (13), 
PECA (14) and N2O in 42, 12, 60% yield respectively. It was also observed that PECA 
(14) is not a precursor to PEU (13) as PECA (14) is stable under aqueous conditions.
Nitrous oxide (N2O) can be formed from the dimerisation-dehydration of nitroxyl 
(HNO) (Equation 1) thus N2O detection can be used as an indication of nitroxyl 
generation.
2HNO  HON=NOH  N^O + HgO (1)
However mechanisms have been proposed without the intermediacy of 
n i t r o x y l .T h e  two products from the reaction, PECA (14) and PEU (13), have the
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same carbon oxidation state as the carbon in the TZ-hydroxyguanidine (22). This 
suggests that oxidation has occurred at the hydroxy-substituted nitrogen. The 
mechanisms given (Scheme 9) propose that nitric oxide is initially reduced by the N~ 
hydroxyguanidine (22) to give nitroxyl which can then dimerise and yield some N^O. 
Although not considered to be a good H-abstractor it has been shown that nitric oxide 
will abstract a hydrogen from hydroxylamine and alkyl hydroxylamines under basic 
conditions.
Mechanism A-B-C-D and A-B-C-E (Scheme 9) require the nitric oxide to act 
as a radical trap for nitroxyl to form the dimer intermediate and all the N2O which is 
produced to have come from dimerisation-dehydration of nitroxyl. Mechanisms F-G-H 
and F-I-J involve the H-abstraction step as the first step. Subsequent trapping of nitric 
oxide by the nitrogen centred species results in a A-nitroso compound which decomposes 
to give N2O directly. Depending on whether H-abstraction occurs from the oxygen or 
nitrogen the product is either the urea or cyanamide.
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The observed acceleration with O2 is likely to be greater than indicated as nitric 
oxide is unstable in the presence of O2. This means that the aerobic reaction contains less 
nitric oxide than the anaerobic reaction. The reason for O2 enhancement could be that H- 
abstraction by nitric oxide is slow (either A or B in Scheme 9) and the oxidation 
products from reaction of nitric oxide with O2 , e.g. ONOO* or NO2 are better H- 
abstractors or alternatively addition of O2 may lead to the production of N2O3 
(Equations 2-4) which may then act as the nitrosating agent (Equation 5) degrading 
via either D, H or J to give either the cyanamide or the urea.
NO + O2  ----------  ONOd (2)
ONOO + NO  ------► 2NOj (3)
NO2  + NO  ----------   N2 O3  (4)
N2O3 + RXH ^  RX-NO + NO2 + H+ (5) 
X=N. C or O
Although the mechanisms discussed are unproven they do give a reasonable 
explanation for the generation of other vasoactive species from the interaction of nitric 
oxide with iV-hydroxyguanidines. It has been shown that N-hydroxyguanidines can 
reduce nitric oxide to produce nitroxyl and/or an nitric oxide-adduct as the product. The 
phaiTnacological activity of the reaction products may be due to either nitric oxide directly 
or an nitric oxide releasing intermediate. The possible //-nitrosated species which result 
from the trapping of the nitric oxide by a nitrogen centred radical (Step G or I Scheme 
9) may lead to the re-release of nitric oxide since compounds with an analogous 
structure, //-nitrosoureas, release nitric oxide by thermal homolytic cleavage of the N-N 
bond.^® Thus the apparent lifetime of nitric oxide may be prolonged by temporary 
"sequestration" by the oxidised//-hydroxyguanidine intermediate. The biological activity 
associated with this reaction cannot be due to N2O as it has been shown that N2O has no 
vasorelaxing properties. All this indicates that nitric oxide is capable of acting as an
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oxidising agent for easily oxidised substrates that may result in the generation of other 
biologically active species with pharmacokinetic properties.
1.2.3 Inhibitors of NOS
Although the NOS enzymes have a very high degree of substrate specificity, they 
will also transform certain arginine derivatives that act as mechanism-based inhibitors, for 
example AT-methyl-L-arginine (NMA) (23). Feldman and co-workers reported work 
that established AH'-methyl-L-arginine (L-NMA) (23) as an irreversible inhibitor of 
murine macrophage nitric oxide synthase (mNOS) and recombinant constitutive brain 
nitric oxide synthase (bNOS).^l
They originally suggested that the first step of the biosynthesis was essentially the 
same as for arginine ie an //-hydroxylation occurs to give ATV-hydroxy-A/Y-methyl-L- 
arginine (24) (Scheme 10). This is then further oxidised to yield citmlline (7) and 
nitrosomethane radical (25). However the nitrosomethane radical was not observed.
OH
Me HN N—  Me
NHNH NH
MeNO
(25)
COOHCOOH COOH
(23) (24)
Scheme 10
The mechanism also fails to explain the observation that formaldehyde was 
formed when NMA was the substrate for N O S .52,53 n  was thus suggested that the first 
step of the process was a single electron oxidation to give a guanidinium radical
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(Scheme 11). It was then assumed that oxygen rebound and deprotonation of the 
latter, similar to that of NOS monooxygenation I, then occurs to give the AY-hydroxy- 
AH'-methyl-L-arginine (NHMA) (24) (Pathway A). Deprotonation and then the loss of 
formaldehyde would yield NOHA (6) which could then be oxidised to citmlline (7) and 
nitric oxide. A competing C-deprotonation (Pathway B) of the guanidinium radical 
followed by oxygen rebound could also occur. Here loss of formaldehyde from the 
intermediate would give the arginine, via a-amino radical and carbinolamine 
intermediates, which could then be oxidised to nitric oxide and citmlline (7) by the 
standard NOS pathway. Interestingly NHMA (24), arginine and formaldehyde have all 
been detected during the enzymatic reaction.
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Other NOS inhibitors synthesised to try and further probe the A^-dealkylation 
pathway and the mechanism of NOS inhibition include M-allyl-L-arginine (NALA) (26) 
and NY-cyclopropyl-L-arginine (NCPA) (27)54 These 2 examples were chosen for
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specific reasons. In the case of NALA (26) the hydrogen abstraction at the a-carbon 
should be promoted due to the ease of oxidation of an allylic methylene (Scheme 12). 
A single electron transfer from the guanidinium nitrogen in NCPA (27), should lead to a 
rapid rearrangement of the nitrogen centred radical to give a carbon radical which should 
irreversibly inhibit the enzyme (Scheme 12).
Enzyme-H
InactivationOH
(26)
Enzyme-e
Inactivation
(27)
HgN
Scheme 12
Further studies have shown that major loss of the heme chromophore 
accompanies enzyme inactivation.^^ There was not one major heme adduct that could be 
detected in these studies and it would seem that multiple modes of inactivation are 
possible. Radiolabelling indicates that a significant amount of NOS modification occurs 
when derivatives derived from A-methylguanidine, but lacking the amino acid side chain, 
are used. This is consistent with formation of the nitrosomethane radical cation.
Recent work by Cowart has concentrated on the synthesis of a number of 
phosphorus containing amino acid analogues as possible inh ib ito rs.T hey  have found
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that L-NMA (23) displays a low selectivity for inhibition of nNOS versus iNOS. This 
led them to synthesise analogues with an enhanced potency and selectivity for nNOS to 
allow them to probe the role of nNOS in CNS pathophysiology.
H2N,
O
.P ^O H
OH
HN/
RN NH2
(28a) R=H 
(28b) R=Me 
(28c) R=NOz
HgN,
OI I.P ^ O H
H
HN/
RN NHg
(29a) R=H 
(29b) R= Me 
(29c) R=N0 2
The ability of the phosphorus analogues to inhibit brain derived NOS (nNOS), or 
the inducible NOS from the macrophages (iNOS) was measured using the method of 
Bredt and Synden^? NOS activity was measured by the inhibition of the conversion of 
10 mM [^HJ-L-arginine to [^Hj-L-citrulline. The nNOS was obtained from rat brain 
cytosol and the iNOS from lipopolysacchaiide-induced RAW macrophage cytosol. The 3 
a-amino-E-guanidino phosphonic acids (28a-c) which contain phosphoms in oxidation 
state (v) were inactive against NOS at concentrations up to 100 mM. More success was 
obtained with the phosphonous acids (29a-c) where the phosphorus is in oxidation state 
(III). Two of the compounds (29b) and (29c) demonstrated inhibitory activity toward 
nNOS. This could be because at physiological pH the phosphonous acid contains one 
negative charge and exists as a zwitterion much like natural amino acid analogues where 
as the phosphonic acid has two negative charges at physiological pH.^^
More recently the synthesis of conformationally restricted L-arginine analogues
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(30) and (31) and the arginine based inhibitors NY-methyl-L-arginine (L-NMA) (23) 
and NY- iminomethyl-L-ornithine (L-NIO) (32) was r e p o r t e d . ^ ^
NH
R' NH
C^OgH
NHg
CO2H
(30a) R = NH2 
(30b) R= NHCH3 
(30c) R=CH3
(31a) R = NH2 
(31b) R = NHCH3 
(31c) R = CH3
CO2H
(23) R = NHCH3 
(32) R = CH3
Previously it has been reported that there is diversion in the active sites of the 
isoforms of NOS and that it should be possible to design selective inhibitors for the 
different isoforms.^® The series of conformationally restricted arginine based analogues 
(30a-c) and (31a-c) was synthesised and compared with the known inhibitors L-NMA 
(23) and L-NIO (32), which have already been shown to have no selectivity between 
the various isoforms.
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The inhibition was determined by monitoring the conversion of L-[l'^C]-arginine 
to L-[^‘^ C]-citrulline using the method described by McMillan and co-workers.^* The 
results of this testing are given below (Table 1). The compounds (30a-c) and (31a- 
c) were all prepared as racemic mixtures although previous work has shown that the L- 
enantiomer of both substrates and inhibitors is required for binding at the active site. 
This would suggest that the inhibitory potency of the inhibitors would be increased if the 
pure L-enantiomers were synthesised, although this assumes that the D-isomers lack any 
appreciable inhibitory properties.
Table 1;- Inhibition of Human NOS by Arginine Based Inhibitors and Conformationally Restricted analogues
Compound R
iNOS
dKi;(pM)i 
p eNOS nNOS
L-arginine NH2 2.202 0.902 1.602
L-NMA (23) NHCH3 0.86 0.40 0.84
L-NIO (32) CH3 0.34 0.81 0.23
30a NH2 2.60 0.25 0.37
30b NHCH3 0.60 0.27 0.41
30c CH3 1.90 1.60 1.30
31a NH2 100 46 44
31b NHCH3 96 8 . 8 8.4
31c CH3 82 39 29
NOTE:- (1) Inhibition constants were obtained by measuring percentage inhibition at a 
single time point with at least 3 concentrations of inhibitor. Values have a standard 
deviation of ^10%  (n=3). (2) Value represents Km for L-arginine in |liM  concentration 
units
Compound (30a) was found to be a potent NOS inhibitor and the observed 
binding affinity for the isoforms is similar to that for L-arginine and since the measured
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binding constant for L-arginine (6) is approximately the same as its Km value then the 
observed values for (30a) are directly comparable to those for L-arginine. Therefore by 
introducing a phenyl ring a maximum four-fold effect was seen on binding affinity. 
Compound (30b) inhibited all three isoforms of NOS comparable to L-NMA, and also 
inhibited NOS-mediated relaxation of rat aortic rings in whole tissue p r e p a r a t i o n s . ^ 2 , 6 3  
Both eNOS (IC5o=2.76 fxM) and iNOS (IC5o=4.46 |iiM) were inhibited in a dose- 
dependent manner which would suggest that the restriction of the L-arginine backbone 
chain with a phenyl group does not affect its transport into the cells. Compound (30c) 
also inhibited all 3 isoforms although with slightly less potency than the comparable 
arginine compound, L-NIO (32). The meta-substituted analogues were weaker NOS 
inhibitors although (31b) did show selectivity for both the constitutive isoforms (eNOS 
and nNOS). It is known that arginine binds in an orientation where the alkyl chain is 
folded in such a manner that allows spatial alignment of the amino acid and terminal 
guanidine moieties for potent binding.
1.3 P450 Oxidation
Work has shown that the P450 enzymes from rat liver would oxidise NOHA (6) 
to citmlline (7) and oxides of nitrogen including nitric o x i d e . I t  was also found that a 
range of other compounds that would produce oxides of nitrogen including alkyl- and 
aryl-aldoximes (33), ketoximes (34), amidoximes (35) and guanidoximes (36) 
(Figure 1). These compounds all contain the grouping C=N(OH). The results 
suggested that compounds containing a C=N(OH) could act as precursors of NO and be 
exogenous equivalents to NOHA (6) for nitric oxide formation. It was concluded that 
the P450-catalysed oxidative cleavage reaction to give oxides of nitrogen was general for 
any class of compound containing the C=N(OH) grouping.
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1.4 NO PRODUCING DRUGS
There have been many varied approaches to the design of NO delivery drugs, 
although much of the research so far has concentrated on their potential for antithrombotic 
applications. A fundamental problem is the inherent instability of compounds such as N- 
hydroxyguanidines for oral administration and therefore a range of compounds have been 
examined.
1.4.1 S-NITROSOTHIOLS
For a number of years there has been a search for alternatives to GTN (2) which 
is used in the treatment of diseases such as angina and other such cardiovascular 
conditions. Alternatives have included nitrates, notably isosorbide di- and tri-nitrates and 
alkyl nitrites. Further study examined 5'-nitrosothiols as alternatives. There have also 
been suggestions that this class of compound may be involved in the storage and 
transport of NO in vivo and this would make them ideal drug candidates.
5-Nitrosthiols can be synthesised by the electrophilic nitrosation of thiols 
(Equation 6 ) where XNO is a carrier of NO+ for example, H2NO2'*', CINQ, BrNO, 
N2O3, N2O4, RONO or R2NNO.65 If the thiol is water soluble then the simplest method 
is via the use of sodium nitrite in dilute aqueous acid. Non-aqueous soluble thiols can be 
treated with sodium nitrite in methanol/aqueous hydrochloric acid,^^ sodium nitrite in 
acetic acid,^^ or tert-hxxtyl nitrite in a number of organic solvents.^^»^^
RSH + XNO ----------------- RSNO + + X“ (6)
Until recently there were only a few examples of .S-nitrosothiols known due to 
their instability. The stable well characterised examples include S-nitroso-tert-hutyl thiol 
(37) and the corresponding triphenyl derivative (38). Recently the increased interest in 
these compounds has led to the synthesis of further stable examples including S-
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nitrosoglutathione (39), ^-nitrosoacetylpenicilamine (40), 5'-nitrosocaptopril (41), S- 
nitrosothioglucose (42).
CHg Ph
HgC- SNO Ph- SNO
CH3 Ph
5-nitroso-^er^-butyl thiol (37) 5-nitroso-triphenyl thiol (38)
SNO
HOgC :
o
^-nitrosoglutathione (39)
Me
SNO
COgH
5-nitrosocaptopril (41)
C^OgH
Me
Me
SNO
HOgC^ NHAc 
S-nitrosoacetylpenicilamine (40)
CHgOAc
SNO
OAc
OAc
5 -nitrosothioglucose (42)
It has been shown that S-nitrosoglutathione (39) (GSNO) releases nitric oxide 
when irradiated at either 340 or 545 nm and that the cytotoxic effect of GSNO (39) on 
leukaemia cells is enhanced upon r a d i a t i o n . ^ o  This could mean that GSNO (39) and 
other nitrosothiols might be useful as photochemotherapeutic agents.
Biologically the properties of nitrosothiols are more significant. It has been 
shown that many effect vasodilatation and also inhibit platelet aggregation, giving them 
the same properties as nitric oxide itself. The most interesting question is whether nitric 
oxide formation from the nitrosothiols accounts for their biological properties. Under 
biological conditions GSNO (39), 5-nitrosoacetylpenicilamine (SNAP) (40), S-
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nitrosothioglucose (42) and 5-nitrosocaptopril (41) have been shown to have 
biologically important p r o p e r t i e s 7^72 has been shown that nitrosothiols release nitric
oxide at pH 7.4 in the presence of ions, however it has been shown that the actual
active species involved in the breakdown of the nitrosothiols to nitric oxide is Cu+.9 
There is still debate as to whether the complete breakdown of the nitrosothiol is required 
to give the nitric oxide. Due to the similarities in properties between nitrosothiols and 
nitric oxide it could be suggested that this is the case. It has been shown that for S- 
nitrosocysteine (43) the formation of cyclic GMP (a precursor for vasodilation) is 
inhibited by the presence of a Cu+ chelator, bathocuprione sulfonate.^^ This suggests 
that nitric oxide formation is essential for the biological properties of these compounds. 
However another group has shown that bronochodilation in guinea pigs is brought about 
by intact GSNO (39) and not by the formation of nitric oxide. This is because the effects 
were not inhibited by haemoglobin which traps nitric o x i d e .  74 This fundamental question 
clearly needs to be resolved.
Nitrosothiols may play an important role in the in vivo storage of nitric oxide. 
The rapid nitric oxide group exchange may be important given the wide reactivity range 
of RSNO compounds towards nitric oxide release. For example stable GSNO (39) is 
readily converted to a more reactive 5-nitrosocysteine (43) by the presence of cysteine.
However these compounds do work in vivo and there is no doubting that their 
biological properties may give them widespread clinical uses in years to come. It has 
been shown, in preclinical trials, that GSNO (39) is very good at inhibiting platelet 
aggregation following coronary angioplasty,^^ and also in the treatment of preeclampsia, 
a high blood pressure condition that affects pregnant w o m e n . T h e  potential of S- 
nitrosoglucose (42) and related compounds in the treatment of a number of diseases has 
also been studied. Glyco-S'-nitrosothiols also outperform SNAP (35) in aqueous 
solubility and stability, with and without EDTA and in the presence or absence of 
Cu2+77
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1.4.2 NITRITE ESTERS
Thatcher and co-workers have synthesised four novel sulfur containing nitrate 
esters in which the sulfur is p to the nitrite ester (44-46).^^
■ONO2
■ONO2
(44)
■ONO2
■ONO2
(46)
■ SO3 Na
■ONO2
■ONO2
(45)
O2NO
(47)
O
The compounds are designed to be vasodilators or function as NO prodrugs 
based upon the action of GTN (2). Three out of the four compounds, the two 
mononitrites (46,47) and the dinitrate (45) were shown to activate GCase at a higher 
level than GTN which is used in the treatment of angina pectoris. These preliminary 
results on the activation of soluble guanlyte cyclase and relaxation of smooth muscle 
suggests that these compounds may be a new class of nitrate esters with potential 
therapeutic significance.
1.4.3 NITROLIC ACIDS
Rehse and co-workers investigated the antithrombotic and vasodilatory activities 
of five nitrolic acids (48-52).'79
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N  O H  N -------O H  N -------O H
C H g  ^  CH3CH2 ---------- ^  H0 0 C (C H 2 ) 4 ----------^
NO2 NO2 NO2
(48)
H 0 H N -0 C -(C H 2 )4
(51)
(49)
N  O H
NO2
CHr
(52)
(50)
N  O-fo  N
OpN
•COOC2H5
■CHr
These compounds were shown to release nitroxyl (HNO), which in turn breaks 
down to form nitric oxide. They are activated by the electron withdrawing nitro group 
and HNO was found to be released from both the hydroxyimino and nitro group. 
Inhibition of thrombus formation in rats was found to be 69% and 46% in arterioles and 
venules respectively after oral administration. Only a 10% drop in blood pressure was 
observed in these experiments, indicating that antithrombotic and vasodilatory effects can 
be dissociated, which is an important consideration in the design of nitric oxide donor 
drugs.
1.4.4 1,3,4-TR IA ZO L-l-O LES, OXATRIAZOLES AND 
NITROSOHYDRAZINES
Investigation of 1,3,4-triazol-l-oles, oxatriazoles and nitrosohydrazines was 
based on the success of the nitrolic acids as nitric oxide donors. It was believed that the 
use of alternative electron withdrawing groups to the nitro group may also yield valuable 
results.
Five 1,3,4-triazol-1 -oles were synthesised and screened for their antithrombotic
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properties.80 The screening was perfoimed on rats and resulted in a small but significant 
drop in blood pressure, indicating that an intermediate capable of giving rise to nitric 
oxide was produced in significant quantity. Although the evidence was strong it was not 
entirely conclusive. The compounds were administered orally and so their 
pharmacokinetic viability was also determined. One compound (53) was found to have 
significant activity relative to the others tested. This activity may be due to its small size 
and lipophilicity.
O H  
NC H 3 CHg
N  N
(53)
The related mesoionic oxatriazoles and noncyclic nitrosohydrazine derivatives 
have also been found to inhibit thrombus formation.^ ^  These compounds are also 
thought to act by the evolution of nitric oxide. The ring opening reaction of the 
oxatriazolimine (54) exposes the nitrosohydrazine structure (55) which is thought to be 
responsible for nitric oxide production. Molsidonine (56), another nitric oxide donor 
drug, produces a similar intermediate (57) following enzymatic hydrolysis (Scheme 
13). A series of acyclic nitrosohydrazines (58) were also studied. Active compounds 
were identified from both the oxatriazolimines and nitrosohydrazines. There were 
marked differences between the in vitro and in vivo results, which strongly suggested 
an enzyme mediated pathway and the importance of absorbability and stability of the dmg 
in the gastrointestinal tract.
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1.4.5 NI TROS OS YN DNONE -5 - IMI NES  AND THIAZOLE-2-  
NITROSIMINES
Extensive studies have been carried out on the use of nitrosimines as potential NO 
donor dmgs.^^ Initial studies concentrated on the chemical reactivity of these compounds 
to gain an insight into their pharmacological properties.
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O
Both nitrososydnone-5-imines (59) and thiazole-2-nitrosimines (60) undergo a 
photolytic cleavage of the C=N-NO bond.^^ This reaction gives rise to the NO radical 
which is believed to be responsible for many physiological processes. In this study nitric 
oxide production was found to be dependent on the solvent. The nitrososydnoimines 
(61) were found to decompose photolytically in water to give exclusively the syndone 
imine (62) and nitric oxide. The reaction rate was enhanced when the reaction was 
performed under nitrogen instead of air. In methanol, however, formation of both 
compound (62) and the syndone compound (63) occurred giving rise to nitric oxide and 
nitrogen respectively (Scheme 14).
H2O MeOjI
CH; CH.CM;(62) (61) (63)
Scheme 14
Similar solvent effects were observed in the decomposition of thiazole-2- 
nitrosimines (60). This illustrates the complex nature of these compounds and suggests 
that when designing drugs, great care must be taken to determine which reactions occur 
in vivo and to what extent and to assess the biological impact of the by-products.
This work was followed up by screening 24 thiazole-2-nitrosimines, in both cell 
free and in vivo systems, for antithrombotic properties.^ ^  Inhibition of platelet 
aggregation was assessed using the Born-tost (inhibition of collagen induced platelet 
aggregation in human plasma). All the compounds that were tested by in vitro methods.
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where cleavage of the C=N-NO bond was achieved by visible light, exhibited some 
inhibition properties. The variation observed was approximately within one order of 
magnitude. There was, however, no observable logical relationship between the nature 
and position of the substituents and the activity observed. Further complications 
occurred when the three most potent compounds were tested in vivo. This was done by 
testing their inhibition of laser induced thrombus formation in rats. Out of the 
compounds tested one showed no activity at all (64), and the other two compounds 
(65,66) were equipotent in vivo despite showing a considerable disparity in their in 
vitro rates with (65) showing a rate much lower than that of (66).
CH.
(65) (66)
These results are not entirely surprising considering that the mechanisms are 
vastly different between in vivo and in vitro testing. The enzymatic interactions 
involved in the in vivo pathways are likely to mean that the process is more selective than 
the in vitro process. This illustrates that sometimes simplified models of biological 
systems are not accurate.
The potential of thiadiazole nitrosimines (67) was also investigated.^'^ These 
compounds, however, showed poor activity due to their chemical stability.
N N
Ri
(67)
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1.4.6 FK  409
Recent work has been done by Fontecave and co-workers involving FK 409 
(6 8 ). FK 409 (68) was isolated from the fermentation broth of Streptomyces 
griseporeus as a semifermentation product. They showed that FK 409 (68 ) rapidly 
decomposes in aqueous alkaline solution at 37 °C releasing nitric oxide but is unaffected 
in acid solution (pH 2.0, k = 9.28 x 10"  ^ min'^; pH 8.0, k = 2.93 x 10'^ min'l).^^’^  ^
Measurement of the of release of nitric oxide was carried out using various methods 
including chemiluminescence analysis, ESR spectroscopy (using carboxy-PTIO) and 
nitrite analysis using the Griess test.*^  ^ The rate of spontaneous nitric oxide release was 
approximately parallel with that of the decomposition in aqueous solution.
HO,\ N
NOg O
(6 8 )
This compound has a potent pharmacological action, which has been attributed to 
the increase in concentration of intracellular cGMP levels. Although there are several 
reports about the pharmacological actions of FK 409 (68), the mechanism of nitric oxide 
release has not yet been elucidated. Fontecave proposed that the FK 409 may decompose 
into (69) and nitric oxide although the mechanism of formation is unclear (Scheme 
15).
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HO,
NH.NH, NO
NO; (69)
Scheme 15
1.5 iV-HYDROXYGUANIDINES AND RELATED DERIVATIVES
As reported previously V-hydroxyguanidines (36) have been shown to release 
nitric oxide following the action of P450 enzymes and for this reason have become a 
focus of work in the area of nitric oxide donor drugs. There are, however, a number of 
other applications of these compounds (Section 2.7.2)
1.5.1 Nitric Oxide Donating Properties
Recent work at St Andrews investigated the use of V-hydroxyguanidines as nitric 
oxide donor drugs.^7 It was found that they were difficult to synthesise without 
contamination from the corresponding urea and that subsequent separation from the urea 
was difficult. 1,1 -Dibenzyl-2-hydroxy guanidine (70) was the only hydroxy guanidine 
obtained in a microanalytically pure form. The urea by-product appears to be formed via 
the unstable aminooxyformamidine (71) or by hydrolysis of the cyanamide intermediate.
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N OH \  O------NH2
More success was achieved when the compounds were made via the thiourea 
derivatives, in particular aminoiminomethanesulfonic acids. The compounds that were 
produced, although still contaminated with the corresponding urea were purer. It was 
shown that hydroxyamidines (35) were easier to synthesise and handle and were 
structurally quite close to hydroxy guanidines.
(35)
Both hydroxyguanidines (36) and hydroxyamidines (35) are physiologically 
active as vasodilators and have also been shown to produce nitric oxide under 
physiological conditions. The hydroxyguanidines (36) were found to be active at lower 
concentrations and they also reached a maximum activity over a smaller concentration 
range. The hydroxyamidines (35) were found to be less active than hydroxyguanidines 
and had a wider activity range. However the concentrations at which they relaxed the 
artery was not determined as using these compounds at the high concentrations required 
may have damaged the artery.
There have been a number of potential vasoactive compounds designed around 
the N-hydroxyguanidine template. The use of 3-amino-l,2,4-oxadiazol-5-ones (72) as 
possible //-hydroxyguanidine prodrugs has been reported.^8 These cyclic compounds 
undergo hydrolysis in vivo to yield the free N-hydroxyguanidine derivative (73) which
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in turn lose carbon dioxide to yield the free A/'-hydroxyguanidine (36) (Scheme 16). 
This free AT-hydroxyguanidine (36) can then undergo reaction with NOS or P450 
enzymes to yield nitric oxide. Biological testing has shown that these compounds have 
significant antithrombotic activity.
OH
NON
(73)(72)
NON NOS-CO NOor P450
NH2
(36)
Scheme 16
The authors submitted compounds (72a-s) (Table 2) to an in vivo thrombosis 
model.
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TABLE 2;- Antithrombotic effects of type 72 l,2,4-oxadiazol-5-ones or acetylsalicylic 
acid (ASA). 2h after p.o administration of 60 mg/kg to rats.Statistics; Man-Whitney U-Test: n.s = not significant
Compound R Inhibition of thror 
arterioles % ± s (p2)
abus formation in 
venules % ± s (p2)
72a Methyl 6 ± 3  (0.01) 6 ± 3 (0.05)
72b n-butyl 10 ± 2  (0 .002) 5 ± 3  (0.02)
72c n-pentyl 15 ± 2  (0.002) 15 ± 4  (0,002)
72d M-hexyl 13 ± 2 (0.002) 7 ± 4 (0.02)
72e «-octyl 5 ± 4  (0.05) n.s
72f benzyl 17 ± 3 (0.002) 12 ± 2 (0 .002)
72g cyclohexylmethyl 6  ± 3 (0.01) 6 ± 3 (0.05)
72b 4-chlorobenzyl 8 ± 2  (0 .01) 4 ± 2  (0.1)
72i 4-nitrobenzyl 8 ± 2  (0 .01) 7 ± 2  (0.002)
72j 2-phenethyl 16 ± 2 (0 .002) 12 ± 3  (0.002)
72k 3-phenylpropyl 17 ± 3  (0.002) 17 ± 5  (0.002)
721 3-cyclohexylpropyl n.s n.s
72m a 11 ±4(0.01) 11 ± 3 (0.002)
72n 1-napthylmethyl 9 ± 2 (0.002) 4 ± 2 (0.02)
72o cinnamyl 6 ± 2 (0 .01) 7 ± 3  (0.1)
72p b 13 ± 2  (0.002) 9 ± 3 (0.002)
72q 3-aminopropyl 8 ± 2 (0 .01) 7 ± 3  (0.01)
72r c n.s n.s
72s 1,6-hexane-bis 5 ± 2 (0.05) n.s
a = 3-phthalimidylpropyl: b = 5-ethoxycarbonylbutyl: 
c = (CH2)3-CH(NHAc)-COOCH3
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The results for 72c and 72d reflect their affinity for cell membranes and their 
possible penetration into the cells where the expected metabolism could occur. The 
authors have shown in previous studies that aryl alkyl substituents exhibit 
"membranetropic” properties.^® To test this theory in this case they synthesised 72f, h, 
i, j, k, m, n and o. The maximum effects were found for the compounds with simple 
aromatic groups attached i.e. 72f, j and k. The derivative 72c was prepared as a N- 
hydroxyguanidine analogue, however no significant activity was observed. The 
introduction of the ethoxycarbonyl group 72p was reasonably well tolerated and a 
significant activity was observed. However introduction of a basic group at a similar 
distance from the oxadiazolone decreased the thrombotic activity. Consequently 72r was 
synthesised, which contained an acylamine group, as a prodrug for N-hydroxyguanidine 
but this compound showed no antithrombotic activity.
Also, when the aromatic ring was substituted as in compounds 72h and i the 
antithrombotic activity was reduced. The same was true for complete hydrogenation of 
the aromatic ring to give the corresponding cyclohexyl derivatives 72g and 1.
1.5.2 Other Medicinal Applications
It was reported by Cherkofsky that certain mono and disubstituted 
hydroxyguanidines are useful as metal chelating agents and as anti depressants.^^ The 
author described two different series of compounds and their uses. The first series (74) 
are useful as metal chelating agents (Figure 2).
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N OH
R2■ \
Ri
N' N — R3
Where =
(74)
OR
Xm Xk
(a) (b)
X = F, Cl, Br, CF3, NO2, Ci-Cg alkyl, alkoxy, Ci-Cg alkylthio 
or Cj-Cg diaikylamino
m = 1 to 3
k = 0 to 3 with the proviso that no more than one NO2 grp is present
Figure 2
The second series of compounds (75) are useful as metal chelating agents and as 
antidepressants in the central nervous system of warm blooded animals (Figure 3).
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R2■ \
Ri/
N"
N OH
R3
Where =
(75)
OR
y
Xm Xk
(a) (b)
OR OR
Yp Yp
(c) (d)
X = F, Cl, Br, CF3, NO2. Ci-Cg alkyl, CpC^ alkoxy, Ci-Cg 
alkylthio or CpCg diaikylamino
Z =  F, Cl, Br, CF3, NO2, CpCg alkyl, C^Cg alkoxy, C^-Cg 
alkylthio or C^-Cg diaikylamino
k = 0 to 3 with the proviso that there are no more than 1 NO2 
Y = F, Cl, Br or C^-Cg alkyl 
p = 0 to 3
Figure 3
Recently the synthesis of a series of sulfonylW-hydroxyguanidines (76) as 
potential antitumour agents was reported.
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(76)
The compounds were designed and synthesised on the basis of the lead 
compound LY-181984 (77) which is a sulfonylurea and constitutes an important class of 
therapeutic agents in medicinal chemistry. LY-181984 and its related compound LY- 
186641 (78) have shown a wide range of activity in several solid tumour models and 
LY-186641 is in extensive clinical trials based on its pre-clinical activity and lack of 
toxicity to proliferating normal tissues.^^ 94 These compounds were discovered by 
utilising in vivo tumour screening models to overcome the poor correlation between 
cytotoxity and antitumour activity. It has been shown that the sulfonylureas accumulate 
in the cell mitochondria suggesting that it might be the target sight for the antitumour 
activity. The problem however with these compounds is that they are susceptible to 
hydrolysis under physiological conditions.
(77) R= H3 C- \  /
LY-181984
(78) R =
LY - 186641
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Recently Chern and co-workers reported that 2,10-dihydro-10-hydroxy-3//- 
imidazo[l,2-b][l,2,4]benzothiadiazine 6 ,6 -dioxide (79), which contains a built-in 
sulfonylhydroxyguanidine functionality, showed activity against several tumour lines 
The hydroxyguanidine functional group combines the imino group of guanidine with the 
hydroxylamino group of hydroxyurea which has been reported to exhibit potent antiviral 
and anticancer activity by inhibition of ribonucleotide reductase.
Although all the sulfonyl-N-hydroxyguanidines (76) tested showed an equal or 
greater cytotoxic activity when compared to LY-181984 (77), A-(4-chlorophenyl)-A’- 
[3,5-dichloro-4-(4-nitro-phenoxy)phenyl]sulfonyl-A” -hydroxyguanidine (80) and N- 
(4-chlorophenyl)-iV’-[[3,5-dichloro-4-(2-chloro-4-nitrophenoxy)phenyl]sulfonyl]-A^” - 
hydroxyguanidine (81) were particularly promising.
NHOH
/
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One compound (81) gave enhanced activity against COLO 205, KB and TSGH 
8302 and was therefore examined against solid tumour lines in a murine K-1735/M2 
melanoma xenograft model along with LY-181984. The tumour growth inhibition was 
64.7 and 70.7 % for LY-181984 and (8 1 )  respectively 20 days after tumour 
transplantation, in addition to this it seemed that (81) was less toxic. As yet the 
pharmocological mechanism has been determined.
Jadhav and co-workers recently reported the synthesis of a 7-membered cyclic 
hydroxyguanidine (82) as possible HIV protease inhibitor.
N
OH
PhPh
Ph.
HO OH
( 8 2 )
The compound was synthesised and then tested as an inhibitor and found to have an 
inhibition constant of 42 nM for HIV Protease. This value is about 10-fold higher than 
for the corresponding cyclic urea and could be further optimised by the variation of the 
substituents.
Recent work by a number of groups has shown that the parent hydroxyguanidine 
(HOG) (22) exhibits cytotoxicity in human leukaemia cell line^^ and antitumour activity 
in vivo against a variety of experimental murine tumours via an unknown mechanism.^^
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The cytostatic effects of hydroxyguanidine (22) on cell growth do correlate with 
a key enzyme in DNA biosynthesis, ribonucleotide reductase, via a different mechanism 
to structurally similar compounds, for example h y d r o x y u r e a ,  Nitric oxide can also 
induce cytostasis in macrophages by scavenging the tyrosyl radical of ribonucleotide 
reductase and thus causing oxidative damage which may be responsible for necrotic 
and apoptotic cell death. 102 Everett and co-workers proposed that the elimination of 
nitric oxide from HOG represents a possible mechanistic basis for both the cytotoxic and 
cytostatic effects of HOG that have both been observed in vitro and in v/vo.l03 This 
means that oxidative denitrification of HOG must be possible via NOS-independent 
pathways since cytotoxicity and cytostasis have both been observed in leukaemia cells 
which lack both isoforms of NOS. The authors probed the release of nitric oxide from 
HOG and found that a one electron oxidation causes a fast and efficient denitrification of 
HOG and release of NO. It was also found that oxygen participated in the reaction 
mechanism. It did not prevent elimination of NO but it may have, promoted the 
formation of more damaging nitrogen oxides, for example ONOO', which may account 
for the aerobic toxicity. Clearly an enzyme that could perform a one-electron oxidation of 
HOG could produce NO. It has been shown, for example, that peroxidases catalyse the 
oxidative denitrification of HOG.^^ HOG induces cytostasis and apopotsis in tumour 
cells, which are devoid of NOS, via mechanisms that involve the oxidative release of 
NO. 104 The investigation of the oxidative denitrification of HOG has provided a 
mechanistic basis for the HOG-induced NO production in vitro and supports the notion 
that A-hydroxyguanidines (36) may be a potential controllable NO source.
Recent work has shown that mono substituted A-hydroxyguanidines (83) can be
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converted to zwitterionic diazeniumdiolates (84) which hydrolytically dissociate at 
physiological pH to give both nitric oxide and nitrous o x i d e .  0^5 y t i e  diazeniumdiolates 
are produced from the corresponding N-hydroxyguanidine (83) using either NO/O2 or 
acetic acid/sodium nitrite (Scheme 17).
H2N NO/ONOH
Or AcOH/NaNO RHNRHN (84)(83)
Scheme 17
The authors became interested in these compounds after it had been recently 
reported that the formation of a 'potential intercellular nitric oxide carrier' occured when 
NY-hydroxy-L-arginine was exposed to aerobic nitric oxide s o l u t i o n s . ^ 0 6  The 
intermediate was UV-active and longer lived as a vasodilator than nitric oxide itself. At 
pH 7.4 the p-methoxybenzyl diazeniumdiolate (85) derivative decomposes to give N-(p- 
methoxybenzyl)urea (8 6 ) and a small amount of //-(p-methoxybenzyl)cyanamide (87) 
and 0.5 moles of nitrous oxide were produced along with 0.3 moles of nitric oxide per 
mole of (85) dissociated (Scheme 18). The diazeniumdiolate also has a ultraviolet 
maxima at 320 nm.
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H2N 10 mM Phosphate buffer
p H  7.4 RHNRHN
(87)(86)(85)
+ NO + N2O
Scheme 18
The authors data suggested that if NT-hydroxy-L-arginine (6) could encounter 
suitable nitrosating conditions in vivo the corresponding diazeniumdiolate (88) would 
constitute a naturally occurring spontaneous nitric oxide donor. Two natural products, 
which contain a diazeniumdiolate functionality, dopastin and alanosine, release nitric 
oxide only when exposed to a one electron o x i d a t i o n . 08 A i g g  the nitric oxide 
generating properties of these compounds may give them potential as prodrugs in the 
treatment of clinical disorders where there is a deficiency of biosynthetic NO.^09
N = 0
(88 )
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Chapter 2
Synthesis and Properties of N-Hydroxyguanidines
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2.1 AIMS
The introduction has given a review of the biological importance of nitric oxide 
and the possibilities in this area of research. This project is concerned with the synthesis 
of a number of O-substituted A^-hydroxyguanidines (89).
(89)
The major challenge in using nitric oxide delivery drugs as therapeutic agents is 
selectively directing the drug and thus the nitric oxide to the required site of action. This 
is especially important because of the variety of biological roles played by nitric oxide.
A/-Hydroxyguanidines can act as a convenient source of nitric oxide because the 
action of non-specific oxidases e.g. P450 will release nitric oxide.^*  ^ It is also possible 
that nitric oxide synthase (NOS) could act upon these compounds and release nitric 
oxide. It should then be possible to introduce selectivity by chemically blocking the 
hydroxyl group of these compounds which means that nitric oxide release can only occur 
after this group has been removed either by an enzyme or by physiological action. Thus 
careful manipulation of this group might lead to a nitric oxide prodmg.
In order to study these compounds the free N-hydroxyguanidines first need to be 
synthesised and tested to ensure that they are indeed nitric oxide donors.
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2 . 2  LITERATURE SYNTHESIS
N-Hydroxyguanidines are inherently unstable and there are very few reported 
literature syntheses of these compounds.
2.2.1 Synthesis Via Cyanamides
Braun and co-workers in 1903 and then subsequently Belzecki in 1976 reported 
the synthesis of V,V-disubstituted hydroxyguanidines (90) from the corresponding 
amine via the intermediate cyanamide (91) (Scheme 19).n®dll
R R R N— OH
\ h  + BrCN \ -----C = N  ....^/  NaOAc /  Dioxan /  \
R‘ R' R' NH2(91) (90)
Scheme 19
Reaction of the amine with cyanogen bromide and sodium acetate in methanol 
gave the disubstituted cyanamide (91). Subsequent reaction with free hydroxylamine in 
dioxan, under dry conditions, then afforded the substituted V,A/’-disubstituted 
hydroxyguanidines (90) in reasonable yields after recrystallisation. Belzecki found that 
dependent on the solvent either the V,A/’-disubstituted hydroxyguanidines (90) or the 
corresponding urea (92) was formed. The urea (92) is formed via the corresponding 
aminooxyformamidine (93) which results from attack of the hydroxylamine oxygen, 
rather than the nitrogen, on the cyanamide (91) (Scheme 20). Alternatively the urea 
can be formed by reaction of the cyanamide with any water present in the reaction. It 
appeared that urea was the major product when the reaction was carried out in a proton 
donating solvent such as ethanol.
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NHgNH
(93)(91)
Scheme 20
A range of examples including a diphenyl derivative (94) and the cyclic 
piperidine (95) and morpholine (96) derivatives were prepared by this route.
N OH
N  OH
v /
N OH
A similar method was also used by Cherkofsky who synthesised a range of mono 
and disubstituted hydroxyguanidines for the treatment of depression.^bH 2 A range of 
cyanamides were synthesised and then used to prepare the corresponding 
hydroxyguanidines (Figure 4, 97-100).
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OHN  OH
NH2
CHg
(98) R = Cl, NO2(97) R = CH3O, F, Br, NO2, CH3, Cl
OHOH
NHg
(99) R = CH3 , CH3 O, Cl (100) R = cyclopentyl or cyclohexyl
Rl = CH3 or CH2CH3
Figure 4
The A^-hydroxyguanidines (97-100) were synthesised in one of two ways. The 
first method involved stirring the disubstituted cyanamide (91) in methanol with either 
one equivalent of hydroxylamine hydrochloride or a slight excess followed by addition of 
potassium hydroxide. The reaction was heated under reflux for two hours. Work up of 
the reaction mixture yielded the desired product as either the free hydroxyguanidine or as 
the hydrochloride salt. The authors found for some of the cyanamides that the use of 
methanol yielded a high proportion of the isomeric aminooxyformamidine (93) and thus 
the urea (92). This problem was overcome by using dioxan as the solvent. The second 
method used involved reacting the cyanamide (91) with an equimolar equivalent of 
hydroxylamine hydrochloride in refluxing methanol with a catalytic amount of potassium 
hydroxide. After work up and recrystallisation the hydroxyguanidines were obtained as 
their hydrochloride salts.
The use of 3-am ino-l,2,4-oxadiazol-5-ones (72) as possible N- 
hydroxyguanidine prodrugs has been reported.88 These compounds were synthesised
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from cyanamide (101) by firstly reacting with ethyl chloroformate to give the N- 
cyanourethane (102) (Scheme 21). The crude A^-cyanourethane (102) was then 
reacted with suitable alkyl bromides to give a variety of iV-alkylated products (103). 
Addition of hydroxylamine to this A-alkylated cyanourethane gave the hydroxyguanidine
(104) which cyclised in polar solvents to give the oxadiazolone (72). The
hydroxyguanidine (104) derivative was thought to be too unstable to be isolated so there 
was no attempt to do so. The oxadiazolones were obtained in yields of up to 86 %.
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CN CN
(101) (102)
RBr
NOH
CN
NH
(103)(104)
NH
(72)
Scheme 21
A range of derivatives were synthesised although the limitation was the 
availability of the starting bromide. The examples that were synthesised and tested for 
antithrombotic activity are given in Table 2 (Section 1.5.1).
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2.2.2 Synthesis Via Thioureas
Feldman reported the synthesis of V®-hydroxy-L-arginine (6), the intemiediate 
in the oxidation of L-arginine (5) to citrulline (7) and nitric oxide, and its labelled 
analogues (105) (106) from an enantiomerically pure starting material, L-ornithine via 
the intermediate thiourea (Scheme 22). The labelled compounds were prepared so that 
they could then be used in the elucidation of the mechanism of NOS, the enzyme that 
converts L-arginine (5) into citrulline (7) and nitric oxide (Scheme 3).^ ^^
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Cbz.
NHc(107)
'’NOH
HpN^A
OH a,b,c
(6); a=b=14
(105); a=14, b=15
(106); a=15, b=14
OH
NH.
HpN OBu'
NHBoc
(108)
HgN N H
Me,\
BocHN N
NOH
BocHNX
d,e
OBu'
NHBoc(109)
f,g
OBu'
NHBoc
(110)
h.i
OBu'
NHBoc
(111)
Reagents and conditions
a) (B0 C)2 0 , dioxan, sat NaHCOg, 23 °C, 24hi-; b)0-tert-butyl-iV,A^-diisopropylisourea; c) H2 ,
Pd on C, MeOH; d) thiophosgene, CaCOs, H2 O, CHCI3 , 23 °C e) NH3 , MeOH, 0 °C; f) Mel, CH3 CN, 
23 °C, 16h; g) (B0 C)2 0 , dioxan, sat. NaHC0 3 , 23°C ; h) (9-benzylhydroxylamine, TEA, AgN0 3 , 
CH3 CN, 0 °C, 2h i) 10% Pd-C (20 wt %), MeOH, H2  (latm), 30mins; j) HCl/ dioxan,
23 °C, 20h
Scheme 22
The synthesis started with the conversion of (107) into the fully protected L- 
ornithine derivative (108) in 3 steps, using modified literature procedures. 114 The acid
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was esterified using 0-?-butyldiisopropylisourea and the CBZ group removed by 
hydrogenation. Addition of (108) in CHCI3 to a suspension of thiophosgene in 
aqueous CaCOg rapidly afforded the isothiocyanate which was dissolved in methanol and 
treated with excess aqueous ammonia to give the thiourea (109). The thiourea, (109), 
was then activated by méthylation with methyl iodide. Subsequent BOC protection of the 
free amine of the thiourea was achieved under the same conditions as an earlier step to 
give the protected ^-alkylated compound (110). Reaction of (110) with O- 
benzylhydroxylamine and triethylamine (TEA) in the presence of AgNOg displaced the
activated sulfur and yielded the (9-benzyl substituted A-hydroxyarginine (111). The 
benzyl group was then removed by hydrogenation using 10% Pd-C as the catalyst. 
Removal of the BOC groups and hydrolysis of the r-butyl ester was achieved in one step 
using HCi/ dioxan at room temperature. The analytically pure L-A-hydroxyarginine 
compound precipitated out of solution. The labelled compounds were prepared in an 
identical manner using labelled precursors.
Recently the synthesis of a series of sulfonyl-A-hydroxyguanidines (76) as 
potential anti tumour agents was reported.^^ The compounds were synthesised from 
sulfonyl chloride (112) which was reacted with liquid ammonia to give the sulfonamide 
derivative (113). Reaction of this compound with the required isothiocyanate gave the 
thiourea (114) (Scheme 23). Sulfonylthioureas are easily attacked by nucleophiles 
and the thioureas were therefore not isolated but were treated in situ with methyl iodide to 
give the psuedothiourea derivative (115). Reaction of the psuedothiourea (115) with 
hydroxylamine hydrochloride yielded the target compounds (76) and the guanidine by­
product (116). Due to the closeness of the two products by tic, intensive column 
chromatography was required to separate them, thus explaining the low yield of the target 
compounds.
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R '' ^Cl 
(112)
R-" NH2 
(113) (114) \  /
R" NH
(76)
_  NH
V XR NH NH
(116) \  /
SCH3 
R^ '" N ^ ^ ^ N H
(115)
V /
a) Liquid NH3 , DCM, -78 °C, 10 min: b) (i) IN NaOH, isothiocyanate, acetone, RT, 4-12 hr 
(ii) IN NaOAc: c) (i) IN NaOH, Mel, acetone, RT, 30 min (ii) IN NaOAc: d) NH2 OH.HCI 
EtgN, CH3 CN, 80 - 90 °C, 10 - 20 hr or DMF, rt, 2 - 3 hr
Scheme 23
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2.3 SYNTHESIS OF CYANAMIDES
For the synthesis of the free A-hydroxyguanidines it was decided to use the 
cyan amide synthetic route as employed by Belzecki.m Therefore it was first necessary 
to prepare the cyanamide starting materials. This was accomplished by reaction of the 
appropriate amine with cyanogen bromide. Nucleophilic attack of the amine nitrogen on 
the cyanide carbon occurs, eliminating bromide ion. The identity of the product 
cyanamide is then readily confirmed by its characteristic spectroscopic data. In the i.r. 
spectrum there is a strong stretch at approximately 2200 cm'^ which is due to the carbon 
nitrogen triple bond stretch. In the NMR spectrum the cyanamide carbon gives a 
characteristic resonance at 115-120 ppm. The work concentrated on disubstituted 
derivatives because it has been previously shown that the monosubstituted derivatives are 
more unstable.
2.3.1. Alkyl Disubstituted Cyanamides
The synthesis was carried out by stirring the amine in methanol at 0 °C and 
adding sodium acetate. A solution of cyanogen bromide was then added dropwise to the 
suspension and the reaction stirred at 0 °C for 3 hours before being stirred at room 
temperature for 2-18 hours. The methanol was then removed and the residue partitioned 
between water and dichloromethane. The organic layer was then washed with dilute 
hydrochloric acid and then a saturated brine solution. Removal of the solvent under 
reduced pressure yielded the product as either an oil or a solid which could be 
recrystallised from ethanol or methanol.
The first example synthesised was A, A-dibenzy Icy an amide (117) as extensive 
work has already been done on this compound and the corresponding hydroxy guanidine. 
Dibenzylamine was reacted with cyanogen bromide to give the product (117) after 
recrystallisation from methanol as a white solid in 72% yield. The solid gave the 
characteristic peak at 118.38 ppm and the CN stretch in the i.r. at 2200 cimk The
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mass spectrum also indicated the presence of the molecular ion, M+, at 222 and the 
melting point of 50-52 °C agreed well with the literature value reported by Traube of 54 
O C . 1 I 5
/  \ _ _ y
N C = = N
(117)
After the synthesis of this compound had been successfully completed the 
synthesis of a range of other derivatives was attempted using this methodology. The 
derivatives (118-128) were chosen to give a variety of substituents on the nitrogen 
including substituted aromatic rings, aliphatic chains and cyclic groups.
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N — N C = N
(118) (119)
N  C
(121)(120)
N C:OgN
(123)(122)
(124)
N  C
(125) (126)
67
\ N- ENy / - y) rv_y
(127) (128)
Ali of these compounds were successfully synthesised and the results are 
summarised below (Table 3).
Table 3:- Cyanamide Derivatives
Derivative : mm /
r  % _
m.p CN resonance/
L . .........
hr. CN 
stretch/ cm 1
(118) 70 43-44 118.3 2200
(119) 84 oil 118.78 2160
(120) 74 oil 117.97 2200
(121) 81 oil 113.61 2225
(122) 69 oil 115.57 2200
(123) 70 130-132 2100
(124) 69 44-46 116.88 2200
(125) 85 oil 118.48 2225
(126) 70 oil 118.02 2175
(127) 85 oil 118.66 2225
(128) 66 oil 117.12 2150
Although A-methyl-A-(j7-nitrophenyl)cyanamide (123) was obtained as a yellow 
solid the NMR data originally suggested that the reaction had not occurred as there was a 
small NH peak in the NMR and no visible CN peak in the ^^C NMR. However the 
mass spectrum gave the expected M+ peak for the product at 177 and the i.r. stretch for
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CN was observed at 2100 cm~^ with no visible NH stretching present. A better, 
overnight, 1% NMR spectrum indicated that the CN resonance may be present at 126.18 
ppm.
The synthesis of A, A-distearylcyanamide (129) a longer chain aliphatic 
analogue of (125) and (126) was also attempted. Here the starting amine was stirred in 
methanol and sodium acetate and cyanogen bromide added. The reaction was stirred at 0 
°C for 3 hours and then room temperature for a further six hours. However upon work­
up the product obtained was insoluble in organic solvents and water and it was unable to 
be characterised so no further work was done on this amine
N —  C = N
(129)
2.3.2 Aromatic Substituted Cyanamides
The syntheses of two diphenyl derivatives, A,A-diphenylcyanamide (130) and 
A-(3-methoxyphenyl)-A-phenylcyanamide (131) were investigated.
OCHg
N C ^ = N
(130)
N  C ^ = N
(131)
The synthesis of A,A-diphenylcyanamide (130) was first attempted using the 
standard methodology. Thus diphenylamine was reacted with cyanogen bromide in
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methanol in the presence of sodium acetate for 5 hours. When the reaction was worked 
up a solid product was obtained, however the NMR spectrum showed no evidence 
of the CN group. This result was confirmed by the absence of the CN stretch in the i.r. 
and the presence of a NH stretch at 3300 cm'l suggesting that the product isolated was 
the starting amine. The mass spectrum confirmed this result with the M+ peak at 169 
rather than the expected peak at 194. The reaction was then repeated with the reaction 
mixture being heated for 14 hours and then stirred overnight at room temperature. Again 
a solid product was obtained but all the data suggested that this product was the starting 
amine rather the desired cyanamide product. The desired cyanamide (130) was 
described in the literature and it was discovered that due to the unreactive nature of the 
amine the target compound had been synthesised by heating the amine and the cyanogen 
bromide under pressure in a sealed vessel. The amine is less reactive because it is an 
aromatic amine therefore less nucleophilic. An attempt to repeat this reaction did indeed 
give a product which showed a peak in the NMR spectrum at 118.31 ppm. 
However it was also clear that a number of other products including the amine were 
present and it was decided to attempt the synthesis using another derivative.
The synthesis of A-(3-methoxyphenyl)-A-phenylcyanamide (131) was thus 
attempted by reacting A-(3-methoxyphenyl)-A-phenylamine with cyanogen bromide and 
sodium acetate in methanol. This amine was chosen as the presence of the electron 
donating substituent should increase the nucleophilicity of the nitrogen. Again the 
reaction was worked up in the usual method and an oil was obtained, however NMR 
and i.r. indicated that this oil was the starting amine rather than the desired cyanamide. It 
was decided to leave this work on these two derivatives at this point to concentrate on a 
number of other examples.
It should be possible to complete the synthesis of these two cyanamides (130)
(131) by reacting the amine together with cyanogen bromide in a sealed vessel at higher 
temperature for a longer period of time.
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2.3.3 Monosubstituted Derivatives
The synthesis of two monosubstituted analogues, A-benzylcyanamide (132) and 
A-(p-methoxyphenyl)cyanamide (133) was also attempted.
N C =  N HgCO-------- ( \  /) --------N------- C =  N\  /
H H
(132) (133)
A-Benzylcyanamide (132) was synthesised as described and initially a yellow 
solid was isolated in 62% yield. This solid gave the characteristic NMR at signal at 
117.17 ppm and the desired strong i.r. signal at 2225 cm'k However over a period of 
two days this solid slowly became a rather viscous yellow oil, although it retained the 
NMR and ir characteristics. Another attempt at this reaction again yielded the yellow 
solid which upon an attempted recrystallisation again became a rather viscous yellow oil.
A-(p-Methoxyphenyl)cyanamide (133) was synthesised in the same way and the 
product was isolated as a solid in a 77% yield. The NMR of the solid did, as 
expected, show the characteristic signal at 117 ppm and i.r. stretch at 2220 cm'k The 
other data was also consistent with the product including the ^H NMR spectrum which 
showed a signal for NH rather than NH2. However it was noticed that after a few weeks 
that this compound gave a different NMR and the NMR spectrum indicated that there 
was more than one compound present, this may be due to an isomérisation occurring. It 
is possible that the cyanamide isomerises to give the carbodiimide (134) (Scheme 24) 
which would then be susceptible to attack by atmospheric water to yield the 
corresponding A-(p-methoxyphenyl)urea (135).
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HgCO
(134)(133)
HgCO
(135)
Scheme 24
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2.4 SYNTHESIS OF iV-HYDROXYGUANIDINES
With a range of starting cyanamides successfully synthesised the next step was 
the synthesis of the corresponding A-hydroxyguanidines. The A^-hydroxyguanidines 
could be synthesised in one of two ways. The first method was reaction of the 
cyanamide with hydroxylamine hydrochloride and sodium carbonate in purified DMF 
(Scheme 25). The reaction was heated at 60-80 °C before being filtered hot to remove 
the inorganic salts. The salts were then washed with a small quantity of warni DMF. 
Concentration of the solution under reduced pressure gave the hydroxyguanidine as either 
an oil or a solid. For the solid examples a recrystallisation then gave the product pure. 
However the oils were first added to a vigorously stirred ice cold solution of water to 
induce crystallisation. Recrystallisation of the solid obtained then yield the desired pure 
hydroxyguanidine. A number of problems were experienced with this reaction. Firstly if 
the reaction was heated at above 80 °C, or under reflux, then the amount of by-products 
produced increased and purification became impossible. Secondly the DMF needed to be 
dried and purified before use. This was accomplished by distilling off magnesium sulfate 
under reduced pressure. The DMF was then used within two or three days of this 
purification.
OH
NaoCO,, DMF
Scheme 25
The second method of preparation involved reacting the cyanamide with 
hydroxylamine hydrochloride and a catalytic amount of potassium hydroxide in refluxing 
methanol (Scheme 26). In this case the reaction was refluxed for 12 hours, cooled and
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then diluted with diethyl ether. At this point a solid formed which was then filtered off 
and reciystallised to give the desired hydroxyguanidine as the hydrochloride salt.
OH
NH3 CIKOH, MeOH
Scheme 26
The disappearance of the cyanamide peak at 115-120 ppm in the NMR 
spectrum and the appearance of the peak due to the C=NOH group at 155-160 ppm 
confirmed that the reaction had occurred as expected. This was also confirmed by the 
presence of NH2 and OH stretching in the i.r. spectrum and the absence of the CN stretch 
at 2200  cm"T
2.4.1 Alkyl Disubstituted Derivatives
1,1 -Dibenzyl-2-hydroxyguanidine (70) was first synthesised within the 
chemistry department at the University of St A ndrew s.S ubsequen t work established 
that the compound did release nitric oxide under biological conditions and following the 
action of chemical oxidants and that the compound (70) is a vasodilator.
/
N  OH
NH2
(70)
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The synthesis of this compound was repeated by reacting the cyanamide with 
hydroxylamine hydrochloride in the presence of sodium carbonate in DMF. The reaction 
was heated for 1.25 hours before working the reaction up as previously described. The 
oil that was obtained was then added to a small amount of ice-cold water with vigorous 
stirring and after a period of up to 30 minutes it became a solid. This solid was 
recrystallised from ethanol to give the product in 65%. Initially the recrystallisation was 
attempted from methanol however it was found that the product crystallised from solution 
too quickly and ethanol was used to slow the crystallisation down and therefore improve 
the crystalline structure of the compound. However this did not work and the solid that 
was obtained was unsuitable for X-ray crystallography. The solid was pure by 
microanalysis and the NMR spectrum showed that the CN peak at been replaced by 
the C=NOH peak at 157.24 ppm. The melting point of 119-120 °C also agreed well with 
the literature value of 120-121 °C.^^
The synthesis of other examples was then attempted from the corresponding 
cyanamides (118-128). However the synthesis of these proved to be problematic and 
only a small number of examples were successfully obtained (136-140) (Table 4).
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N  OH
\
(136)
NHaCf
(137)
N  OH
CH2CH3
\
N'
N OH
NHaQ O N'
(139)
N  OH
NH3CI
(140)
Table 4:- Hydroxyguanidine Derivatives
Hydroxy , 
guanidine ;
Route Î Yield /
L:. % .j
1 m*p /
L "c
Ï3C Peak
(118) (136) B 53 240-242 160.42
(119) (137) A 48 8 8 157.52
( 1 2 1 ) (138) A 61 144-146 154.73
(127) (139) B 30 270-271 160.42
(128) (140) B 64 214-216 155.92
Route A:- NH2OH, Na2C0 3 , DMF Route B:- NH2OH, KOH, MeOH
The synthesis of 1-benzyl-l-(2-phenethyl)-2-hydroxyguanidine (141) using 
similar conditions to those used in the synthesis (70) proved to be less successful and
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when the compound was added to water an oil was formed. This oil was then extracted 
into ethyl acetate and the solvent then removed under reduced pressure to yield an oil, 
which was seen by both and n MR spectra to be a mixture of compounds with 
some of the desired compound present. A number of attempts at purification were carried 
out including recrystallisation from ethanol and flash column chromatography with 
ethanol as the elutant. However, recrystallisation yielded the impure oil again and the 
column chromatography failed to yield any of the desired compound.
\
OH
NH2
(141)
Due to these problems it was decided to try and synthesise this compound as the 
hydrochloride salt. Thus 1-benzyl-l-(2-phenethyl)-2-hydroxyguanidine hydrochloride
(136) was synthesised by reaction of the corresponding cyanamide (118) with 
hydroxylamine hydrochloride in refluxing methanol and in the presence of a catalytic 
amount of potassium hydroxide. The ^H and NMR spectra both indicated that there 
was only one product present with the C=NOH signal at 160.42 ppm. When the 
compound was submitted for microanalysis it indicated that the compound was impure 
and was maybe not one compound, but a simple flame test on the compound indicated 
that the compound was probably contaminated with a potassium salt. Removal of this 
salt proved to be very difficult and despite numerous attempts the compound could not be 
purified to give a microanalytically pure solid.
The synthesis of 1-benzyl-l-butyl-2 -hydroxyguanidine (142) from the 
corresponding cyanamide (120) was attempted using the same procedure that was used
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in the synthesis of (70). However for this compound an oil was obtained and although 
the hydroxyguanidine was present the oil could not be purified to give the desired 
product.
N  OH
(142)
When the synthesis of 1-ethyl-l-(o-tolyl)-2-hydroxyguanidine (143), an isomer 
of 1-ethyl-l-(p-tolyl)-2-hydroxyguanidine (138), was attempted the reaction did not 
work.
CH2CH3
The reaction was carried out in the same way as the synthesis of 1-ethyl-l-(p- 
tolyl)-2-hydroxyguanidine (138) had been successfully completed, however an oil was 
obtained that was could not be purified. This is probably because of the sterically 
hindered nature of the cyanamide and also it may be that the cyanamide is not as reactive 
due to the different substitution.
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Preparation of 1-methyl-l-(>-nitrophenyl)-2 -hydroxyguanidine (144) from the 
corresponding cyanamide (123) resulted in an unusual observation. The reaction was 
carried out using the standard method and when the DMF was removed a brown solid 
was obtained which looked to be correct by and NMR spectra and the i.r. 
spectrum showed that there was no CN stretch. When the brown solid was reciystallised 
from ethanol a crystalline green solid was then obtained. The NMR spectrum of this 
compound proved to be strange because it appeared that upon recrystallisation the 
molecule seemed to have reacted with two moles of DMF. The mass spectrum of the 
green solid indeed confirmed this result with the M+ peak at 356 and not as would be 
expected for the correct product at 210. As it was suspected that the nitro group would 
affect the biological activity of this compound and in light of this strange result further 
investigation of this compound was not attempted.
The synthesis of both 1,1 -dibutyl-2-hydroxyguanidine (145) and l,l-dioctyl-2- 
hydroxyguanidine (146) proved to be unsuccessful. The synthesis was carried out as 
before and in both cases an impure oil that contained some of the desired product was 
obtained but as in previous examples purification of these compounds proved to be 
impossible.
(145) (146)
2.4.2 Monosubstituted Analogues
The syntheses of 1 -benzy 1-2-hydroxy guanidine (147) and 1 -(p-methoxypheny I)- 
2-hydroxyguanidine (148) were attempted from iV-benzylcyanamide (132) and N-{p- 
methoxyphenyl)cyanamide (133) respectively.
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N  OH
NHg
(147)
H3 CO'
(148)
N  OH
NH,
These were carried out using the second method described because it had been 
shown in previous work that monosubstituted analogues were unstable and could not be 
isolated from all the by-products. 7^ The cyanamide was heated under reflux in methanol 
with one equivalent of hydroxylamine and catalytic potassium hydroxide for 14 hours. 
The two reactions were then cooled to room temperature and poured onto a large excess 
of diethyl ether and for one, l-(p-methoxyphenyl)-hydroxyguanidine (148), a solid was 
obtained. An attempt to filter this solid failed as the compound was clearly hygroscopic 
and upon absorbing atmospheric water disappeared. The filtrate of this reaction also 
failed to show any trace of the expected product. The other reaction, 1-benzy 1-2- 
hydroxyguanidine (147), yielded an oil which could not be separated from the 
methanol/diethyl ether solution. These two reactions would seem to confirm earlier 
observation that the monosubstituted analogues are more unstable and therefore not so 
easy to access.
2.4.3 Crystal Structure of l-benzyl-l-methyl-2-hydroxyguanidine (137)
1-Benzyl-1-methy 1-2-hydroxy guanidine (137) was the only example to 
crystallise in a suitable form for X-ray crystallography. The X-ray crystal structure 
(APPENDIX 1) showed that the compound existed in a dimeric form in the unit cell 
(Figure 5)
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FIGURE 5:- Crystal structure of 1-benzyl-1-methy 1-2-hydroxy guanidine (137)
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Chern and co-workers have reported the synthesis of substituted sulfonyI-A/^ ~ 
hydroxyguanidines (Section 2.7.1). The authors reported the crystal structure of one 
of these compounds, A^-(4-chlorophenyI)-A^'-[benzo[2,l,3]thiadiazol-4-yl)sulfonyl-A^"- 
hydroxyguanidine (149) and compared with theoretical calculations.^
\  / Cl
(149)
There are three possible tautomers of the hydroxyguanidine group (Figure 6 , 
150-152). The NMR spectrum of (149) was consistent with tautomers (150) and 
(152) but not (151). The crystal structure showed that the distances between the central 
carbon of the hydroxyguanidine group and the 3 nitrogens was neither a pure single N-C 
bond or a pure double bond. This would suggest some form of coexistence of the three 
forms and/or a degree of delocalisation between these three bonds. However from the 
crystal structure it was possible to determine the location of the proton density and along 
with the NMR data it would suggest that tautomer (150) is the most favoured form for 
this sort of compound. This result was confirmed by computer modelling using MOP AC 
with PM3 force field p a ra m e te rs .T h e  modelling showed that favoured tautomer 
(150) had an energy difference of 1.8 kcal/mol over the other favoured tautomer (152).
O Q NHOH
Ar N" 'NH-Ar'
(150)
O O NHOH Q 0 NOH
X  y  I \  y
Ar NH N —Ar’ Ar NH NH-Ar’
(151) 
Figure 6
(152)
82
The crystal structure of 1-benzyl-l-methyh2-hydroxyguanidine (137) showed 
that the despite the possible cis and trans isomers of the C=N bond only the trans isomer 
was present in the crystal structure. This has been assumed for these compounds but 
until now had never been proven without doubt. The bond lengths from the X-ray data 
are given (Figure 7). It can be seen from the full data (Appendix 1) that the bond 
lengths for the aromatic ring are unreliable and therefore the data needs to be improved.
Bond lengths (A) in l-benzyl-l-methyl-2-hydroxyguanidine (135)
1.45 OH
1.32
1.45 1.42 1.35
NH
CH
Figure 7
However the data given (Figure 7) does imply that the double bond character is 
found predominantly between the two terminal nitrogens, N2 and N3, and the guanidino 
carbon, C9. There is, as expected, no double bond character between the quaternary 
nitrogen N 1 and the guanidino carbon C9 which has a bond length of 1.42 Â compared 
to the C9-N2 and C9-N3 bond lengths of 1.35 and 1.32 Â respectively. The crystal 
structure also showed that the C-O bond was a single bond. These results in some 
respects agree with Chern's which show that there are 3 forms of these compounds but 
that 2 are favoured and that there is a degree of delocalisation over all the bonds. As 
already stated some of the bond lengths in the aromatic ring are inaccurate but this is 
because the X-ray data was obtained at room temperature which resulted in 
decomposition of the crystals. The solution would be to carry out the X-ray diffraction at
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low temperature. This was not undertaken as the original attempt at obtaining the crystal 
stmcture had degraded the ciystals and difficulty was experienced when trying to obtain a 
new batch of suitable crystal.
2.5 UREA SYNTHESIS
The synthesis of some of the related urea derivatives was also undertaken. These 
derivatives were required for a number of reasons. Firstly they were required as 
standards in later work on the decomposition of the 0 -substituted analogues of the 
hydroxyguanidines, as they could be the product of hydrolysis rather than the 
hydroxyguanidine. Secondly they were also necessary for biological testing to ensure 
that the guanidino functionality of the A-hydroxyguanidine was required for the 
biological activity and that the cyanamide or urea were not the active species.
Two alternative routes were investigated, using A-ethyl-A-(p-tolyl)urea (153) as 
the initial example.
H3C-
(153)
A-Ethyl-A-(p-tolyl)cyanamide (121) was thus hydrolysed under both basic (2M 
NaOH) and acidic conditions (2M, H2SO4) in ethanol. After stirring at room temperature 
for 18 hours the product was extracted and examined. The acid catalysed reaction gave a 
product that appeared to be pure by ^H NMR spectroscopy and showed a characteristic 
urea C=0 resonance at 160 ppm in the NMR spectrum. Mass spectrometry gave a 
molecular ion at 178 confirming the identity of the product. The base catalysed reaction 
appeared to give a mixture of products with a peak in the mass spectrum at 160 which
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corresponds to the cyanamide. As a result of these observations further reactions were 
carried out using acid conditions.
A ,A -D ibenzylurea (154) was then synthesised by reacting N,N-  
dibenzylcyanamide (117) in ethanol and aqueous sulfuric acid for sixteen hours at room 
temperature. After work-up the reaction yielded an off-white solid which was 
recrystallised from ethanol to give a white crystalline solid with a melting point of 122- 
124 °C which agreed well with the literature value of 125 °C. The C=0 resonance was 
found in the NMR spectrum at 160.32 ppm and the M+ was found at 222. N- 
Benzyl-A-methylurea (155) was also synthesised using this method and the crude 
product was obtained as a solid in 34% yield. Recrystallisation from ethanol yielded the 
product as a microanalytically pure white solid with a M+ in the mass spectrum at 164. 
The NMR spectrum showed the C=0 resonance at 159.83 ppm.
/  \ O
NHg
(154) (155)
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2.6 B IO L O G IC A L  T E S T IN G  OF l-B E N Z Y L -l-M E T H Y L -2 - 
HYDROXYGUANIDINE (137)
Following the procedure of Flitney 1-benzyl-l-methyl-2-hydroxyguanidine 
(137) was found to have vasodilatory activity.l^^ This work was carried out by Ian 
Megson at the University of Edinburgh. When added to the perfused artery the 10'^ M 
solution caused a fall in pressure of approximately 71% (Figure 8). When used at 
similar concentrations it is known that some 5'-nitrosothiols give 100% relaxation of the 
artery. This is a positive result as it indicates that 1-benzyl-l-methyl-2-hydroxyguanidine 
(137) is a reasonable vasodilator at these concentrations.
fall in.pressure  
-70%
20  mmHg
5 min
HOGAUN (A) (10-5 M)
Hb (10 ■ 5 m)
F igu re 8
It was shown that this relaxation was directly due to nitric oxide because when the 
known nitric oxide scavenger haemoglobin was added the effect was reversed thus
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confirming the role of nitric oxide. Haemoglobin works because it traps the nitric oxide 
and forms a stable complex.
2.7 CHEMICAL OXIDATION OF iV-HYDROXYGUANIDINES
2.7.1 Introduction
Previous work carried out on //-hydroxyguanidines and related derivatives have 
shown that these compounds can be oxidised by a range of oxidising agents for example 
hydrogen peroxide or m-chloroperbenzoic acid (mCPBA).^^ Previous work within the 
department has also shown that 1,1-dibenzy 1-2-hydroxyguanidine (70) can be oxidised 
by hydrogen peroxide to give a near quantitative yield of nitrite, which was detected 
using the Griess test.^^ The nitrite is derived from nitric oxide and it is therefore possible 
to measure the nitric oxide release from these compounds. It was observed that two 
equivalents of the oxidant were required to carry out this oxidation.
The Griess test is used because it is known that the nitric oxide released from the 
//,//-hydroxyguanidines will react with oxygen as shown to give nitrous acid, (Figure 
9), which then dissociates in aqueous solution to give nitrite (NO2" ). This nitrite can 
then be detected using the Greiss test.
NO + 1/2 O2 NO.
NO2 + NO N 2O 3
N2O3 + H2O 2HN0 .
HNO.
Figure 9
87
2.7.2 Griess Test
The Griess test involves the formation of an azo dye between sulfanilamide 
(156) and A^-(l-naphthyI)ethylenediamine dihydrochloride (157).^^
SO2NH2
NH2
(156)
H N  NH2 2 H C 1
(157)
The N0 2 “ produces nitrous acid under the acidic conditions of the test. The 
sulfanilamide (156) is then converted to the diazonium ion (158). Finally the 
diazonium ion (158) couples with the //-( 1 -naphthyl)ethylenediamine (157) to give the 
azo dye (159) (Scheme 27). This azo dye is highly conjugated and is responsible for 
the purple colour associated with this test. The absorbance of the solution is directly 
related to the concentration of the nitrite that is present in the solution.
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S 0 2 N H 2
NH2
(156) (158)
HN NH2
2 H C 1
(157)
HN NH2
SO2NH2
(159)
Scheme 27
The two solutions used in the Griess test are sulfanilamide (156) in aqueous 
solution containing 2 % v/v hydrochloric acid and the N-( 1 -naphthyl)-ethylenediamine 
dihydrochloride (157) in aqueous solution containing 1% v/v hydrochloric acid. The
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first step in this work was to obtain a nitrite calibration curve by measuring the 
absorbance of the standard nitrite solution. A 110 x 10'^ mol dm‘  ^ was used as stock 
solution and was diluted to give a range of concentrations. The Greiss test was carried 
out by removing 1 cm^ of the standard nitrite solution and adding 0.5 cm^ of 
sulfanilamide (156) solution followed 5 minutes later by 0.5 cm^ of the A^-(l- 
naphthyl)ethylenediamine dihydrochloride (157) solution. The colour was then allowed 
to develop for 15 minutes before the absorbance was measured at 550 nm. The nitrite 
calibration curve was then plotted and was used to work out the concentration of the 
nitrite in the reaction solutions.
2.7.2.1 Oxidation of l-benzyl-l-methyl-2-hydroxyguanidine (137)
For the oxidation reactions a 0.1 mmol dm"  ^ solution of 1-benzyl-1-methy 1-2- 
hydroxyguanidine (137) was employed, to give suitable concentrations of nitrite for the 
Griess test. Initially reactions were carried out in aqueous solution however this caused 
problems with the solubility of the oxidising agents, so a solution of water/acetonitrile 
(85/15%) was used to solve this problem. The solution of 1-benzyl-1-methy 1-2- 
hydroxyguanidine (137) was placed in a water bath at 37 °C and the oxidising agent was 
added. The reaction was then tested for nitrite after various time intervals using the 
Greiss test.
It had been reported that hydrogen peroxide gave the best results for the oxidation 
of these compounds, so it was decided to try this reagent first.87 An aliquout of 0.2 cm^ 
of 30% hydrogen peroxide was added, which gave a sufficient excess to give complete 
reaction (Table 5).
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Table 5:- O x i d a t i o n  o f  (137) b y  h y d r o g e n  p e r o x i d e
■ Time/ 
min
Absorbance Cone, of nitrite/ 
x l 0 “6  m #  dnr^
w m m m r n
30 0.0195 0.5 1
60 0.0299 1 . 0 2
90 0.278 1 . 0 2
The final concentration of nitrite should be 55 x l0 ‘  ^ mol dm’ ,^ giving an 
absorbance of 1.46. Therefore it can be seen that only a very low yield of nitrite, 2% 
after sixty minutes, was obtained using hydrogen peroxide.
Taking into account these results it was decided to attempt the oxidation using an 
excess (0.0Ig) of mCPBA and the results are given below (Table 6). In this case after 
30 minutes of reaction there was a 27% yield of nitrite.
Table 6 :- Oxidation of (137) by mCPBA
Timé/'ëiîrn Cone of nitrite / 
: . ^1 0 "^  mol dm“3
% Oxidation
30 15 27
60 14 25.5
90 11.5 21
A third oxidation using an excess (0.012g) of oxone as the oxidant was carried 
out and the results are given below (Table 7).
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Table 7:- Oxidation of (137) by oxone
Time/ min Cdim of nitrite
. . x lO- 6  mpl dm 3
% Oxidation
30 1 2
60 1.5 3
90 1.5 3
120 2 4
After 120 minutes of reaction the yield of nitrite in this case was only 4%.
A comparison of the maximum % oxidation for the 3 oxidants (Table 8 ) reveals 
that mCPBA gives the highest degree of oxidation.
Table 8 :- Comparisons of oxidation reactions
©xidant
H2O2 2
mCPBA 27
Oxone 4
It would seem that oxone is not very effective at oxidising the 1-benzyl-1-methyl-
2-hydroxyguanidine (137) and that despite reports that suggested 100% oxidation 
occurred with hydrogen peroxide this was not the case.^7 What is interesting is that a 
microanalytically pure compound would be expected to give 100% oxidation but this is 
clearly not occurring for some reason. However it may be that it was the presence of an 
impurity in the compounds that were previously tested that helped the oxidations occur 
which is not present in the compounds tested. As the results appeared to suggest that 
mCPBA was the best oxidising agent it was decided to use this oxidising agent in all 
further oxidations.
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2.7.2.2 Oxidation of l,l-dibenzyl-2-hydroxyguanidine (70)
A 0.1 mmol dm-3 solution of 1,l-dibenzyl-2-hydroxyguanidine (70) in 
water/acetonitrile (85/15%) was oxidised with an excess (0.01 g) of mCPBA and the 
results are shown below (Table 9), giving 18% oxidation after 60 minutes..
Table 9: Oxidation of (70) by mCPBA
Tim eim in % Oxidation
30 16
60 18
90 18
2.7.2.3. Oxidation of l-ethyl-l-(/?-tolyl)-2-hydroxyguanidine (138)
A 0.1 mmol dm'^ solution of 1-ethyl-l-(/?-tolyl)-2-hydroxyguanidine (138) was 
oxidised using an excess (0.01 g) of mCPBA (Table 10).
Table 10: Oxidation of (138) by mCPBA
Time/ min Cone, of nitrite/ 
x l 0 ‘  ^ mol 1-1
30 5.5
60 6
90 5.5
After 60 minutes there was only 6 % oxidation of 1-ethyl-l-(p-tolyl)-2- 
hydroxyguanidine (138).
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2.7.3.4 Oxidation of l-morphoIino-2-hydroxyguanidine hydrochloride 
(140)
The oxidation of a 0.1 mmol dm“3 solution of l-morpholino-2-hydroxyguanidine 
hydrochloride (140) was carried out using an excess (0.01 g) of mCPBA. The results 
are below (Table 11)
Table 11: Oxidation of (140) by mCPBA
Time/ min % Oxidation
30 6
60 7
90 6
The % oxidation of l-morpholino-2-hydroxyguanidine hydrochloride (138) after 
60 minutes is 7%
2.8 CONCLUSIONS
The synthesis of the substituted A-hydroxyguanidines proved to be more difficult 
than originally envisaged. This is probably due to the inherent instability of these 
compounds. The range of 77-hydroxy guanidines synthesised (Section 2.4) was small 
compared to the number of substituted cyanamides (Section 2.3) that were 
successfully prepared. However one compound, 1-benzyl-l-methyl-2-hydroxyguanidine
(137) proved particularly useful in a number of areas. As reported the compound was 
obtained in a crystal form suitable for X-ray structural analysis (Section 2.4.3). The 
data, while not perfect, showed that the double bond character was mainly between the 
terminal nitrogens as had previously been assumed but never determined. The compound
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was also tested under biological conditions and was found, as expected, to be a 
vasodilator. However the concentration of the compound that was required for 
vasodilation is quite high and may not be suitable for in vivo use Previous work has 
shown that 1,1 -dibenzyl-2 -hydroxyguanidine (7 0 )  was a vasodilator at similar 
concentrations, and it can therefore be assumed that the other free 77-hydroxyguanidines 
are also likely to be vasodilators.
The chemical oxidation of these compounds gave unexpected results. Previous 
reports suggested that the chemical oxidation of both 1,1 -dibenzy 1-2-hydroxy guanidine 
(70) and 1-benzyl-1-methy 1-2-hydroxy guanidine (137) with hydrogen peroxide gave a 
near quantitative yield of nitric oxide, as measured via the Greiss test.^^ However the 
work undertaken in this project showed only 2% oxidation with hydrogen peroxide. The 
previous work also indicated less success with m-chloroperbenzoic acid (mCPBA). 
However oxidation of 1-benzyl-1-methy 1-2-hydroxy guanidine (1 3 7 ) by mCPBA 
indicated a 27% oxidation. However it may be that the previous work, which used a non 
microanalytically pure sample of 1-benzyl-l-methyl-2-hydroxyguanidine (137), gave a 
false result and that the impurity that was present was responsible for the oxidation. 
However the major impurity was likely to be the corresponding urea and when the 
chemical oxidation was attempted using 1-benzyl-1-methylurea (1 5 5 ) there was no 
indication of any oxidation as expected.
The instability of the products meant that the range of derivatives synthesised was 
not as great as hoped but the results obtained from the testing of the derivatives obtained 
confirms their potential as nitric oxide donor drugs.
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Chapter 3
Synthesis and Studies on O-Substituted A-Hydroxyguanidines
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3.1 INTRODUCTION
It was decided to approach the synthesis of the O-substituted N-  
hydroxyguanidines using a different synthetic methodology to that employed for the 
unsubstituted derivatives. The use of activated sulfur leaving groups has been reported in 
the synthesis of A^-hydroxy-L-arginine (Scheme 28).^  13 in this synthesis the thiourea 
derivative (160) was alkylated with methyl iodide to give the methylated sulfur 
derivative (161) that was then displaced with 0-benzylhydroxylamine in the presence of 
a silver salt to give the 0-benzyl A^-hydroxy-L-arginine derivative (162) (Scheme 27).
SMe
Mel
(161)(160) (162)
R =
Scheme 28
The problem with this synthesis is that the last step, the replacement of the 
activated sulfur group requires the presence of a silver salt which is generally toxic and 
the by-product is smelly. Methyl iodide, used earlier in the synthesis, is also toxic. The 
activated sulfur species are not very stable and are probably best formed in situ and then 
reacted on without isolation.
There have been a number of milder methods reported for this conversion. Miller 
reported the synthesis of guanidino acids (163) (Scheme 29).^^^ Reaction of the 
desired aminoiminomethanesulfonic acid (164) with an amino acid derivative (165) 
under aqueous conditions with base at room temperature gave the desired guanidino acids 
(163) in good yields.
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NHR
NHR
(165) (163)(164)
Scheme 29
The conversion of aminoiminomethanesulfonic acid (166) to monosubstituted 
guanidines (167) has also been r e p o r t e d .  jh e  authors reacted the sulfonic acid
(166) with a primary amine in absolute methanol to give the product as the bisulfite salt 
(168) which was then neutralised to give the monosubstituted guanidine (167) 
(Scheme 30)
S O 3 H
(166)
R = Cyclohexyl 
Cyclooctyl
+ RNH2
NHg H S 0 “3
HgN' 'N H R  
(168)
t
NH
HgN NHR
(167)
Scheme 30
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It was decided that aminoiminomethanesulfonic acids were a good starting point 
in the synthesis of (9-substituted A^-hydroxyguanidines. To synthesise these compounds 
the intermediate thiourea was required, which could then be oxidised to give the 
corresponding aminoiminomethanesulfonic acid.
3.2 THIOUREA SYNTHESIS
One of the most convenient syntheses of thioureas (169) is the reaction of 
thiophosgene (170) with an amine (Scheme 31). The first step is reaction of the 
amine and thiophosgene to give the intermediate thiocarbamyl chloride (171) which is 
unstable and reacts to give the corresponding isothiocyanate (172). This isothiocyanate 
(172) is then reacted with ammonia to give the thiourea (169).
NH; NH
(171)(170)
HCl
N— CNH;
(169) (172)
Scheme 30
There are, however, problems associated with this synthesis when the amine that 
is being used is secondary rather than p r i m a r y . W i t h  a secondary amine often the 
A^W’-tetrasubstituted thiourea (173) is obtained rather than the desired N,N-  
disubstituted thiourea (169). This occurs because the thiocarbamyl chloride (171), is
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more stable and also because the secondary amine is more nucleophilic. Thus the 
thiocarbamyl chloride (171) can react with another mole of the amine forming the N,N’- 
tetrasubstituted thiourea (173) (Scheme 32). Formation of the MiV’-disubstituted 
thiourea, as a byproduct, can also occur with primaiy amines if the thiocarbamyl chloride 
(171) that is formed is stable
For R and R’ NOT = H
NH
(171) (173)
Scheme 32
As thiophosgene (170) is toxic alternatives to this compound have been sought. 
One recent example is 1,1 -thiocarbonyIdiimidazole (174) which was used by Stammer 
and co-workers in the synthesis of A-hydroxyurea (175).
R eaction  of 2 ,4-d im ethoxy benzyl am ine (176) with N,N'~  
dithiocarbonyIdiim idazole (174) in dry chloroform followed by column 
chromatography, yielded the desired isothiocyanate which was then reacted with 
hydroxylamine hydrochloride in the presence of sodium hydrogen carbonate to give N- 
(2,4-dimethoxybenzyl)-A’-hydroxythiourea (177) (Scheme 33). Removal of the 2,4- 
dimethoxybenzyl protecting group was then achieved using trifluoracetic acid to give the 
target A-hydroxythiourea (175) in 34% overall yield.
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NH2
(174)
a) CHCI3 , rt 3hrs then 
silica
b) H2 NOH.HCI, NaHCOs, 
MeOH
(176)
NHOH
CF3 COOH
resorcinol dimethyl ether
NHOH
(175)
Scheme 33
Another alternative method for thiourea synthesis involves the use of ammonium 
thiocyanate (178). Heating ammonium thiocyanate (178) at 160 °C for a number of 
hours is known to produce thiourea (179) (Scheme 34).
Heat
HgN(178) (179)
Scheme 34
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Various groups have reported the extension of this work for the synthesis of a 
range V, V-disubstituted thioureas and V-substituted thioureas using this 
m e t h o d o l o g y . 125 The reaction occurs because when the amine and ammonium 
thiocyanate (178) are added together the primary or secondary ammonium ion (180) is 
formed which then rearranges upon heating to give the desired thiourea (169) (Scheme
35).
R R R
\  + H n  \ +  -  Heat \  ^NH + NH4 SCN NHgSCN  -   ->-  N ^ NHg
R''^ (178) R'^ (ISO) R’ (169)
Scheme 35
The reaction is carried out either in an inert organic solvent which has been 
saturated with dry hydrogen chloride gas prior to addition of the amine and ammonium 
thiocyanate, or in aqueous hydrochloric acid. The reaction is suitable for both aliphatic 
and aromatic amines.
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3.2.1 A/^-Benzylthiourea (181)
The first target compound was A^-benzylthiourea (181). Its synthesis was 
undertaken using the reaction of thiophosgene (170) and benzylamine (182) (Scheme
36).
i) DCM/H2 ONHg + NH2
(182) (170) (181)
Scheme 36
Benzylamine (182) and an excess of thiophosgene (170) were stirred together 
in a suspension of dichloromethane and water in a two phase reaction. After stirring for 
two hours at room temperature the layers were separated and the organic layer was 
washed with water. The organic layer was concentrated under reduced pressure to give 
an orange oil which was dissolved in methanol and aqueous ammonia added. The 
reaction was stirred at 0 °C for three hours and then concentrated under reduced pressure. 
Recrystallisation of the crude solid from ethanol to gave the product (181) as a white 
solid in 20% yield. The melting point of 159-161 °C corresponded well with the 
literature value of 161-162 and the microanalysis indicated that the product was
pure. The characteristic C=S peak in the NMR spectrum was found at 183.71 ppm.
3.2.2 Other Monosubstituted Examples
It was decided to synthesise the other thioureas using the methodology of 
Passing. This method was used because it was an easy and convenient synthesis of both 
primary and secondary thioureas unlike the thiophosgene method (Section 3.1). The
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reaction also involved the reaction of the readily available, cheap and non toxic 
ammonium thiocyanate. The inert solvent that was used for the reaction was 
chlorobenzene which was saturated with dry hydrogen chloride gas for thirty minutes 
before reaction. To this cloudy solution was added the amine followed by the ammonium 
thiocyanate (178) which resulted in a thick suspension. This suspension was then 
heated under reflux for 8-10 hours. On cooling the product crystallised from solution. 
The crude solid product was then stirred in water to remove the inorganic salts, filtered 
and dried.
7/-(2-Phenylethyl)thiourea (183) was synthesised using this procedure from 
phenethylamine. The product was obtained as a white solid in 51% yield.
NHgn
(183)
The structure was confirmed by the molecular ion at 180 in the mass spectrum 
and also the presence of the C=S peak in the NMR spectrum at 183,51 ppm. The 
compound also gave a correct microanalysis.
3.2.3 Disubstituted analogues
Two disubstituted analogues, iV,A^-dibenzylthiourea (184) and N-benzyl-#-(2- 
phenethyl)thiourea (185), were also successfully prepared using this procedure in 59% 
and 76% yields respectively. The major difference was that the preparation of 7/-benzyl- 
7/-(2-phenethyl)thiourea (185) was carried out in aqueous hydrochloric acid. This was 
because an earlier attempt using chlorobenzene had given no product which may have 
been because the product was soluble in chlorobenzene and so an attempt was made 
using the aqueous acid solution.
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\  /  \ N' NH; NH;
\  /
(184) (185)
7/,/7-Dibenzylthiourea (184) was obtained as a white solid and the molecular ion 
in the mass spectrum was found at 256 and the NMR spectrum showed the C=S 
peak at 182.84 ppm. The i.r. spectra also showed a C=S stretch at 1510 cm'l and the 
melting point of 134-135 °C was in agreement with the literature value of 134-136
//-Benzyl-A^-(2-phenethyl)thiourea (185) was obtained as a solid which gave the 
expected molecular ion peak, M+, at 270 and the C=S stretch in the NMR spectrum 
at 184.56 ppm. The i.r. also showed the C=S stretch at 1490 cm"k
The synthesis of N-ethyl-N-(p-tolyl)thiourea (186) was attempted using this 
method. However when the reaction was attempted in refluxing chlorobenzene the 
starting amine was isolated and this was also true when the reaction was attempted in 
aqueous acid. This seemed to confirm that the aromatic amines are less basic and also 
less nucleophilic and therefore do not react with the ammonium thiocyanate. A similar 
problem was seen when the synthesis of AiTZ-diphenylcyanamide (130) was attempted 
from the corresponding amine and cyanogen bromide.
HgC- \  / CH2CH3
(186)
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It was then decided to attempt the synthesis using the thiophosgene analogue, 
thiocarbony Idiimidazole (174). The reaction was carried out by reacting N-ethyl- 
iV-(/7-tolyl) amine with MAT'-thiocarbony Idiimidazole (174) in THF for an hour. The 
reaction mixture was then concentrated under reduced pressure and aqueous ammonia 
solution added and the reaction stirred overnight at room temperature. Removal of the 
solvent under reduced pressure yielded an orange oil which was shown by tic to be at 
least two products which were separated using column chromatography. However the 
NMR of the product indicated that the product that was isolated still contained an 
imidazole group and this was confirmed by the mass spectrum which showed the 
molecular ion at 245 and not the expected 194. This suggested that the second step of the 
reaction had not worked and that the product isolated was the reaction intermediate 
(187).
HgC- \  /
(187)
Another attempt was made at this reaction except when the aqueous ammonia was 
added the solution was heated for six hours and then stirred overnight at room 
temperature. Similarly after column chromatography the product obtained still contained 
an imidazole group and the mass spectrum confirmed that (187) rather than the desired 
product had been formed. The synthesis was then attempted using thiophosgene (170). 
Here the amine was stirred in DCM and a suspension of thiophosgene in water was 
added and the reaction stirred at room temperature for three hours. Separation of the 
organic layer and subsequent concentration of this layer under reduced pressure yielded 
an orange oil which was dissolved in methanol and aqueous methanol was added and the
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reaction then stirred at room temperature overnight. Concentration of the reaction under 
reduced pressure yielded an orange oil which was shown by NMR spectroscopy to be 
mainly the starting amine. The explanation for the unreactive nature of these compounds 
has been discussed and the less reactive nature of these compounds has proved to be a 
limiting factor in the number of derivatives that can be synthesised.
3.2.4 Other Examples
The synthesis of a number of examples were attempted, including N,N-  
dioctylthiourea (188), N,N-dibutyIthiourea (189) and N,N-dicyclohexylthiourea 
(190) using the reaction of the corresponding amine and ammonium thiocyanate.
(188)
NH2
(189)
The synthesis of the two dialiphatic derivatives, iV,A-dibutylthiourea (188) and 
7/,A/-dioctylthiourea (189), could not be achieved using this route and were not 
attempted using either of the other routes. The problem here must be that the amines are 
less nucleophilic and more soluble in the organic solvent. However the synthesis of
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A/',//-dicyclohexylthiourea (190) was successfully achieved by heating the 
corresponding amine in chlorobenzene in the presence of ammonium thiocyanate. The 
desired product was obtained as a white solid in 77% yield. The presence of the product 
was confirmed by the NMR spectram which showed the presence of the C=S peak at
182.1 ppm
3.3 AMINOIMINOMETHANESULFONIC ACID SYNTHESIS
As previously discussed it was decided that the use of 
aminoiminomethanesulfonic acids would prove useful as an alternative to the use of the 
alkylated sulfur derivatives (See Section 3.1). Aminoiminomethanesulfonic acids can 
be synthesised from the corresponding thiourea by oxidation. It has been reported that 
this oxidation can be carried out using hydrogen peroxide in either methanol or water in 
the presence of a catalyst, sodium molybdate dihydrate (Na2Mo0 4 .2H2 0 ).l^^ The use of 
this catalyst was first reported by Maryanoff and co-workers who had attempted to 
ox id ise  A -p h e n y  I th io u re a  ( 1 9 1 )  to the corresponding N -  
phenylaminoiminomethanesulfonic acid (192) in the absence of a catalyst (Scheme 
3 7 ) .1 2 9
(192)
NH2
(191)
Scheme 37
The authors used the reported literature procedure which employed freshly 
prepared peracetic acid or hydrogen peroxide to carry out the o x i d a t i o n . However 
they found that the oxidation was slow in comparison to the decomposition of the 
intermediates and a number of products were formed. The yield was improved by
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increasing the rate of oxidation in comparison to the rate of decomposition of the 
intermediates. It has long been known that the metal peroxo d^ complexes catalyse 
oxidation by hydrogen peroxide and that molybdenum catalysts have been used in the 
oxidation of sulfur containing groups. Marynoff found that sodium molybdate acted as a 
catalyst in the oxidation of N-phenylthiourea (191) giving the desired N-  
phenylaminoiminomethanesulfonic acid (192) in good yield.
3.3.1 Monosubstituted Derivatives
The synthesis of A-benzylaminoiminomethanesulfonic acid (193) was 
successfully undertaken using a modification of the above literature method. N- 
Benzylthiourea (181) and sodium molybdate were stirred in water at 0 °C and hydrogen 
peroxide was added dropwise to this suspension. After addition of the hydrogen 
peroxide was complete the reaction was removed from the ice bath and an exothermic 
reaction then occurred. When the exotherm was complete the reaction was cooled back 
down to 0 °C and the solid filtered and dried. A-Benzylaminoiminomethanesulfonic acid 
(193) was obtained in 85% yield.
SO3H
N NH2
(193)
The product gave a resonance in the NMR spectrum at 165.96 ppm compared 
to that for the thiocarbamyl group at 183.71 ppm. The melting point of 163-165 °C also 
agreed well with the literature value of 168 °C and the negative ion electrospray mass 
spectrum gave the necessary molecular ion, [M-H]', at 213.
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When the oxidation was initially carried out on iV-(2-phenethyl)thiourea (183) a 
product was obtained which appeared to be pure by NMR spectroscopy. However the 
negative ion electrospray mass spectrum gave the molecular ion, [M-H]", at 212 rather 
than the expected 228. It, therefore, seemed that complete oxidation had not occurred 
and that the intermediate A-(2-phenethyl)aminoiminomethanesulfinic acid (194) rather 
than A(2-phenethyl)aminoiminomethanesulfonic acid (195) had been obtained.
SOgH
N NHg
(194)
SO3H
'N" 'NH2 
(195)
However this problem was overcome by using a greater excess of hydrogen 
peroxide which ensured that the oxidation went to completion. When the reaction was 
repeated a solid was obtained in 59% yield which was seen by negative ion electrospray 
to be the product with the [M-H]" ion at 228.
3.3.2 Disubstituted Derivatives
The syntheses of A, A-dibenzylaminoiminomethanesulfonic acid (196) and N- 
benzyl-A-(2-phenethyl)aminoiminomethanesulfonic acid (197) were also completed 
using this method in 55% and 57% yields respectively.
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SOgH
(197)
The structure of iV,A-dibenzylaminoiminomethanesulfonic acid (196) was 
confirmed by the presence of the peak in the NMR spectrum at 167.69 ppm and the 
presence in the mass spectrum of the molecular ion, [M-H]" at 303.
A-Benzyl-iV-(2-phenethyl)ammoiminomethanesulfonic acid (197) also gave the 
expected [M-H]" ion at 317 in the mass spectmm and a peak in the NMR spectmm at 
168.20 ppm.
The synthesis of A,77-dicyclohexylaminoiminomethanesulfonic acid (198) was 
carried out from A/,7/-dicyclohexylthiourea (198). The product was obtained as a solid 
in 47% yield and the NMR spectrum showed the desired C-SO3H peak at 167.90 
ppm and the mass spectrum found the [M-H]" ion at 287.
SOgH
N ^  NH
(198)
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3.4 SYNTHESIS OF O-SUBSTITUTED HYDROXYLAMINES
In order to prepare the O-substituted A/-hydroxyguanidines it was decided to 
employ O-substituted hydroxy lamines as nucleophiles to react with either the 
aminoiminomethanesulfonic acids or the cyanamides. Only a few 0-substituted 
hydroxylamines are commercially available, e.g. benzyl, methyl, and so other examples 
had to be synthesised.
The route to the 0-substituted hydroxylamines requires initial A-protection, 
reaction at oxygen and then deprotection to reveal the free amino group. Two N- 
protecting groups have been examined in this work, the phthalamide group and the 
acetohydroximic acid ethyl ester.
A-Hydroxyphthalimide (199) is commercially available and substituents can be 
attached to the oxygen either via a Mitsunobu type coupling or a nucleophilic 
displacement from a carbon centred electrophile to give the (9-substituted N- 
hydroxyphthalimide (200). Removal of the phthalimide group can then be carried out 
using hydrazine hydrate to yield the desired O-substituted hydroxylamine (2 0 1 ) 
(Scheme 38). However it is clear that the use of hydrazine limits this reaction to 
hydrazine stable substituents on the oxygen atom.
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N OH N ORWhere R could be acetate, alcohols, sugars
(200)(199)
OR
(201)
Scheme 38
The use of the phthalimide methodology was employed by Nicolaou in his 
synthesis of calicheamicin yi (202 ). 3^2 Calicheamicin is a minor groove binder that 
causes double-stranded scission of DNA at oligopyrimidine runs. It is an interesting 
natural product because it cleaves the DNA selectively. The unusual feature of 
calicheamicin is the highly unusual oligosaccharide on C-8 which includes a 
hydroxylamine glycosidic linkage and an iodinated, hexasubstituted thiobenzoate. The 
oligosaccharide fragment serves as a recognition and delivery system and it binds the 
molecule to a remarkably specific sequence in the minor groove of duplex DNA at 5- 
TCCT and 5’-TTTT.
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MeO OH
HO.
MeSSS
Me
Me
OH
Me
MeO
( 202 )
The authors felt that the ring in the centre of the molecule would prove to be the 
most difficult part of the synthesis due to the array and complex nature of the 
functionality including the unusual hydroxylamino glycosidic linkage, the sulfur atom at 
the 4-position, the 2,6-dideoxy positions and by far the most challenging problem, the 2- 
deoxy~P-glycosidic linkage. The production of such linkages employ a participating 
group in the 2 position (e.g. an ester or thiophenyl) and then reductive removal of the 
group at the 2 position which in the presence of the N-O bond, which is sensitive to 
reduction, would not be synthetically possible. The authors developed new methodology 
which involved the generation of the unsaturated lactol (203) (Scheme 39). The ester 
in position 2 helps in the stereoselective incorporation of the p-hydroxylamino glycoside 
through a Mitsunobu reaction with iV-hydroxyphthalimide (200) to give (204). With 
the glycosidic linkage installed the remaining functionality of the ring can be built up. 
The exchange of the ester for a thionocarbonate or carbamate (205) would allow 
deoxygenation of position-2 and introduction of the sulfur at position-4 by a [3,3]- 
thermal sigmatropic rearrangement to yield (206). Reaction of this with an electrophile 
allows oxygenation at position-3 which is delivered stereoselectively in an intramolecular 
reaction to yield a cyclic thiocarbonate (207). Mild reduction then removes the 
electrophile and yield the protected target ring (208) which can be deprotected to give the 
target molecule (209)
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OH 0  NPhth
Mitsunobu
(203) (204)
Exchange
O NPhth NPhth
Heat
XR XR(206)
NPhthNPhth
mild
reduction
(207) (208)
Deprotection
O—  NH2
(209)
Scheme 39 
 TIE—
The most important thing about the phthalimide protecting group is the number of 
steps and range of conditions under which it remains stable, as can be seen in the 
synthesis of calicheamicin yl (202). The group can then be selectively removed by 
reaction with hydrazine hydrate in ethanol at room temperature.
The other potential route involves the use of acetohydroximic acid ethyl ester 
(210), which is also a commercially available, as the hydroxylamine equivalent. Again 
it can be envisaged that reaction of this compound either via a Mitsunobu coupling or by a 
nucleophilic displacement of a leaving group from a carbon centred electrophile would 
yield the (9-substituted acetohydroximic acid ethyl ester (211) (Scheme 40). Removal 
of the nitrogen protecting group is carried out by using hydrogen chloride gas and one 
equivalent of water.
CHg
C2H5O
:N OH
(210)
R
Scheme 40
C H 3
R could be acetate, 
alcohols, sugars, peptides etc
\ :N OR
C2H5O' (211)
HCl
HgN OR
(202)
3.4.1 0-(TetrahydrO "2-pyranyl)hydroxylam ine
Zinman reported the preparation of 1,1,3-trisubstituted hydroxyguanidines (212) 
from C-chloroformamidinium chlorides (213), which were synthesised from either the 
corresponding urea or thiourea (214). Reaction of the C-chloroformamidinium chloride 
(213) with C-tetrahydropyranylhydroxylamine (215) yielded the 0-THP protected
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1,1,3-trisubstituted hydroxy guanidine (216). Removal of the protecting group by acid 
hydrolysis yielded the 1,1,3-trisubstituted hydroxyguanidines (212) (Scheme 41). ^ 33
X = S or O
X
NOH
Cl
COCI2
Toluene
(213)
HgN— O"
(215)
N O-
Acid
R1R2N NR3R4
(212)
R‘iR2N'  ^ NR3R4
(216)
Scheme 41
O'
The synthesis of O-tetrahydropyranylhydroxylamine (215) was first reported by 
Warrener and Cain in 1976.134 They were preparing l-hydroxy-2-thiouraciI and 
required a synthesis of (9-tetrahydropyranylhydroxylamine (215). Reaction of N- 
hydroxyphthalim ide (200) with dihydro-2H-pyran (217) in THF with 
phosphoryloxychloride acting as a catalyst yielded C>-tetrahydropyranyl-/7- 
hydroxyphthalim ide (218) (Scheme 42). The O -te tra h y d ro p y ra n y l-# -  
hydroxyphthalimide (218) was then reacted with hydrazine hydrate in toluene to give the 
desired 0-(tetrahydropyranyl)hydroxylamine (215) as a clear oil.
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(217)N OH N O
(200) (218)
HgN O
(215)
Scheme 42
When the first step of the synthesis of O - te trah y  d ro p y ran y l-N - 
hydroxyphthalimide (218) was attempted instead of the expected white solid a black 
solid was obtained. Examination by tic showed a number of compounds so an attempt to 
purify by silica column chromatography using 4:1 ethyl acetate/ petroleum ether as the 
eluant was made. A white solid was obtained from the column however analysis by 
NMR spectroscopy showed no protons due to the tetrahydropyranyl group. One of the 
advantages of the tetrahydropyranyl protecting group is that it can be removed under mild 
acidic conditions so it appears that the silica used on the column was acidic enough to 
remove the protecting group.
An alternative catalyst for the reaction was then sought. There are various reports 
of catalysts for the tetrahydropyranalytion of alcohols. The use of iodotrimethylsilane as 
a catalyst in the protection of a number of primary and secondary alcohols with THP has 
been r e p o r t e d .  The alcohol and dihydropyran are stirred in dichloromethane with a
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catalytic amount of iodotrimethylsilane (or allyltrimethylsilane or hexamethyldisilane and 
a few crystals of iodine). The corresponding tetrahydropyranyl protected alcohols are 
obtained in excellent yields within 20 to 30 minutes. The use of triphenylphospine 
bromide as a catalyst has also been reported, however its use is restricted to tertiary 
a l c o h o l s .  3^6 Two groups reported that pyridinium p-tolunesulfonate (219) will act as a 
catalyst for the tetrahydropyranalation of a l c o h o l s . ^^^438 Both groups had problems 
when they tried to protect their acid sensitive alcohols using p-toluenesulfonic acid as the 
catalyst but pyridinium p-toluenesulfonate (219) is a milder reagent and is useful where 
there are acid sensitive groups present in the molecule.
The catalyst was prepared by stirring p-toluenesulfonic acid in an excess of 
pyridine at room temperature. Removal of the excess pyridine yields a solid which is then 
recrystallised from acetone to give the product (219) as a white solid in 74% yield. The 
microanalysis of the compound showed that the compound was pure and the melting 
point of 117-118 °C agrees well with the literature value of 120 °C.138
This catalyst was then used in the tetrahydropyranylation of N~ 
hydroxyphthalimide to produce (9-tetrahydropyranyl-7/-hydroxyphthalimide (218). The 
reaction was carried out in dry dichloromethane at room temperature. The white solid 
that was obtained after recrystallisation from ethyl acetate was found to be correct by 
NMR spectroscopy and had a melting point of 119-121 °C which agreed with the 
literature value of 123 °C.^39
The 0-tetrahydropyranyl-7/-hydroxyphthalimide (218) was then reacted with 
hydrazine hydrate in refluxing toluene for 5-6 hours. The reaction was filtered to remove 
the by-product (220), and the solvent removed under reduced pressure to obtain a 
yellow oil. Excess hydrazine hydrate was then removed by extraction into water. The 
yellow oil that was obtained was found to be correct by NMR spectroscopy. However 
the yield of this reaction was quite low, <20%, so an alternative route was sought. The 
reaction was tried again in toluene this time at room temperature. The reaction was 
followed by tic and after 12 hours the reaction appeared to be complete. Again the by­
product was removed by filtration and the filtrate was concentrated under reduced
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pressure to yield a clear liquid. The clear liquid was weighed, redissolved in toluene, 
washed with water and reweighed. After this it was noted that the majority of the product 
was not recovered suggesting that the product obtained was very soluble in water. This 
meant that washing with water to remove the excess hydrazine hydrate could not be 
carried out without losing significant amounts of the product in the aqueous layer.
OH
OH
(220)
Due to its unstable, explosive nature it is not possible to remove excess hydrazine 
by distillation. To overcome this problem a deficiency of hydrazine hydrate was 
therefore used rather than an excess. The reaction was thus carried out in ethanol at room 
temperature to yield a yellow residue which was distilled under reduced pressure using a 
Kugelrohr apparatus. The 0-tetrahydropyranylhydroxylamine (215) was then obtained 
as a white solid in 36% yield. The NMR spectrum of the compound showed that all the 
resonances relating to the phthalimide had disappeared and there were was a resonance in 
the spectrum due to the NH2 at 5.47 ppm. The mass spectrum also confirmed the 
structure with a peak at 118 corresponding to the [M+H]+ ion. As the yields of the 
reaction were variable, in an attempt to optimise the conditions five reactions were carried 
out in either toluene or ethanol, at various temperatures and for different periods of time.
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Table 12:- C o n d i t i o n s  a n d  r e s u l t s  o f  t h e  o p t i m i s a t i o n  o f  t h e  d e p r o t e c t i o n  o f  (215)
Reaction 
 ^ number
So Went Temp. Reaction 
. Time
%
m m
1 Ethanol RT 16 hours 34
2 Toluene RT 16 hours 43
3 Ethanol Reflux 4 hours 66
4 Toluene Reflux 4 hours 51
5 Ethanol RT 4 hours 38
It can be seen that the best results (Table 12) were obtained when the reaction 
was carried out in refluxing ethanol for 4 hours and the worst when the reaction was 
carried out in ethanol at room temperature. The reaction was then tried on a large scale 
using refluxing ethanol and 0-(tetrahydro-2-pyranyl)hydroxylamine (215) was obtained 
in a 69% yield. In addition to this increased yield the reaction was now reproducible and 
similar yields could be obtained repeatedly.
3.4.2 O -A cetylhydroxylamine
The preparation of O-acetyl hydroxylamine (221) would act as a simple model 
synthesis for the preparation of more complicated peptide derivatives for example y-L- 
glutamyl hydroxylamine (222) which was a longer term synthetic target.
O O
HgN O' CHs H2N-----
OOpH
NHp
H
(221) (222)
121
Synthesis of O-acetyl-A^-hydroxyphthalimide (223) was initially carried out in a 
very similar manner to the preparation of 0-(tetrahydro-2-pyranyl)-A '^- 
hydroxyphthalimide (218).
O
O
O
O CHs
(223)
The reaction was carried out using A^-hydroxyphthalimide (200) and an excess 
of both acetic anhydride and pyridine in dry DCM as the solvent. The yields for the 
reaction were variable and ranged from 30 to 50% and the product that was obtained was 
difficult to purify. In an attempt to improve the yield the reaction was carried out in the 
presence of a catalytic amount of DMAP (2,2-dimethylaminopyridine) (224). In this 
reaction the DMAP (224) acts as a nucleophilic catalyst and initially reacts with the acetic 
anhydride to give an more electrophilic species (225) which then reacts with the N- 
hydroxyphthalimide (200) (Scheme 43).
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CH CH3
R— OH(224)
(225)
CH
(223)
Scheme 43
A^-Hydroxyphthalimide (199), triethylamine, acetic anhydride and DMAP (224) 
were stirred in dry THF at room temperature for 18 hours. Work up gave the product as 
a white solid in 60% yield. The product had a cleaner NMR spectrum than previous 
attempts and contained a new resonance in the NMR spectrum at 162.10 ppm which 
was due to the acetate carbonyl. The mass spectrum of this solid also contained the 
desired M+ ion at 205. The deprotection of the compound was then attempted. It was a 
concern that the hydrazine might attack at the acetyl carbonyl rather than the phthalimide 
carbonyl thus giving acetyl hydrazine (226) rather than the desired O-acetyl 
hydroxylamine (221) (Scheme 44)
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N — O H
H2N —  NH
CH
( 22 6 )
(221)
Scheme 44
Indeed when this reaction was carried out the product obtained was a white solid, 
which when analysed by NMR spectroscopy and mass spectrometry was found to be N- 
hydroxyphthalimide (199). This confirmed that the acetyl carbonyl was indeed more 
susceptible to attack by hydrazine than the phthalimide carbonyl. It was decided for this 
reason to try and synthesise O-acetyl hydroxylamine (221) via the O-acetyl 
acetohydroximic acid ethyl ester (227) instead.
O
H3C,
C2H5O'
:N 0 ‘ ‘CHg
(227)
However the synthesis of the intermediate (227) proved to be very difficult. The 
synthesis was only attempted twice and in each case the product obtained was shown by 
NMR spectroscopy and tic to be 2 products. The reaction was carried out by the
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dropwise addition of a solution of freshly distilled acetyl chloride in ether to a solution of 
acetohydroximic acid ethyl ester (210) and pyridine in ether. After stirring at room 
temperature for four hours in the first experiment and sixteen hours in the second the 
reaction was worked up. In both cases the dark yellow oil was a mixture of at least 2 
components. However in both reactions there was a good indication that reaction had 
gone to some extent, because in the NMR spectrum there was a peak at 165 ppm 
which is consistent with a C=NO. However purification to obtain the desired product 
proved to be impossible.
3.4.3 O-Benzoylhydroxylamine Hydrochloride
The synthesis of (9-benzoy 1-hydroxy lamine hydrochloride (228) from the 
intermediate 0-benzoylacetohydroximic acid ethyl ester (229) has been reported in the 
literature (Scheme 45). 1^ 0
H3C.
C2 H5O
y = = N --0  H
(210)
O O
Cl Pyridine H3C
Ether
(230)
Scheme 45
C2H5O
N—O
(229)
HCl (g) 
H2O
O
CIH3N —O
(228)
Acetohydroximic acid ethyl ester (210) was therefore reacted with benzoyl 
chloride (230) in the presence of pyridine in dry ether at room temperature for 3 hours.
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Removal of the pyridinium chloride and then concentration of the filtrate yielded a white 
solid. Recrystallisation of this solid from petroleum ether (40-60 °C) gave 0-benzoyl 
acetohydroximic acid ethyl ester (229) in 58% yield (Scheme 45). The solid was 
found to be microanalytically pure and the mass spectmm showed the expected M+ ion at 
208. The melting point of 72-74 °C was close to the literature value of 77-79 °C.140
The 0-benzoyl acetohydroximic acid ethyl ester (229) was then deprotected 
using hydrogen chloride gas and one molar equivalent of water. Dry HCl gas was 
bubbled into a solution of O-benzoyl acetohydroximic acid ethyl ester (229) in dioxan 
and the O-benzoyl hydroxylamine hydrochloride (228) crystallised out of solution. The 
compound was then characterised and the NMR spectrum showed no resonances due to 
the acetohydroximic acid ethyl ester protecting group suggesting that it had been 
removed. The mass spectrum showed the expected molecular ion at 174 and the melting 
point of 106-108 °C, agreed well with the literature data of 110-112 °C.^40
3.4.4 O -U rethane Derivatives
As a comparison with the deprotection of 77-acetyl-phthalimide (223) it was 
decided to synthesise 0-butylcarbamyl-iV-hydroxyphthalimide (231). Due to the 
resonance effect of the O and N atoms the carbonyl in the urethane derivative is much less 
reactive than the carbonyl in the acetyl derivative.
O
O
(231)
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O-Butylcarbamyi-A/'-hydroxyphthalimide (231) was easily prepared by the 
reaction of iV-hydroxyphthalimide (199) and «-butyl isocyanate in dry THF. The 
solvent was removed under reduced pressure when the tic indicated that the two starting 
materials had disappeared. The product was obtained as an orange oil and NMR 
spectroscopy indicated that the reaction had indeed occurred due to the presence in the 
NMR spectrum of the carbonyl peak at 164.26 ppm The deprotection of 0~ 
butylcarbamyl-A-hydroxyphthalimide (231) was then attempted by refluxing with 
hydrazine hydrate in ethanol for four hours. A dark oil was obtained which, when 
examined by tic, was shown to contain a number of products. It proved to be impossible 
to separate these products using column chromatography and only the starting material, 
^/-hydroxyphthalimide (199), was isolated.
The preparation of these compounds was then attempted via the acetohydroximic 
acid ethyl ester derivatives. In the synthesis via the phthalimide derivative an aliphatic 
isocyanate was used to give groups which would be easier to identify on the NMR 
spectra. However in this case it was important not to have aliphatic groups as they were 
already present on the acetohydroximic acid ethyl ester and so it was decided to work 
with benzyl isocyanate and synthesise 0-benzylcarbamyl acetohydroximic acid ethyl 
ester (232).
H3C.
\ = N  O
(232)
Acetohydroximic acid ethyl ester (210) was stirred in dry ether and benzyl 
isocyanate added dropwise to this solution. The reaction was stirred at room temperature 
for 3 hours and then the solvent removed under reduced pressure to yield a dark oil 
which was shown by tic to contain some product but also some of both starting materials.
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However the synthesis of 0 -(p-methoxyphenyl)hydroxylamine (233) was 
achieved using p-methoxyphenyl isocyanate (234) and acetohydroximic acid ethyl ester 
(210). This reaction occurs more readily because the isocyanate is more reactive due to 
the presence of the electron withdrawing ;?-methoxyphenyl substituent. The isocyanate 
(234) and the acetohydroximic acid ethyl ester (210) were heated at reflux for an hour 
and then stirred for 18 hours at room temperature before being worked up to give the 
crude p-methoxyphenyl acetohydroximic acid ethyl ester (235) (Scheme 46). This 
compound was stable enough to be purified by column chromatography and give the 
purified product as a white solid in 40% yield. The NMR spectral data was consistent 
with the expected product with the carbonyl resonance found in the NMR spectrum 
at 149.51 ppm.
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HON C OH3CO
(234) (210)
Ether
.OH
H3CO
(233)
Scheme 46
The deprotection was then achieved by cooling a solution of 0 - (4 -  
methoxyphenylcarbamyl)acetohydroximic acid ethyl ester (235) in dioxan and water to 0 
°C and bubbling dry hydrogen chloride gas through for thirty minutes. The reaction was 
diluted with diethyl ether and the precipitated solid was filtered and washed with diethyl 
ether and dried to give the product (233) as a white solid in 95% yield. The and 
NMR spectra both confirmed the absence of the acetohydroximic acid ethyl ester 
resonances and the presence of the expected resonances due to the methoxyphenyl group.
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3.4.5 O-Trimethylsilylhydroxylamine
The advantage of a trimethylsilane protecting group is that removal is normally 
carried out using TBAF (tetra butyl ammonium fluoride, BU4N+ F'). There are at least 
two syntheses of 0-trimethylsilylhydroxylamine (236) in the literature with the first 
reported in 1983.1' !^
ÇH3
H3C Si O  NH2
CH3
(236)
The 0-trimethylsilylhydroxylamine (236) was used as an intermediate in the 
synthesis of A-(diphenylphosphinoyl)hydroxylamine (237).
Ph NHOH
(237)
The 0-trimethylsilylhydroxylamine (236) was prepared by reaction of finely 
ground hydroxylamine hydrochloride and a mixture of 1,1,1,3,3,3-hexamethyldisilazane 
and tripropylamine. The reaction was stirred at room temperature for 24 hours and then 
filtered under nitrogen to remove the solid (PrgNHCl). Distillation of the filtrate yielded 
the desired 0-trimethylsilylhydroxylamine (236) in 72% yield. The problem with this 
synthesis would be the distillation as the product and by-products all have very similar 
boiling points and the distillation required specialist apparatus.
Zwierzak and co-workers reported the synthesis 0-trimethylsilylhydroxylamine 
(236) via an alternative route (Scheme 47).^^2
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ÇH3 ÇH3
HO —  NH3CI + Cl— S i----CH3 H 2N C H 2C H 2N H ^ 11 — 0 ----- SI— CH3
D C M
CH3 CH3
(238)
Scheme 47
(236)
They prepared the 0-trimethylsilylhydroxylamine (236) by vigorously stirring 
finely powdered hydroxylamine hydrochloride in ethylenediamine in dichloromethane. 
This mixture was stirred at room temperature for 6 hours until there were two clearly 
defined liquid phases present. Chlorotrimethylsilane (238) was added dropwise over a 
period of an hour. After reflux was complete the reaction was stirred at room temperature 
for 24 hours. Removal of the salt and evaporation of the solvent yielded a clear liquid 
that was distilled to give the 0-trimethylsilylhydroxylamine (236) as a clear liquid (b.p. 
98-100 °C) in 58% yield. The advantage of this reaction is that the by-products have 
boiling points which are different enough from the product that the distillation becomes 
simpler.
This reaction was attempted using the above method and the clear liquid was 
obtained in three different fractions in 56% yield. The b.p. of this liquid, 98-100 °C, 
was in good agreement with the literature value of 98-100 °C under an identical vacuum.
3.4.6 0 “Glycosylhydroxylam ine
One of the longer term aims of the project was the synthesis of A-substituted 
hydroxyguanidines (239) with a sugar moiety attached to the oxygen via a glycosidic 
linkage. These could be synthesised from O-glycosylhydroxylamines (240) and the 
desired aminoiminomethanesulfonic acid (164) (Figure 10).
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Figure 10
Therefore the synthesis of O -(te tra-0 -ace ty l-D -g lucopyranose) 
hydroxyphthalimide (241) was undertaken. Initially this synthesis was attempted from
2,3,4,6-tetra-O-acetyl-1 -bromo-a-D-glucopyranose (242) and N-hydroxyphthalimide 
(199) (Scheme 48)
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(241)
Scheme 48
2,3,4,6“Tetra-0-acetyl-l-bromo-a-D-glucopyranose (242) was synthesised 
from D-glucose which was dissolved in acetic anhydride and hydrobromic acid in acetic 
acid was added. The reaction was then stirred at room temperature before further excess 
hydrobromic acid in acetic acid was added and the reaction stirred overnight. Work up of 
the reaction yielded a white solid which was further purified by recrystallisation from 
from ether. The melting point of the solid, 87-88 °C, agreed well with the literature value 
of 88-89 °C.143
A^-Hydroxyphthalimide (199) was then dissolved in dry THF and sodium 
hydride was added in small portions. To the dark solution that was produced was added
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2 ,3 ,4 ,6-tetra-O-acetyl-l-bromo-a-D-glucopyranose (242) before the reaction was 
stirred overnight at room temperature. The reaction was worked up by first adding 
water, to quench any unreacted sodium hydride and then concentrating under reduced 
pressure. The residue that was obtained was redissolved in water and extracted with 
ethyl acetate. The ethyl acetate was removed under reduced pressure to yield a white 
solid. This white solid was shown to be 2,3,4,6-tetra-O-acetyl-l-bromo-a-D- 
glucopyranose (242) by the and NMR spectroscopy showing that the reaction 
had been unsuccessful.
The synthesis of the protected phthalimide derivative (241) was then attempted 
using a Mitsunobu coupling of A^-hydroxyphthalimide (199) and 2,3,4,6-tetra-O-acetyl- 
a/p-D-glucopyranose (243). The 2,3,4,6-tetra-O-acetyl-a/p-D-glucopyranose (243) 
was synthesised in a simple two step procedure from D-glucono-y-lactone (244) 
(Scheme 49).
HO AcO
HO AcOHO AcO
O H
(244)
OAc
(245)
NaBH,
THF
AcO
AcO
AcO
OAc O H
(243)
Scheme 49
134
D-Glucono-y-Iactone (244) was acetylated using acetic anhydride and zinc 
chloride. The reaction was stirred at room temperature for 40 minutes and then poured 
onto ice, extraction of the aqueous layer with dichloromethane and subsequent vigorous 
removal of the solvent yielded 2,3,4,6-tetra-O-acetyl-D-glucono-y-lactone (245) as a oil 
in quantitative yield. The NMR spectra showed the compound to be correct with a 
resonance in the spectrum for C-1 (lactone) at 164.59 ppm and the mass spectrum 
showed the M+ ion at 347. Reduction of the ketone functionality occurred by dissolving 
(245) in THF and cooling the solution to 0 °C and adding a solution of sodium 
borohydride in water. The reaction was stirred at 0 °C for three hours before DOWEX 
SOW ion exchange resin was added. Removal of the resin by filtration and concentration 
of the filtrate under reduced pressure yielded an oil. This oil was washed with methanol 
to give the product, 2,3,4,6-tetra-O-acetyl-a/p-glucopyranose (243) as an oil in 58% 
yield. The NMR spectrum showed the disappearance of the C-1 resonance at 164.59 
and the presence of new C-1 resonances at 90.15 and 95.54 ppm coiTesponding to the a  
and P anomers respectively.
The Mitsunobu coupling of (243) was then attempted by dissolving (243) in 
dry THF and adding A^-hydroxyphthlamide (199) and triphenylphosphine. To the 
resulting suspension diethyl azodicarboxylate was added and the reaction stirred for 
twenty hours at room temperature. Concentration of the reaction yielded an oil which 
was purified by column chromatography to yield a number of compounds. When the 
NMR spectra of these compounds were checked it was seen that these materials were 
starting materials indicating that reaction had not occurred. Other attempts were made at 
this reaction including one using 2,3,4,6-tetra-O-benzyl-D-glucopyranose (246) instead 
of (243). In this reaction methanol was added to the crude reaction product and a solid 
precipitated which was purified by column chromatography and found by NMR 
spectroscopy to be the starting material. As it was clear that this reaction was not 
occurring an alternative method of coupling the protected glucose to N- 
hydroxyphthalimide (199) was sought.
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BnO
BnO
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O H
(246)
Work within the group has shown that 2,3,4,6-tetra-(9-acetyl-a-D - 
glucopyranosyl trichloroacetimidate (247) can be coupled with hydroxyl groups in the 
presence of boron trifluoride etherate. ^ 44
AcO
AcO
AcO
OAc
O CCI3
(247)
2.3.4.6-Tetra-0~acetyl-a-D-glucopyranose (243) and trichloroacetonitrile were 
stirred in DCM and glowing hot potassium carbonate was added. The reaction was 
stirred for twenty five hours at room temperature and then the inorganic salts were 
removed by filtration and the reaction concentrated under reduced pressure to give an oil 
which was purified by column chromatography to yield 2,3,4,6-tetra-O-acety 1-a-D- 
glucopyranosyl trichloroacetimidate (247) in 43% yield. The NMR spectrum 
showed the expected doublet due to H-1 at 6.55 and the resonance due to the NH at 8.7 
ppm and the NMR spectrum showed resonances at 92.88 and 160.87 due to the C-1 
and C=NH respectively.
2.3.4.6-Tetra-O-acetyl-a-D-glucopyranosyl trichloroacetimidate (247) and N- 
hydroxyphthalimide (199) were then stirred in dry DCM and cooled to -15 °C. To the 
suspension was added boron trifluoride diethyl etherate and the reaction was stirred for 
75 minutes before it was recooled and further, excess boron trifluoride diethyl etherate
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was added and the reaction stirred overnight at room temperature. The reaction was then 
worked up and an oil obtained which was stirred in methanol until a solid precipitated. 
The solid was filtered and gave the desired product, 0 -(te tra -0 -ace ty l-a -D - 
glucopyranose)-iV-hydroxyphthalimide (241) in 29% yield. The mass spectrum of this 
solid showed the molecular ion corresponding to [M+Na]+ at 516 and the NMR 
spectrum showed a resonance corresponding to C-1 at 103.91 ppm. The major problem 
with this reaction is the low yield of the coupling reaction band also the low yield of the
2,3,4,6-tetra-O-acetyl-a-D-glucopyranosyl trichloroacetimidate (247). Further work is 
required to optimise this reaction to provide synthetically useful amounts of the material.
O
AcO
OAcAcO
(241)
OAc
The removal of the phthalimide group proved to be difficult so it was decided to 
look at an alternative protecting group, 2,3,4,6-tetrachloro-A^-hydroxyphthalimide 
(248). The desired compound was synthesised by reacting tetrachlorophthalic 
anhydride (249) and hydroxylamine in refluxing 2M aqueous sodium hydroxide 
(Scheme 50). The reaction was heated under reflux for eight hours and then stirred at 
room temperature overnight before partial concentration under reduced pressure yielded 
the product in 56% yield.
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However before it was required to use this protecting group the deprotection of 
0-(tetra-0-acetyl-a-D-glucopyranose)-iV-hydroxyphthalimide (241) was successfully 
achieved using hydrazine hydrate in refluxing THF. The reaction was heated under 
reflux for ten minutes and then cooled to room temperature and diluted with sodium 
bicarbonate solution. Extraction with diethyl ether and then concentration under reduced 
pressure yielded the crude 0-(tetra-0-acetyl-D-glucopyranose)hydroxylamine (250) 
The solid was contaminated with some of the phthalizine (220) by-product, however it 
was decided to react this product on in a crade form to see whether or not the next step 
would occur.
3.4.7 (9-Mono and Disubstituted Nitrophenylhydroxylamines
The syntheses of 0-(4-nitrophenyl)hydroxylamine (251) and 0 -(2 ,4 - 
dinitrophenyl)hydroxylamine (252) were attempted.
O2N
H2N— O' \  /
(251)
NO. H2N O- \  / NO2
(252)
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The O-protected N-hydroxyguandine derivatives of (251) and (252) should 
give N-O bond cleavage to give the guanidine derivative (253), which is in fact 
undesirable (Scheme 51). However it would be useful to know how these derivatives 
behaved in comparison to other example especially in light of the difficulties with the 
attempted removal of the benzyl group from (9-benzyl N-hydroxyguanidines (Section 
3.5.4). The (9-benzyl derivatives gave N-0 bond cleavage despite the fact that the 
benzyl group is a poorer leaving group than either of the nitro derivatives.
N — O
NHg
N —  OH
NHg NH2
(253)
HO NO2
Scheme 51
It was envisaged that these compounds could be synthesised from N- 
hydroxyphthalimide (199) and the corresponding fluoronitrobenzene. Initial attempts 
involved the attempted synthesis of (9-(4-nitrophenyl)-N-hydroxyphthalimide (254). N- 
Hydroxyphthalimide (199) was stirred in dry DCM and 4-fluoronitrobenzene and 
pyridine added, after sixteen hours at room temperature the reaction was checked by tic 
and found not to have occurred. The reaction was then heated at between 40 and 60 °C
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for twelve hours and then stirred for seven days at room temperature. After work up an 
orange solid was obtained which was checked by NMR spectroscopy and tic. The NMR 
spectra showed that the solid was a mixture of compounds and this was confirmed by tic. 
The 4-fluoronitrobenzene may not have been electrophilic enough and it was decided to 
use the 2,4-dinitrofluorobenzene derivative instead.
N—-o NO2
(254)
OpN
N — O NO,
(255)
The preparation of 0-(2,4-dinitrophenyl)-A-hydroxyphthalimide (255) was 
initially attempted using the method that had been successful in preparing 0-acetyl- 
hydroxylamine (223), the addition of catalytic DMAP. A-Hydroxyphthalimide (199), 
2,4-dinitrofluorobenzene, triethylamine and a catalytic amount of DMAP were stirred in 
dry THF. The reaction was stirred at room temperature for twenty four hours and then 
worked up in an identical manner to the preparation of 0-acetyl-A-hydroxyphthalimide 
(223). The solid was then characterised by tic and NMR spectroscopy and both of these 
showed that the solid was a mixture of two compounds with the expected phthalimide 
protons at 7.9-8.1 ppm being absent from the spectrum. It was then thought that N- 
hydroxyphthalimide might not be nucleophilic enough to attack the 2,4- 
dinitrofluorobenzene so it was decided that it might be possible to improve its 
nucleophilic character by initially deprotonating the /7-hydroxyphthalimide (199) using 
sodium hydride, this then should react with the 2,4-dinitrofluorobenzene to give the 
desired substituted phthalimide (Scheme 52).
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When the reaction was attempted, A^~hydroxyphthalimide (199) was stirred in 
dry THF and sodium hydride was added in small portions. When evolution of hydrogen 
was complete 2,4-dinitrofluorobenzene was added. The reaction was then stirred at room 
temperature for forty eight hours and worked up. A yellow solid was obtained, however 
the NMR spectra of this solid suggested that it was a mixture with at least two 
compounds present. A subsequent attempt where the reaction was refluxed for six hours 
also failed.
It was then decided to take a different approach, and attempt a Mitsunobu 
coupling between A-hydroxyphthalimide (199) and 2,4-dinitrophenol. N- 
Hydroxyphthalimide (199) was dissolved in cold THF and 2,4-dinitrophenol and 
triphenylphosphine were then added. Diethyl azodicarboxylate was then added dropwise 
over a period of 10 minutes. The resulting solution was stirred at room temperature for 
30 minutes and then worked up. The NMR spectra of the crude product showed that a
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number of products were present, these were mainly the byproducts from the reaction 
and this was confirmed by tic. However attempts to purify this compound by column 
chromatography failed. All the by products were isolated but the desired product 
appeared to be left on the column.
In light of this failure it was decided to leave the synthesis of these two 
hydroxylamines and concentrate on the other derivatives.
3.5 SYNTHESIS OF O-SUBSTITUTED A-HYDROXYGUANIDINES 
3.5.1 Synthesis Of O-Benzyl A-Hydroxyguanidines
The synthesis of 0-benzyl substituted hydroxyguanidines (256) was attempted 
first because O-benzylhydroxylamine hydrochloride (257) is a commercially available 
compound allowing the optimisation of the reaction conditions without using material that 
had required a multistep synthesis to obtain. The initial synthetic procedure examined 
was the reaction of O-benzylhydroxylamine hydrochloride (257) with the substituted 
aminoiminomethanesulfonic acids (164) (Scheme 53)
SO3H
R
R' /  (164)
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N OCHzCgHs
NH2
(256)
The first attempts at the reaction employed triethylamine as the base and 
acetonitrile as the solvent. The reaction was stirred at room temperature for twenty four 
hours and then it was concentrated under reduced pressure to yield an oil. Extraction of 
the product into diethyl ether gave an oil which was shown by NMR spectroscopy to be 
inconsistent with the expected product.
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The reactions were then carried out by stirring the potassium carbonate and 0~ 
benzylhydroxylamine hydrochloride in water until a solution was obtained and then the 
aminoiminomethanesulfonic acid added in small portions over a ten minute period. The 
reaction was stirred at room temperature for twenty four hours and then the product was 
filtered off if it was solid, or extracted into ethyl acetate if it was not quite solid.
3.5.1.2 Monosubstituted Derivatives
(9-Benzyl-l-benzyl-2-hydroxyguanidine (258) was synthesised using this 
procedure. The reaction was stirred at room temperature for eight hours and then the 
white solid that was present was filtered off and dried under vacuum to give the product 
in 48% yield.
(258)
The white solid was microanalytically pure and showed a new CH2 resonance 
due to the (9-benzyl group at 4.7 ppm in the NMR spectrum and 74.27 ppm in the 
NMR spectmm. The resonance due to the C of the guanidino group was observed at 
154.95 ppm in the NMR spectrum, which was different from the quaternary carbon 
resonance at 165.96 ppm in the NMR spectrum of the starting material. The mass 
spectmm of the compound gave the expected M+ ion at 255.
Initially there were problems with the synthesis of (9-benzyl-1 -(2-phenethyl)-2- 
hydroxyguanidine (259).
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(259)
This was probably caused by the problems described for the oxidation step and it 
is known that the SO2H group is not as good a leaving group as SO3H and it may have 
been that the reaction was slower. However once the correct sulfonic acid had been 
obtained the reaction of A-(2-phenethyl)aminoiminomethanesulfonic acid (195) 
proceeded as previously described. However instead of a solid being obtained a sticky 
mass was found in the bottom of the flask. This mass was extracted into ethyl acetate 
and the product was subsequently obtained as a colourless oil in 46% yield. The ^H and 
NMR spectra showed the resonances for the CH2 of the benzyl group at 4.70 ppm 
and 72.17 ppm respectively. The mass spectrum of the oil also gave the desired M+ ion 
at 269.
3.5.1.2 Disubstituted Derivatives
The synthesis of 0-benzyl-l,l-dibenzyl-2-hydroxyguanidine (260) was 
achieved in 89% yield. The solid that was obtained was purified by recrystallising the 
crude solid from ethyl acetate.
(260)
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The product was found to be microanaytically pure and gave the correct M+ ion at 
345 in the mass spectrum. The NMR spectrum also showed a peak at 75.97 ppm 
due to the CH2 of the benzyl group and a peak at 157.63 ppm due to the guanidino 
carbon.
Various attempts have been made to synthesise O-benzyl-1-benzyl-1-(2- 
phenethyl)-2-hydroxyguanidine (261) from the corresponding sulfonic acid (197). 
Initially standard reaction conditions were used, O-benzylhydroxylamine hydrochloride 
and potassium carbonate were dissolved in water and the sulfonic acid added in small 
portions over a period of 10 minutes. The reaction was stirred for 14-18 hours at room 
temperature. Normally a solid is formed that can be filtered off however in this case a 
thick oil was produced, which was extracted into ethyl acetate. Concentration of the ethyl 
acetate under reduced pressure to give an orange oil. NMR showed that this oil was 
probably a mixture of two components, although the second component was only a 
minor impurity. Numerous attempts were made to try and either crystallise the product or 
the impurity from this oil, however they were all unsuccessful. Separation was attempted 
by column chromatography using 3:1 ethyl acetate / petroleum ether as the eluant, 
however when this was attempted none of the desired product (261) was obtained.
\ N
(261)
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3.5.1.3. Attempted Synthesis of O-Benzyl Derivatives From The 
Corresponding Cyanamides
In light of the difficulty in synthesising 0-benzyl-V-benzyl-iV-(2-phenethyl)-2- 
hydroxyguanidine (261) from the sulfonic acid it was decided to attempt the synthesis 
from the corresponding cyan amide (118). V-BenzyI-7/-(2-phenethyl)cyanamide (118) 
was stirred in DMF and O-benzylhydroxylamine hydrochloride (257) and sodium 
carbonate added. The reaction was then heated under reflux for 2 hours before the 
reaction mixture was filtered hot and the inorganic salts washed with warm DMF. The 
combined organic extracts were concentrated under reduced pressure to yield an oil which 
showed the presence of the O-benzyl group by NMR and NMR. When an 
attempt to purify the compound using distillation was undertaken a clear oil was obtained 
which when examined by NMR was found to be O-benzylhydroxylamine. The 
distillation residue was also examined and found to contain none of the desired product. 
At this point at was assumed that the distillation must have caused a degradation of the 
compound back to the starting material. However when the synthesis of O-benzyl-1- 
ethy 1-1 -(p-tolyl)-2-hydroxyguanidine (262) was attempted a similar result was achieved.
N O
H3C ^ N NH2
CH2CH3 
(262)
However in this reaction the purification was attempted using column 
chromatography. These two reactions would suggest that the reaction via the cyanamide 
does not occur which seems a strange result and at present limits the synthesis of O- 
substituted N-hydroxyguanidines to derivatives where the aminoiminomethanesulfonic 
acid can be synthesised.
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3.5.1.4 Deprotection of D-benzyl A-hydroxyguanidines
Originally it was envisaged that one possible route to the free N- 
hydroxyguanidines was by deprototection of the 0-benzyl substituted derivatives 
(Schem e 54)
Rl N----- OCH2 C6 H5  N----- OH\ ^  Deprotection ^ ^
Scheme 54
The obvious method to remove the benzyl group was reaction with hydrogen gas 
with a palladium on carbon catalyst. Initial attempts using 5% palladium on carbon 
proved to be unsuccessful with a mixture of compounds being obtained. This was also 
the case when 10% palladium on carbon was employed.
Although there was the potential for the added complication of the removal of the 
A-benzyl group, experiments have been carried out under more vigorous conditions. 
The deprotection of 0-benzyl-1-benzy 1-2-hydroxy guanidine (258) was attempted using 
ethanol with a catalytic amount of acetic acid and 10% palladium on charcoal in non- 
catalytic amount ( 1:1 catalyst to compound). The reaction was stirred under an 
atmosphere of hydrogen gas for sixty one hours. The reaction was monitored by tic and 
worked up when the reactant spot had disappeared. The product was obtained as an off 
white solid. The NMR spectrum of the product showed that the peaks due the CH^ of 
the 0-benzyl group had disappeared from both the Hd and spectra. The tic also 
showed that the product was only one compound and the Rf value was different from the 
starting material. However, when the mass spectrum was obtained it showed that the 
principal molecular ion M+ was at 149 and not at 165 as would be expected if the 
compound was 1 -benzy 1-2-hydroxyguanidine (263). There were 2 other possible
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products that could of been obtained from the reaction. The first was benzylurea (264) 
which could be formed by attack of water at the carbon but this compound has a 
molecular weight of 150. The second product could arise from the hydrogen adding 
across the N-O bond rather than the C-O bond to give #-benzylguanidine (265). This 
reaction could be catalysed by the acetic acid.
NH2
(264) (265)
It was decided to investigate this N-O bond cleavage as there appears to be no 
literature precedent for this reaction for //-hydroxyguanidines. The first problem was to 
obtain //-benzylguanidine (265) but as the compound is not commercially available a 
synthesis had to be found. The most logical method was to try reacting aqueous ammonia 
with iV-benzylaminoiminomethanesulfonic acid (193) (Scheme 55).
SO3H NH
NH2
(193) (265)
Scheme 55
The reaction was carried out in water with potassium carbonate as a base. After 
stirring at room temperature for 24 hours the solvent was removed and the residue was 
stirred in ethanol. The insoluble salts were then filtered and the filtrate reduced under 
reduced pressure to give a white solid. The NMR spectrum of the product was
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inconclusive as there is very little present in the molecule, however the mass spectrum 
indicated that the expected M+ ion at 149 was present. The authentic compound was then 
compared to the compound obtained from the hydrogenation and there was found to be 
good agreement in the data and the tic showed that both compounds had the same R f 
value.
At the same time it was decided to try a number of control experiments. The first 
was an attempted acid hydrolysis of O-benzyl-l-benzyl-2-hydroxyguanidine (258) 
(Scheme 56). The protected hydroxyguanidine (258) was dissolved in ethanol and a 
few drops of acetic acid were then added. Palladium on charcoal was then added before 
the flask was purged with nitrogen and stirred under an nitrogen atmosphere for forty 
eight hours. The reaction was then worked up and a yellow oil was obtained. The NMR 
spectmm showed that the 0-benzyl group was still present in the compound. It was also 
shown by tic that the product, which was a single spot, had the same Rf value as the 
starting material. The second experiment was a hydrogenation without the presence of 
the acetic acid. The reaction was stirred at room temperature for forty eight hours and 
then worked up. Again both the NMR spectrum and tic suggested that the yellow oil that 
was obtained was starting material. These controlled experiments would suggest that the 
hydrogenation does not occur without the presence of the acetic acid but that in the 
presence of the acid the N-O bond is cleaved rather than the C-O bond.
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N ——  OHN OCHoCeHj
10# inC
NH. OH NH
(258) (263)
OH
NH NH,
(258) (263)
Scheme 56
These deprotections were also been attempted on (9-benzyl-l-phenethyl-2- 
hydroxy guanidine (259) and (9-benzyl-1,1 -dibenzy 1-2-hydroxy guanidine (260) and 
again the free A^-hydroxyguanidine was not obtained.
The deprotection of (9-benzyl-1-benzy 1-hydroxyguanidine (258) has been 
attempted in a number of other solvents. Attempts have been made in ethyl acetate and 
trifluroethanol but again these reactions appear to be incomplete. There are literature 
reports where palladium hydroxide on carbon has been used as a catalyst for the removal 
of benzyl groups where all attempts with palladium on carbon have failed. This catalyst 
was used in an attempt to remove the benzyl group from (9-benzyl-1-phenethyl- 
hydroxyguanidine (259) however again there was very little evidence that the benzyl 
group had been removed.
Jung and co-workers reported a deprotection of alkyl ethers using 
trimethylsilyliodide (266) (Scheme 57).^^5
150
HgC S i  1R  O
CHg
(266)
CHg
o  S i— CHg + Ri CH;
OHOH
Scheme 57
There are literature reports that suggested that this reaction is slower with //-alkyl 
species and in the presence of both the reaction will preferentially occur at the alkyl ether 
group. The reaction was thus attempted by dissolving O-benzyl-1,1-dibenzy 1-2- 
hydroxyguanidine (260) in chloroform under a nitrogen atmosphere. 
Trimethylsilyliodide (266) was then added and the reaction stirred at room temperature 
for two hours. Methanol was then added to quench the reaction, the solvent was 
removed under vacuum to give the product as a dark red oil. Purification involved 
slowly passing the compound through a silica column with dichloromethane/ isopropanol 
(95:5%) as the eluant. The NMR spectrum of the compound appeared to be correct but
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the mass spectra of the compound showed an M+ ion at 149 which was consistent with 
the formation of the //,//-dibenzylguanidine species.
It was decided since the synthesis of the free A/'-hydroxyguanidines had been 
completed by other methods that there was no requirement to do any further work on this 
deprotection reaction. However the results seem to be inconsistent with the work of 
Feldman (Section 2.2.2 jje reported the synthesis of A/-hydroxy-L-arginine, 
where the last step of his synthesis was removal of the O-benzyl protecting group using 
catalytic hydrogenation. This step was reported to give a 30% yield of the desired 
product. There was no mention of any problem with N-O bond cleavage.
3.5.2 SYNTHESIS OF <9-THP //-H Y D RO X Y G U A N ID IN ES
The preparation of 0-T H P-1,1 -dibenzyl-2-hydroxyguanidine (268) was 
attempted by reacting 7V,//-dibenzylaminoiminomethanesulfonic acid (196) with O- 
THP-hydroxylamine (215) together in dry DMF (Scheme 58). The sulfonic acid, O- 
THP-hydroxylamine (215) and sodium carbonate were stirred together in dry DMF and 
then stirred at 40-60 °C for seven hours followed by fourteen hours at room temperature. 
On work up a solid was obtained however the purification of this compound was 
impossible. A number of recrystallisations were tried and all failed and a small portion 
was passed down a short silica column using ethyl acetate as the eluant and another solid 
obtained. However the NMR spectra showed the absence of the THP group and 
suggested that the column had cleaved this group from the molecule. It is known that 
THP groups are acid sensitive and it seems that silica is acidic enough to remove the 
group.
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SOgH
NH
(196) (215)
DMF 
40-60 °C
NHg
(268)
Scheme 58
The synthesis of 0-TH P-1,1 “dibenzyl-2-hydroxyguanidine (268) was then 
attempted using identical methodology to that which had been successful in the synthesis 
of the O-benzyl derivatives (Section 3.5.1). 0-THP-Hydroxylamine (215) and 
po tassium  carbonate  were d isso lved  in w ater and N , N -  
dibenzylaminoiminomethanesulfonic acid (196) was added over ten minutes. The 
reaction was stirred overnight at room temperature and then the solid that was present 
was filtered off and dried. The NMR spectrum showed that there was some of the 
expected product present because there was a C=N resonance at 158 ppm. However the 
purification of this compound proved to be very difficult and various techniques were 
tried including a small scale reverse phase silica purification using a Sep-pack. However 
although this did indeed give the desired product in a 1% yield it was not 
microanalytically pure and clearly the yield was less than desirable.
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After a number of attempts at the purification it was found that the pure compound 
could be obtained by heating the crude mixture in refluxing diethyl ether and then the 
insoluble by-product could be removed by filtration. The pure product then crystallised 
from the filtrate. The white solid was found to be microanalytically pure and the 
NMR spectmm contained all the expected peaks including the peak at 158.05 ppm due to 
the guanidino carbon. The desired molecular ion, M+ was also observed in the mass 
spectrum at 340. Although the yield of the reaction was only 28% this was still a distinct 
improvement over previous attempts.
The synthesis of other derivatives including 0-TH P-1-benzyl-1-methy 1-2- 
hydroxy guanidine (269) and O-THP-1 -benzyl-1 -(2-phenethyl)-2-hydroxyguanidine
(270) was then attempted.
(270)
For 0-TH P-1 -benzyl-1 -methyl-2-hydroxyguanidine (269) the reaction was 
carried out as described before using A-benzyl-A-methylaminoiminomethanesulfonic
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acid, 0-THP-hydroxylamine (215) and potassium carbonate in water. Purification of 
the product was attempted by heating in refluxing diethyl ether and subsequent removal 
of the insoluble by-products. However the ^H NMR spectrum of the white solid which 
was obtained showed the absence of the THP group and the spectrum was very similar to 
that obtained for 1-benzyl-1-methy 1-2-hydroxy guanidine (137). When the NMR 
spectrum was obtained of the white solid it was confirmed that the product was the 
hydroxyguanidine because there was a peak at 156 ppm due to the C=N. This is an 
interesting result because for 1-benzyl-1-methy 1-2-hydroxy guanidine (137) to have been 
obtained the O-THP-hydroxylamime must have reacted to give the desired product (269) 
which was then hydrolysed to give the free hydroxyguanidine (137). This confirms a 
previous result with (9-THP-l-benzyl-l-methyl-2-hydroxyguanidine (269) which was 
seen to decompose when an attempt to purify the reaction by washing with dilute acid 
was undertaken. The 0-THP-1-benzyl-1-methy 1-2-hydroxy guanidine (269) had been 
seen to be present in the reaction mixture before this acid wash and after the wash the 
product was shown by ^H and NMR to be 1 -benzyl-1 -methyl-2-hydroxyguanidine 
(137). This seems to suggest that 0-TH P-1-benzyl-1-methy 1-2-hydroxy guanidine 
(269) is less stable than the dibenzyl substituted analogue and that purification may only 
be possible using reverse phase HPLC.
The synthesis of 0-THP-1 -benzyl-1 -(2-phenethy 1)-2-hydroxyguanidine (270) 
has proved equally unsuccessful and again the problem is with the purification which 
proved totally unsuccessful even using the method that worked for 0-THP-1,1-dibenzy 1- 
2-hydroxyguanidine (268). The synthesis of this compound was also attempted via the 
A-benzyl-A-(2-phenethyl)cyanamide (118). A-Benzyl-A-(2-phenethyl)cyanamide 
(118) was added to a solution of 0-THP-hydroxylamine (215) in DMF. Sodium 
carbonate was then added to this solution before the reaction was heated under reflux for 
periods of time ranging from four to twelve hours. In every case when the inorganic 
salts were removed and the DMF concentrated under reduced pressure an oil was 
obtained which was added to water in an attempt to crystallise the product. However no 
ciystallisation occurred and the oil was extracted back into ethyl acetate. Removal of the
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ethyl acetate yielded an oil which was shown in the NMR spectrum to contain no THP 
group. This suggested that reaction had not occurred and the oil obtained was the 
cyanamide starting material.
The situation was the same with O-THP-1-benzy 1-2-hydroxy guanidine (271). 
The reaction was carried out and it was shown by NMR spectroscopy that the crude 
product contained some of desired product. However purification of the product was not 
possible.
(271)
The problems in purification might be solved by the use of preparative HPLC 
because work done on these compounds (Chapter 4) has shown that they are stable and 
can be separated from possible by-products.
3.5.3 SYNTHESIS OF O-GLYCOSYL iV-HYDROXYGUANIDINES
Due to lack of time only the synthesis of D-(tetra-O-acetyl-D-glucopyranose)-1,1- 
dibenzyl-2-hydroxyguanidine (272) was attempted.
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N-----
AcO
OAc
OAc
OAc
NH2
(272)
The synthesis of the compound was attempted by reacting the corresponding 
A^,A/^-dibenzylaminoiminomethanesulfonic acid (196) with 0-(tetra-0-acetyl-D - 
glucopyranose)hydroxylamine (250) in the presence of potassium carbonate in water. 
The reaction was stirred overnight at room temperature and then the aqueous layer was 
extracted with dichloromethane. Concentration of the dichloromethane yielded an oil 
which was purified by flash column chromatography to give a product that was one spot 
by tic.
The NMR spectra of the product were then obtained and the spectrum showed 
all the required peaks in the right proportions indicating that reaction had indeed occurred. 
The NMR spectrum showed the resonance for C-1 of the glucose at 105.13 as 
expected and also the presence of a resonance at 159.45 ppm due to the guanidino group 
of the hydroxyguanidine. The mass spectrum of the product also found the molecular 
ion, [M+Na]+, at 618. No further work was possible with these derivatives and it was 
not possible to obtain the intermediates in larger quantities or to purify the very small 
amount of O-(tetra-O-acetyl-D-glucosepyranosyl)-1,1 -dibenzyl-2~hydroxyguanidine
(272) any further.
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3 .5 .4  SYNTH ESIS OF OTHER O - S U B S T I T U T E D  N - 
HYDROXYGUANIDINES
Although other 0-substituted hydroxylamines were synthesised there was very 
little further work done with these compounds.
The synthesis of 0-benzoyl-1-benzy 1-2-hydroxyguanidine (273) was attempted. 
The synthesis was attempted from N-benzylaminoiminomethanesulfonic acid (193) and 
0-benzoylhydroxylamine hydrochloride (228) in the presence of potassium carbonate 
under aqueous conditions. Extraction of the aqueous layer with ethyl acetate and 
subsequent concentration of the ethyl acetate yielded a dark oil. The NMR spectrum of 
this dark oil indicated that it was not the expected product as there was no benzoyl group 
present and NMR indicated that the product was most probably the A-benzylurea.
O
NH2
(273)
3 . 5 . 5  D I R E C T  A C Y L A T I O N  
HYDROXYGUANIDINE
OF l , l - D I B E N Z Y L - 2
In light of the failure to produce (9-acetylhydroxylamine it was decided to attempt 
the direct acylation of 1,1-dibenzy 1-2-hydroxy guanidine (70). Although, previous 
reports had suggested that an attempt at acylating an A^-hydroxyguanidine would lead to 
full acylation of both the oxygen and the free nitrogen and give a diacylated species
(274) it was decided to attempt this reaction.
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(274)
In an attempt to prevent this diacylation from occurring one molar equivalent of 
the acylating agent, in this case acetic anhydride, was used. The l,l-dibenzyl-2- 
hydroxyguanidine (70) was stined in pyridine and acetic anhydride added, the reaction 
was stirred for eighteen hours at room temperature before the pyridine and acetic acid 
were removed under reduced pressure. The NMR spectrum indicated that there was a 
mixture of products which were probably the mono (275) and diacylated (274) 
products so it was decided not to pursue this work any further
O
N O'
N ' NH2
'CHg
(275)
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3.6 CHEMICAL OXIDATION OF O - T H P - 1 , 1 - D I B E N Z  Y L - 2 -  
HYDROXYGUANIDINE (268) AND 0 - B E N Z Y L - l , l - D I B E N Z Y L - 2 -  
HYDROXYGUANIDINE (260)
Two of the O-substituted A-hydroxyguanidines, (9-THP-l,l-dibenzyl-2- 
hydroxy guanidine (268) and O-benzy I-1,1-dibenzy 1-2-hydroxy guanidine (260) were 
subjected to chemical oxidation and the amount of nitric oxide released measured using 
the Greiss test (See Section 2.7 for discussion).
3.6.1 0-Benzyl-l,l-dibenzyl-2-hydroxyguanidine (260)
A solution of O-benzyl-1,1-dibenzyl-2-hydroxyguanidine (0.1 mmol dm-3) 
(260) in water/acetonitrile (85/15%) as the solvent was placed in a water bath at 37 °C 
and an excess (0.01 g) of mCPBA was added and the amount of nitrite released was 
measured at various intervals (Table 13)
Table 13:-oxidation of (260) by mCPBA
1 ime/ min Cone, of nitrite/ 
f. xiO"  ^ mpl dm 3
% nitrite
30 3 6
60 4 7
90 4 7
The results show that there is clearly some release of nitrite occurring which is a 
slightly unexpected result, although there only 7% oxidation as the oxygen is protected 
by a benzyl group it would be thought that oxidation to nitric oxide would be impossible. 
However this result implies that the benzyl group must be removed, to a limited extent
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under the reaction conditions. The l,l-dibenzyl-2-hydroxyguanidine (70) thus 
produced then oxidises as previously observed.
3.6.2 0-TH P-l,l-dibenzyl-2-hydroxyguanidine (268)
A solution of 0.1 mmol dm"^ solution of O - T H P - 1,1-dibenzy 1-2- 
hydroxyguanidine (268) in water/acetonitrile (85/15%) as the solvent was placed in a 
water bath at 37 °C and an excess of mCPBA (0.01 g) was added and the nitrite 
concentration measured at various time periods (Table 14).
Table 14:-oxidation of (268) by mCPBA
Time/ min Cone of nitrite /  
xlO”^  mol dm"3
% oxidation
30 7 13
60 7.5 14
90 7.5 14
It can be seen that 0-THP-1,1 -dibenzyl-2-hydroxyguanidine (268) does indeed 
give a positive test for nitrite. This is not entirely unexpected as the THP group is acid 
sensitive and the conditions are acidic enough to hydrolyse the THP group and yield 1,1- 
dibenzyl-2-hydroxyguanidine (70) which has already been shown to oxidise. Although 
not quantitative 14% oxidation is observed which is close to the 18% obtained for pure 
1,1 -dibenzyl-2-hydroxyguanidine (70).
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3.7 CONCLUSIONS
More was achieved in this area of the project, with a number of 0-substituted 
hydroxyguanidines being synthesised. One of the limiting factors was the successful 
preparation of the required substituted hydroxylamine and then subsequent reaction to 
give the 0-substituted hydroxyguanidines. In particular a number of substituted 
hydroxylamines including, 0-benzoylhydroxylamine hydrochloride (228) and O- 
trimethylsilylhydroxylamine (236) were prepared but their subsequent reaction could not 
be achieved using the various methods attempted. Also it was surprising that the 
synthesis of the 0-substituted derivatives from the corresponding cyanamides was 
unsuccessful. It could be that the O-substitution of the hydroxylamine makes the 
nitrogen less nucleophilic and therefore makes the reaction less likely. This problem 
means that the synthesis is restricted to derivatives where the corresponding thiourea and 
aminoiminomethanesulfonic acid can be obtained. The synthesis of some thioureas was 
not achieved, especially the less nucleophilic aromatic amines.
The preparation of an 0-glycosylhydroxylamine was achieved, however at the 
moment the low yields during the preparation are a limiting factor and a consistent 
methodology for its synthesis needs to be found. However the subsequent reaction of O- 
( t e t r a - 0  - a c e t y l - D - g l u c o p y r a n o s e ) h y d r o x y lamine  ( 25 0)  and Æ, N- 
dibenzylaminoiminomethanesulfonic acid (196) was successful and indicated that if 
reasonable quantities of the substituted hydroxylamine can be obtained then the synthesis 
of O-(tetra-O-acetyl-D-glucopyranose)-1,1-dibenzyl-2-hy droxy guanidine (272) and 
other derivatives will be possible. These may be very interesting pro-drugs especially if 
it can be shown that the glucose can be cleaved off enzymatically.
The major success of this work was the synthesis of a number of O-benzyl 
substituted hydroxyguanidines and 0-THP substituted hydroxyguanidines. The 
synthesis of the O-benzyl derivatives was easily achieved and a number of disubstituted 
derivatives and one mono substituted derivative were prepared from the corresponding 
aminoiminomethanesulfonic acid and O-benzyl hydroxylamine. However in an attempt
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to obtain a number of the free A^-hydroxyguanidines the removal of the 0-benzyl group 
was attempted by various methods. Removal of the group was not possible and when 
the reaction was attempted using catalytic hydrogenation N -0 bond cleavage was 
observed. This is a very unusual result especially as previous reports had suggested that 
removal of this group should have occuned.^^^
A number of O-THP derivatives were obtained in a impure form, however it has 
been shown (Chapter 4) that it should be possible to purify these products using 
preparative HPLC. Chemical oxidation of 0-THP-1,1 -dibenzy 1-2-hydroxy guanidine 
(268) indicated that some nitric oxide was obtained.
The results from the work undertaken in this area indicate that it should be 
possible to design an appropriate O-substituent that could be used on a prodrug and thus 
allow selective taigeting of the nitric oxide.
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Chapter 4
Studies on the Acid Catalysed Decompositiono f0-T H P-l,l-d ibenzyI-2-  hydroxy guanidine
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4.0 INTRODUCTION
The THF group was used in the synthetic part of the project for a number of 
reasons. Firstly the group is very acid sensitive and should therefore be removed under 
acidic conditions and would therefore act as a prodrug because the free N- 
hydroxyguanidine would then be released. The THP group was also a simple model for 
the more interesting and probably more useful sugar derivatives. It was thus necessary to 
examine the acid catalysed decomposition of 0-THP-1, l-dibenzyl-2-hydroxyguanidine 
(268) to demonstrate that the corresponding A-hydroxyguanidine, 1,1-dibenzy 1-2- 
hydroxy guanidine (70), was indeed formed. There was some circumstantial evidence 
for this from earlier synthetic experiments (Section 3.6) but it needed to be clearly 
demonstrated. Also the rate of reaction and its variation with pH was of interest, as a 
basis for the design of future molecules as nitric oxide donor pro-drugs. The proposed 
pathway for the production of nitric oxide in vivo from 0 -T H P -1,1 -dibenzy 1-2- 
hydroxy guanidine (268) is given (Scheme 59).
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NHg
(268)
N OH
NH.
(70)
Oxidation
Nitric Oxide
Scheme 59
4.1 ANALYSIS OF THE DECOMPOSITION REACTION
In order to monitor the hydrolysis of (9-THP-l,l“dibenzyl-2-hydroxyguanidine 
(268) a suitable analytical technique to measure the concentration of either the reactant or 
the product was required. Many of the well used methods were unsuitable for example 
the NMR of the product and reactant were too similar and would be too difficult to 
analyse, the compounds were not volatile enough for GC analysis and tic is not a 
quantitative method. For these reasons it was therefore decided to investigate the use of
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HPLC. In order to be able to do this the first step was to show that the two possible 
products of the reaction, 1,1-dibenzyl-2-hydroxyguanidine (70) and A ,^A^-dibenzylurea 
(154) could be separated from (9-THP-1,1-dibenzyl-2-hydroxyguanidine (268). The 
HPLC analysis was carried out using a CECIL instruments HPLC and a reverse phase 
silica column. Initially a Phenomenex JUPITER column and 80/20 acetonitrile/water 
solvent system was used, however it could be seen that the trace of 1,1-dibenzy 1-2- 
hydroxy guanidine (70) contained a number of peaks (Figure 11).
It was thought that under the conditions employed protonation of (70) could take 
place giving various protonated forms of the compound (Figure 11, 70A-D), which 
were separable by HPLC.
N OH OH
NH2
(70B)(70A)
HN OH OH
NH NH2
(70C) (70D)
Figure 11
The trace for O-THP-1,1-dibenzy 1-2-hydroxy guanidine (268) (Figure 12) also 
showed that it was not a single peak again due to protonation and the presence of a variety 
of protonated forms of the molecule being present.
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In order to remove this problem it was decided to use a basic solvent system 
because obviously the HPLC could not be run under acidic conditions as this would 
cause hydrolysis of the THF derivative (268). Initially 1% triethylamine was added to 
the solvent system. The three standards were then run using 50/50 acetonitrile/water with 
1% triethylamine. Both 1,1-dibenzyl-2-hydroxyguanidine (70) and O-THP-1,1- 
dibenzyl-2-hydroxyguanidine (268) did indeed give single peaks with retention times of
4.1 and 8.1 minutes respectively.
MA'^-Dibenzylurea (154) which had given a single peak using the original 
solvent system became two peaks with retention times of 2.25 and 4.45 minutes however 
as it was clear that the products could be separated it was decided to attempt an initial 
reaction.
0-THP-1,1 -dibenzyl-2-hydroxyguanidine (268) was added to a solution of IM 
hydrochloride acid and the reaction was monitored by removing aliquots after 5, 20, 40 
and 60 minutes reaction. The samples were quenched by adding excess triethylamine and 
then acetonitrile was added to this solution to solubilise it. The solutions were then 
examined by HPLC. It was immediately clear that the amount of the THP derivative 
(268) was decreasing and after 60 minutes there was no trace of it present (Figure 
13+14).
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Figure 13: 5 minutes reaction
d  -
Figure 14:- 60 minutes reaction
d  -
d  -
d  -
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The remaining reaction mixture was then concentrated under reduced pressure and 
the white solid that was obtained was analysed by NMR spectroscopy. The NMR 
spectrum did not reveal much except to suggest, contrary to the HPLC trace, that there 
was only a single product. The NMR spectrum showed a resonance at 161.81 ppm 
indicating that the product was a salt of the desired 1,1 -dibenzyl-2-hydroxyguanidine 
(70). Both the and NMR spectra were also identical to the NMR spectra 
obtained for the authentic 1,1 -dibenzyl-2-hydroxyguanidine (70). Further evidence that 
this was indeed the case was obtained when the white solid was oxidised. As described 
previously (Section 2.7) the Griess test can be used to show the presence of nitrite 
which is derived from nitric oxide. A solution of the decomposition product (0.1 mol 
dm^) was incubated at 37 °C and an excess of mCPBA was added. The reaction was 
tested for nitrite after various periods of time (Table 15)
Table 15:- Oxidation of decomposition reaction product.
Time / 
min
Cone of nitrite / 
xlO"  ^ mol dm'^
% Oxidation
30 6 11
60 7.5 14
90 9.5 17
120 7.5 14
The maximum % oxidation (100% oxidation, concentration of nitrite = 55 x 10'^ 
mol dm^) after 90 minutes of 17% compares favourably to the 18% observed for the 
authentic 1,1-dibenzy 1-2-hydroxyguanidine (70).
This reaction confirmed that it was possible to protect the oxygen of an N- 
hydroxyguanidine with the THP group and then remove this under acidic conditions to 
give the free A-hydroxyguanidine. This free A-hydroxyguanidine could then be oxidised 
using mCPBA to give a positive Griess test, indicating that nitric oxide had been
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produced (Scheme 59). It was thus decided to carry out a kinetic study on the reaction 
and examine the ease of hydrolysis.
4.2.KINETIC STUDIES OF HYDROLYSIS REACTION
It was decided to examine the reaction over a range of pH values and determine 
the pH profile of the reaction. Reactions were run at 37 °C i.e. physiological 
temperature. In the preliminary study, the reactions had been quenched by the addition of 
triethylamine. However on close analysis it was observed that this did not completely 
stop the reaction, and the amount of the 0-THP-1,1 -dibenzyl-2-hydroxyguanidine (268) 
observed by HPLC was still slowly decreasing. As an alternative it was decided to 
quench the reaction with a molar equivalent of aqueous IM sodium hydroxide. 
Unfortunately this had an effect on the HPLC traces, splitting the peak due to 0-THP-
1,1-dibenzy 1-2-hydroxy guanidine (268) into two separate peaks. It was also observed 
that tailing and broadening of the peaks was becoming a problem. An alternative reverse 
phase column was then investigated, which is recommended for use at high pH. The 
column used was a Phenomenex LUNA Cig column. Eventually suitable conditions 
were found that gave good peak separation. These were 60/40 acetonitrile/water with 1% 
triethylamine which gave a single peak for 0-THP-1,1 -dibenzyl-2-hydroxyguanidine 
(268) at approximately 8 minutes.
Using the new analysis conditions the hydrolysis of 0-TH P-1,1 -dibenzyI-2- 
hydroxyguanidine (268) at pH 0 and 37 °C was examined. Aliquots (0.02 cm^) were 
removed after various times and quenched with an equal volume of IM sodium 
hydroxide. The aliquot was then diluted with acetonitrile and analysed by HPLC. The 
peak at approximately 8 minutes was seen to disappear over a period of 20 minutes 
(Figure 15).
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Figure 15
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Using the computer software the area of the peak, which was a measure of the 
concentration of the O-THP-1,1-dibenzy 1-2-hydroxy guanidine present, was calculated. 
A plot of In of the area of peak against time (G raph 1) gave a straight line confirming 
that the acid catalysed hydrolysis was pseudo first order. Linear regression was used to 
give the best fit line and to calculate the errors, in addition all the graphs gave fairly good 
straight line. The gradient was 5 . 9 4 8 x 1 s"  ^ which is the observed first order rate 
constant, kobs-
G raph 1:- Plot of In (THP peak area) against time for acid catalysed decomposition of 
(9-THP-1,1-dibenzy 1-2-hydroxyguanidine (268) at pH 0
I
16
y = 15.093 - 5.9495e-3x = 0.992
15
14
13
400200 3001000
Time / s
From the rate of reaction it is possible to calculate half life as follows:
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1/2
tl/2  = .
In 2
^obs
0.6932
^obs
For this reaction the ti/2 is equal to 116 seconds.
The reaction was repeated in order to check that the results were reproducible. 
Again the reaction gave a straight line graph with a gradient, kobs, of 5.366 xl0‘3 s"^ the 
ti/2 is equal to 129 seconds. Averaging this values out gives the average values shown 
(Table 16).
Table 16:- Average kinetic values for decomposition reaction at pH 0
, Parameter - J \  Average value .-Èrfcpr .
kobs 5.66 xlO"^ s't ± 0.29 (5%)
tl/2 122 s ±  6.5 (5%)
The reaction was then examined at pH 0.5, 1, 1.5 and 2 (Graphs 2-5) and the 
kinetic parameters calculated for these reactions. The reactions at pH 1.5 and 2 were 
quenched by addition of an equal volume of triethylamine as it had been observed that 
upon addition of an equal volume of sodium hydroxide that multiple peaks were seen in 
the HPLC trace. The values for kobs and ti/2 for these reactions were calculated along 
with the errors associated with those values (Table 17). The errors were calculated by 
using the linear regression of the straight line.
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Graph 2:- p l o t  o f  In ( p e a k  a r e a )  a g a i n s t  t i m e  f o r  t h e  a c i d  c a t a l y s e d  d e c o m p o s i t i o n  o f
(268) a t  p H  0 .5
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Graph 3:- P l o t  o f  In  ( p e a k  a r e a )  a g a i n s t  t i m e  f o r  t h e  a c i d  c a t a l y s e d  d e c o m p o s i t i o n  o f
( 2 6 8 )  a t  p H  1
s
CL
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Graph 4:- P l o t  o f  In  ( p e a k  a r e a )  a g a i n s t  t i m e  f o r  t h e  a c i d  c a t a l y s e d  d e c o m p o s i t i o n  o f
( 2 6 8 )  a t  p H  1 .5
ID .
y = 15.857 -1.3616e-4x R^2 = 0.988
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Graph 5:- P l o t  o f  In  ( p e a k  a r e a )  a g a i n s t  t i m e  f o r  t h e  a c i d  c a t a l y s e d  d e c o m p o s i t i o n  o f
(268) a t  p H  2 .0
I
16.0
y = 15.899 - 2.1548e-5x R^2 = 0.997
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Table 17:- Calculated values of kobs ^nd t%/2 for the pH
pM ' Concentration of 
: IÏ+ / mol dm^
kobs /  s^ i" t l /2 /  S
0 1 (5.66 + 0.29) X10-3 122 + 6.5
0.5 0.316 (1.31 + 0.12) xlO-3 530 + 84
1 0.1 (8.71 +0.17)xl0-4 796 ± 16
1.5 0.0316 (1.36 ±0.02) xlO-4 5100 + 60
2.0 0.01 (2.16 ± 0.06) xlO-5 3200 + 970
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A pH profile of the reaction (Graph 6) indicates that kobs decreases as pH 
decreases. This would indicate that kobs is proportional to [H+]. A plot of the 
concentration against kobs can then be made (Graph 7). From the plot (Graph 7) it 
can be seen that this gives a straight line which indicates that, as suspected, that the 
reaction is first order in H+. This would also suggest that the rate equation can be 
expressed as shown:-
Rate =  k o b s  [268] 
Rate = k2 [H+][268]
This implies that the reaction involves specific acid catalysis rather than general 
acid catalysis. It is likely that the oxygen attached to nitrogen is protonated as the first 
step of the reaction followed by cleavage of the C-O bond facilitated by the oxygen in the 
six membered ring.
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Graph 6 : -  P l o t  o f  p H  a g a i n s t  k o b s  f o r  t h e  a c i d  c a t a l y s e d  d e c o m p o s i t i o n  o f  O - T H P - 1 ,1
d i b e n z y l - 2 - h y d r o x y g u a n i d i n e  ( 2 6 8 )
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Graph 7:- Plot of concentration against rate of reaction for the acid catalysed 
decomposition of 0-THP-1,1 -dibenzyl-2-hydroxyguanidine (268)
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This result was also confirmed when a reaction was carried out at pH 3. The 
reaction indicated that even after 7 days at 37 °C there had only been a 5 % decrease in the 
concentration of O-THP-1,1-dibenzyl-2-hydroxyguanidine (268).
Work has been carried out by Fife to examine the rates of acid catalysed 
hydrolysis of a series of 2-alkoxy and 2-aryloxytetrahydropyrans (Figure 16) in a 50%
dioxane-water m i x t u r e .  ^^ 7
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R = OCHa, NOo, CHo, Cl
Figure 16
It was found that reaction rate was dependent on the nature of the substituent on 
the aryl group and that the reaction rate for the hydrolysis of 2-(/7-nitrophenoxy)- 
tetrahydropyran was pH dependent. The pH profile indicated that at low pH reaction rate 
was fast, however at higher pH the reaction rate plateaued which is very similar to the 
results obtained from our studies. At pH 1.3 the half life of the reaction was 9 mins for 
the 2-(p-methoxyphenoxy)-tetrahydropyran. From our studies it can be estimated that at 
pH 1.3 the hydrolysis of (268) would have a half-life of 46 minutes. This would 
indicate that the acid catalysed decomposition of (268) is slower than that of aromatic 
compounds presumably because of the A-hydroxyguanidine is a poorer leaving group.
4.3 CONCLUSION
The results of the kinetic work indicate that the decomposition reaction 0-THP-
1,1-dibenzy 1-2-hydroxy guanidine (268) is first order and dependent on the 
concentration of H+ ions. The work also shows that the rate of reaction at pH 3 is 
negligible which is a disappointing result because it means that the THP derivatives may 
be too stable to act as an efficient prodrugs. However the work has shown that it is 
possible to protect the hydroxyl group of an N-hydroxyguanidine and then remove the 
protecting group and yield the free nitric oxide donor drug which can be oxidised to give 
nitric oxide.
183
The results of this study mean that further work will have to be done to find a less 
stable protecting group or it may be that removal of the protecting group could occur by 
enzymatic action. Suitable alternatives for the THP group might include glycosidic 
groups or peptides (Figure 17).
RO
Where R2 = pg 
RO^
OR
Figure 17
These groups have an advantage because it is possible that both of them could be 
removed by enzymatic action rather than relying on an acid catalysed decomposition.
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Chapter 5
CONCLUSIONS AND FUTURE WORK
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It has been shown by the work undertaken that A^-hydroxyguanidines remain a 
potential source of nitric oxide donor drugs. However their biological usefulness is 
limited by their inherent chemical instability and the inability to find a suitable, versatile 
and reliable method for their synthesis and subsequent purification. It maybe that HPLC 
may will prove to be the most suitable and convenient method to obtain useful amounts of 
pure A-hydroxyguanidines. Two disubstituted derivatives, 1,1-dibenzyl (70) and 1- 
benzyl-1-methyl (137) were obtained pure and subsequent chemical and biological 
testing confirmed their potential.
The synthesis of O-substituted analogues proved easier and more productive. 
The synthesis of a number of O-substituted hydroxyguanidines was achieved from the 
corresponding O-substituted hydroxylamines. The major problem was the 
transformation of the hydroxylamine into the 0 -substituted hydroxyguanidine, the 
reaction with the cyanamide did not occur and the range of aminoiminomethanesulfonic 
acids was limited due to problems with the synthesis of the thioureas. However if this 
synthetic problem could be solved then a significant range of (9-substituted 
hydroxyguanidines could be synthesised.
The work done with 0-THP-1,1-dibenzyl-2-hydroxyguanidine (268) showed 
that the compound could be hydrolysed under acidic conditions to give the free 1,1- 
dibenzyl-2-hydroxyguanidine (70) which could then be chemically oxidised to give nitric 
oxide. The hydrolysis is fast at low pH (ti/2 = 122 s at pH 0) but does not appear to 
occur appreciably at pH 2 or above. However it does show that the group can be cleaved 
to give free //-hydroxyguanidine.
Thus the principle of preparing pro-drugs by protection of the oxygen has been 
demonstrated. The next step will be to design alternative 0-substituerits which can be 
removed under milder, more physiological like conditions. The most appropriate strategy 
maybe to target enzymatic removal of the substituent. Potential groups would be O- 
glycosyl or peptide like substituents (Figure 18), which could be cleaved by 
glycosidases or proteases respectively.
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RO
Where Rg = rO 
RO^
OR
COgH
Figure 18
More work also needs to be undertaken to probe the release of the nitric oxide 
from these compounds. It may be that the oxidation can be carried out either by P450 
enzymes or by nitric oxide synthase or both. Again once more has been elucidated about 
the release of nitric oxide from these compounds the design of more suitable N- 
substituents can be addressed to prepare derivatives which are more water soluble and 
will have better pharmacokinetic properties.
However all the results of the work presented indicate that it may be possible to 
achieve the synthesis of a medically useful N-hydroxyguanidine derivative. This 
derivative could be targeted to the desired site of action by design of a suitable O- 
substituent to be removed by enzymatic action, which is required before release of nitric 
oxide is possible.
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Chapter 6 
Experimental
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6.1 General
Melting points were recorded using a gallenkamp melting point apparatus and are 
uncorrected.
Elemental analyses were carried out in the departmental microanalytical laboratory.
Optical rotations were measured at room temperature using an Optical Activity Ltd. AA 
1000 polarimeter and 10 cm path-length cells.
NMR spectra were recorded on a Varian 2000 f.t spectrometer (^H, 300 MHz;l3c, 75.42 
MHz) and a Varian Gemini f.t spectrometer (^H 200 MHz; 50.31 MHz), ^H NMR 
spectra are referenced on chloroform, TMS, d^-methanol or d^-DMSO; NMR are 
referenced on chloroform, TMS, d^-methanol or d^-DMSO. NMR spectra are described 
in parts per million downfield shift from TMS and are reported consecutively as position 
(ÔH or ôc), relative integral, multiplicity (s-singlet, d-doublet, t-triplet, q-quartet, m- 
multiplet, dd-doublet of doublets and br-broad), coupling constant (Jx,y Hz if applicable) 
and assignment.
I.R. spectra were taken on a Perkin-Elmer series 1420 i.r. spectrometer or a Perkin Elmer 
Paragon 1000 FT-i.r. The samples were prepared as nujol mulls or thin films and run 
between sodium chloride plates. Absorption maxima are given in wavenumbers (cm'^) 
relative to a polystyrene standard.
Low and high resolution mass spectra were recorded on an A.E.I MS-902 spectrometer 
using electron impact at 70 eV or were obtained on an E.P.S.R.C service basis based at 
the University of Swansea using a VG ZAB E. Low and high resolution Cl mass spectra 
were recorded on a VG Autospec using w<?butane as the ionising gas. Low resolution 
electropray mass spectra were also obtained using a VG platform.
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Flash column chromatography was performed according to the procedure of Still using 
sorbisil C^o (40-60 mm mesh) silica gel. '^^^
Analytical thin layer chromatography was carried out on 0.25mm precoated silica gel 
plates (Whatman PE SIL G/UV254) and spots were visualised by UV fluorescence, 
iodine vapour or dipping in 5% sulfuric acid in aqueous ethanol followed bychairing.
Solvents, where required to be dry, were dried as follows using the methods of Perrin 
and A i * m a r e g o . l 4 9  Dichloromethane, and pyridine were refluxed over, then distilled from 
calcium hydride; diethyl ether and tetrahydrofuran were refluxed over, then distilled from 
sodium/benzophenone; methanol, ethanol and butanol were refluxed over, then distilled 
from magnesium/iodine (Grignard reaction). Dimethylformamide was distilled from 
magnesium sulfate under reduced pressure.
UV readings were taken using a UVICON 932 spectrophotometer and 1 cm path length 
plastic cuvettes.
HPLC work was carried out on a CECIL instruments CE 1200 High Performance 
Variable Length Monitor and a CE 1100 Liquid Chromatography Pump. A Phenomenex 
LUNA C l8 5p. (150 X 4.6 mm) column or a Phenomenex JUPITER Cig 5|1 (150 x 4.6 
mm) column was used. The data were examined using an Icicle 486 PC and Datacontrol 
software package. Solvents were purified by filtration. Deionised water was obtained 
using a Milli-Q-RG ultrapure water purification system. The solvents were then 
degassed for 15 minutes using an Ultrawave sonic bath.
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6.2 COMPOUNDS SYNTHESISED
N,iV-Dibenzylcyanamide (117)
/  \
N C =  N
Cyanogen bromide (2 g, 20 mmol) was dissolved in dry methanol (10 cm^) and added 
dropwise to a cooled suspension of WV-dibenzylamine (3.94 g, 20 mmol) and 
anhydrous sodium acetate (2.98 g, 30 mmol) in methanol (20 cm^). The resultant 
suspension was stirred for 2.5 hours in the ice/water bath and then at room temperature 
for a further 3 hours. The solution was concentrated under reduced pressure to give a 
solid residue which was dissolved in water and extracted with DCM (3 x 20 cm^). The 
combined organic extracts were washed with HCl (2M, 20 cm^) and brine (20 cm^), 
dried (MgSO^), filtered and concentrated under reduced pressure to yield a yellow solid 
which was recrystallised from methanol to yield the product (117) as a cream solid (3.22 
g, 72%), m.p. 50-52 °C (lit.,H5 54 °C); (Found: C, 81.13; H, 6.28; N,12.50; Calc, for 
C15H 14N2: C, 81.5; H, 6.35; N, 12.60%); Umax (nujol)/cm"l 2200 (CN), 725 and 750 
(aromatics); ôh (200 MHz, C^HClg) 4.1 (4H, s., CH2 x2), 7.29-7.42 (lOH, m., 
aromatics); ôc (75.42 MHz, C^HCls) 54.14 (CH2 x2), 118.38 (CN), 129.19, 129.32 
and 129.47 (aromatics), 134.38 (quat. aromatic); in/z (El) 222 (M"**, 19%), 131 (14, [M- 
C6H5CH2]+), 91 (100, [C6H5CH2]-*-), 77 (8, [CgHsJ^), 65 (20, [CsHg]^)
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A-Benzyl-V-(2-phenylethyl)cyanamide (118)
N C = N
This compound was prepared in an identical manner to V,V-dibenzylcyanamide (117) 
using V-benzyl-2-phenylethylamine (4.22 g, 4.19 cm^, 20 mmol) to give the product 
(118) as a solid (3.70 g, 70%); m.p. 43-44 °C; (Found: C, 81.43 ; H, 6.90; N, 11.68: 
Calc, for C16H16N2: C, 81.32; H, 6.82; N, 11.85%); Umax (nujol)/cm-l 2200 (CN), 765 
and 705 (aromatic); Ôh (300 MHz, C^HCls) 2.94 (2H, t., J 7.5, PhCH2CH2), 3.17 
(2H, t., 7 7.4, CH2C/72N), 4.13 (2H, s., PhCH2N) 7.17-7.35 (lOH, m., aromatics); 
ÔC (50.31 MHz, C^HCls) 34.54 (PhCH2CH2), 52.15 and 56.67 (CH2CH2N and 
PhCH 2N), 118.3 (CN), 127.36, 128.89, 129.07, 129.22, 129.31 and 129.41 
(aromatics), 135.09 and 138.04 (quat. aromatics); m/z (El) 236 (M+, 15%), 145 (9, [M- 
C6H5CH2]+), 91 (100, [C6H5CH2]+), 77 (10, 65 (22, [CgHs]^)
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V-Benzyl-V-methylcyanamide (119)
N C:
CHg
N
This compound was prepared in an identical manner to V,V-dibenzylcyanamide (117) 
using V-benzylmethylamine (2.42 g, 2.58 cm^, 20 mmol) to give the product (119) as a 
pale yellow oil (2.44 g, 84%); Umax /cm'^ 2160 (CN), 720 and 690 (aromatic); Ôh (300 
MHz, C^HCls) 2.76 (3H, s., C F 3), 4.15 (2H, s., PhCHa), 7.33-7.39 (5H, m., 
aromatics); ôc (50.31 MHz, C^HClg) 37.60 (CH3), 56.92 (CH2), 118.78 (CN), 128.34 
128.55 and 128.85 (aromatics), 134.29 (quat. aromatic); m/z (El) 146 (M+, 59%), 91 
(100, [C6H5CH2]+), 77 (7, [C^Hsl^), 65 (27, [CgHs]"^), 51 (12, [C4H3Ï+)
V-Benzyl-iV-butylcyanamide (120)
N
1 .
 C = N
This compound was prepared in an identical manner to 7/,7/-dibenzylcyanamide (117) 
using V-butylbenzylamine (1.63 g, 10 mmol) giving the product (120) as an oil (1.40 g, 
74%); Umax/cm-1 2200 (CN); Ôh (300 MHz, C^HCy) 0.87 (3H, t., /  7.5, CH3 ), 1.30- 
1.38 (2H, sextet, J 7.O., CH2-3), 1.58-1.63 (2H, quintet, J 7.O., C/72-2), 2.9 (2H, t., J
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7.4, C/72-1), 4.16 (2H, s., ArC/72), 7.30-7.37 (5H, m., aromatics); 5c (75.42 MHz, 
C % C l3) 13.32 (C-4), 19.39 (C-3), 29.19 (C-2), 49.83 (C-1), 55.6 (ArCH2), 117.97
(CN), 128.29, 128.42 and 128.8 (aromatics), 134.84 (quat. aromatic)
A-Ethy 1-A-(p-tolyl)cyanamide (121)
3' 2'
N C = = N
w ‘5' 5' CH2CH3
This compound was prepared in an identical manner to A,A-dibenzylcyanamide (117) 
using A-ethyl-p-toluidine (1.35 g, 10 mmol) giving the product (121) as an oil (1.29 g, 
81%); Umax/cm-l 2225 (CN), 800, 775 and 650 (aromatics); Ôh (300 MHz, C^HCls) 
1.41 (3H, t., J  7.2, CH2C/73), 2.3 (3H, s., C/73Ar), 3.58 (2H, q., J  7.2, CA2CH3), 
6.97 (2H, d., J 8.7, /7-2’,6’), 7.13 (2H, d., J  8.7, /7-3’,5’) ; 5c (75.42 MHz, C^HC^)
12.52 (CH2CH3), 20.35 (CH3Ar), 44.17 (CH3CH2), 113.61 (CN), 115.94 (C-2 ’,6 ’), 
130.12 (C-3\5'), 133.18 (C-4') 137.47 (C-T); Wz (El) 160 (M+, 72%), 145 (20, [M- 
CH3]+), 132 (82, [M-C2H4]+), 91 (100, [CH3C6H4J+), 77 (29, [CeHsJ^), 65 (19, 
[C5H5]+), 51 (11, [C4H3]+)
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A-Ethyl-A-(o-tolyl)cyanamide (122)
CH2CH3
N C = N
This compound was prepared in an identical manner to A,A-dibenzylcyanamide (117) 
using A-ethyl-o-toluidine (1.35 g, 10 mmol) giving the product (122) as an oil (1.11 g, 
69 %); Umax/cm-1 2200 (CN), 750 and 650 (aromatics); 5h (300 MHz, C^HCls) 1.35 
(3H, t., J  7.2, CH2CA3), 2.19 (3H, s., CH3Ar), 3.21-3.28 (2H, q., J  7.2, C/72CH3), 
6.66-6.73 (4H, m., aromatics); Ôc (75.42 MHz, C % C l3) 12.99 (CH3CH2), 17.63 
(CH3Ar), 48.64 (CH3CH2), 115.57 (CN), 124.79, 127.23, 127.69 and 131.75 
(aromatics), 134.03 (C-2'), 139.18 (C-T); m/z (El) 160 (M+, 100%), 145 (20, [M- 
CH3]+), 132 (89, [M-C2H4]-»-), 91 (33, [CH3C6H4]+), 77 (26, [CôH5]+), 65 (2 2 , 
[C5H5]+), 51 (15, [C4H3]+)
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A^-MethyI-A^-(/;-iiitrophenyl)cyanamide (123)
02^
3' 2"
\  /
This compound was prepared in an identical manner to //,//-benzylcyanamide (1X7) 
using A^-benzyl-4-nitroaniline (15.21 g, 100 mmol) giving the product (123) as a yellow 
solid (12.4 g, 70%), m.p. 130-132 °C; Ôh (300 MHz, C^HCls) 2.95 (3H, s., % ) ,
6.52 (2H, d., /  9.3, H-2’,6’), 8.09 (2H, d., J  9, 7/-3’5’); ôc (75.42 MHz, C^HCb) 
30.69 (CH3), 118.24 (C-2',6'), 126.18 (CN), 126.90 (C-3',5'), 138.43 (C-1'), 154.66 
(C-4'); m/z (El) 177 (M+, 28%), 149 (11, [M-CN]+), 77 (54, [C6H5]+)
N,N-Dicyclohexylcyanamide (124)
2 13
4
5
N
This compound was prepared in an identical manner to 7/,7/-dibenzylcyanamide (117) 
using 7/,N-dicyclohexylamine (3.63 g, 20 mmol) giving the product (124) as a solid 
(2.85 g, 69%) m.p. 44-46 °C; Dmax (nujoI)/cm"l 2200 (CN); Ôh (300 MHz, C^HaO^H) 
1.10-1.95 (lOH, m., C/72-2 ,3 ,4 ,5 ,6), 2.88 (2H, m., C/7-1); ôc (75.42 MHz, 
C2H3Q2H) 26.19 and 26.27 (C-3,4,5), 33.06 (C-2,6), 59.37 (C-1), 116.88 (CN); m/z 
(El) 206 (M+, 71%), 124 ([M-C6Hiq]+, 81), 83 ([C6Hn]+, 100)
196
N,A^-Dibutylcyanamide (125)
4
N'
This compound was prepared in an identical manner to A^,A^-dibenzylcyanamide (117) 
using A ,^A -^dibutylamine (2.59 g, 3.38 cm^, 20 mmol) giving the product (125) as a 
pale yellow oil (2.62 g, 85%); Dmax/cm-1 2225 (CN); by (200 MHz, C^HCls) 0.93 (3H, 
t., J  7.4, C/73), 1.32-1.40 (2H, m., C/72-3), 1.58 (2H, quintet, J 7.2, C/72-2), 2.97 
(2H, t., 7 7.2 Hz, C/72-1); ôc (50.31 MHz, C^HCla) 14.17 (C-4), 20.18 (C-3), 30.17 
(C-2), 51.68 (C-1), 118.48 (CN); (El) 154 (M+, 34%)
A^,A^-Dioctylcyanamide (126)
N C ^ 5 N
This compound was prepared in an identical manner to 77,7/-dibenzylcyanamide (117) 
using 7/,/7-dioctylamine (4.83 g, 6 cm^, 20 mmol) giving the product (126) as an oil 
(3.56 g, 70 %); Dmax/cm'l 2225 (CN); Ôr (300 MHz, C^HCls) 0.85 (3H, t., 7 7.2, 
C/73) 1.3 (lOH, s., C/72-3,4,5,6,7), 1.6 (2H, m., C/72CH2NCN), 2.9 (2H, t., 7 7.2, 
CH2C/72NCN); 5c (74.43 MHz, C^HCla) 13.94 (C-1), 22.48, 26.37, 26.79, 27.55,
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29.03 and 31.64 (CHi), 51.45 (C-8) and 118.02 (CN); m/z (El) 268 (M+, 15%)
77-Piperidylcyanamide (127)
N C = N
This compound was prepared in an identical manner to iV,7/-dibenzylcyanamide (117) 
using piperidine (8.52 g, 9.89 cm^, 100 mmol) to give the product (127) as a yellow oil 
(9.40 g, 85%); Dmax/cm-l 2225 (CN); Ôr (300 MHz, C^HCls) 1.53-1.61 (6H, m., 
C/72-3,4,5) and 3.14-3.17 (4H, m., C/72-2 ,6); Ôq (50.31 MHz, C^HCla) 22.87 (C-4), 
24.42 (C-3,5), 50.06 (C-2,6) and 118.66 (CN); m/z (El) 110 (M+, 83%), 82 (12, [M- 
CN]+), 69 (55, [C5H9]+), 55 (60, [C4H?]+)
A^-Morpholinocyanamide (128)
O N------C =  N\ _ y
This product was prepared in an identical manner to 77,7/-dibenzylcyanamide (117) 
using morphiline (1.74 g, 20 mmol) to give the product (128) as a yellow oil (1.49 g, 
66%); Dmax/crn-1 2200 (CN); ÔR (300 MHz, C^Clg) 3.19 (2H, t., 7 4.8, C/72N), 3.7 
(2H, t., 7 4.8, C7/20); ôc (75.42 MHz, C^HClg) 48.59 (CH2 N), 65.4 (CH2 O), 117.12 
(CN); m/z (El) 112 (M+, 67%)
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A^-Benzylcyanamide (132)
This compound was prepared in an identical manner to 7/,7/-dibenzylcyanamide (117) 
using benzylamine (2.64 g, 20 mmol) to give the product (132) as a yellow oil (1.65 g, 
62%); Umax (nujol)/cm“l 2225 (CN), 950, 850 and 800 (aromatics); ô r  (200MHz, 
C^HCls) 4.1 (2H, s., C/72), 4.7 (IH, br. s.,N/7), 7.3 (5H, s., aromatics); §c (50.31 
MHz, C^HCls) 50.30 (CH2), 117.17 (CN), 128.32, 128.83 and 129.38 (aromatics),
136.90 (quat. aromatic)
A^-(p-Methoxyphenyl)cyanamide (133)
H3CO \  /  iN C = : NIH
This compound was prepared in an identical manner to 7/,7/-dibenzylcyanamide (117) 
using p-anisidine (2.74 g, 22 mmol) to give the product (133) as a solid (2.27 g, 77%), 
m.p. 60-62 °C; Umax (nujol)/cm’l 2220 (CN), 840 and 790 (aromatics); Ôr (200MHz, 
C^HCls) 3.8 (3H, s., C/73O), 6.05 (IH, br. s., N77), 6.8-7.0 (4H, m., aromatics);
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l,l-Dîbenzyl-2-hydroxyguanidine (70)
/  \ N OH
NHg
7/,7/-Dibenzylcyanamide (117) (0.44 g, 2 mmol) and hydroxylamine hydrochloride 
(0.21 g, 3 mmol) were stirred in dry DMF (10 cm^). Sodium carbonate (0.59 g, 5.6 
mmol) was then added to this suspension slowly over a period of 10 minutes. The 
resultant suspension was heated at 60-80 °C for 1.25 hrs and then filtered. The inorganic 
salts were washed with a small quantity of warm DMF ( 2 x 5  cm^) and the combined 
washings and filtrate concentrated under reduced pressure to yield a yellow oil. The 
yellow oil was added dropwise to ice cold water (10 cm^) and a solid was obtained. This 
solid was filtered and recrystallised from ethanol to give the product (70) as a white solid 
(0.33 g, 65%), m.p. 119-120 °C (lit.,»? 120-121 °C); (Found: C, 70.30; H, 6.59; N, 
16.27; Calc, for C 15H17N3O: C, 70.57; H, 6.71; N, 16.46%); Umax (nujol)/cm-l 3475 
and 3425 (NH2), 3250 (OH), 950, 900 and 750 (aromatics); Ôr (300 MHz, C^HCb) 
4.35 (4H, s., CH2 x2), 4.4 (2H, s., N //2), 7.2-7.35 (lOH, m., aromatics); ôc (75.44 
MHz, C2HC13) 50.79 (CH2 x2), 127.31, 127.47 and 128.70 (aromatics), 138.04 (quat. 
aromatic), 157.24 (C=NOH)); m/z (Cl) 256 ([M+H]+, 100%)
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l-Benzyl-l-methyl-2-hydroxyguanidine (137)
N OH
This compound was prepared in an identical manner to 1,1-dibenzy 1-2-hydroxy guanidine 
(70) using 7/-benzyl-7/-methylcyanamide (119) (0.29 g, 2 mmol) to give the product 
(137), after recrystallisation from ethanol, as white crystals (0.17 g, 48%), m.p. 88 °C 
(lit.,91 89-90 °C); (Found: C, 60.48; H, 7.42; N, 23.50; Calc, for C9H 13N 3O: C, 
60.32; H, 7.42; N, 23.50%); Umax (nujol)/cm-l 3450 (NH2), 2800 (OH), 990 and 880 
(aromatics); Ôr (200  MHz, C2HCI3) 2.74 (3H, s., CH3 ), 4.30 (2H, s., C7/2Ph), 7.24-
7.33 (5H, m., aromatics); Sq (50.31 MHz, C^HCb) 36.17 (CH3), 54.62 (CH2), 
127.28, 127.37 and 128.76 (aromatics), 138.43 (quat. aromatic), 157.52 (C=NOH)); 
m/z (Cl) 180 ([M+H]+, 100%)
201
l-Ethyl-l-(p-toluidine)-2-hydroxyguanidine (138)
N OH
CH2CH3
This compound was prepared in an identical manner to 1,1 -dibenzy 1-2-hydroxyguanidine 
(70) using 7/-ethyl-N-(p-toluidine)cyanamide (121) (3.2 g, 20 mmol) to give the 
product as a solid (2.36 g, 61%), m.p. 144-146 °C; (Found: C, 62.03; H, 7.98; N, 
21.98; Calc, for C10H 15N3O: C, 62.15; H, 7.82; N, 21.74%); Umax (nujol)/cm-l 3475 
and 3375 (NH2), 3250 (OH), 900, 825 and 800 (aromatics); Ôr (300 MHz, C2HCI3)
1.10 (3H, t., J 7.2, C/73CH2), 2.34 (3H, s., CH^hx), 3.60 (2H, q., J 7.2, CH3CH2),
7.10 (2H, d., J 8.4, /7-2',6'), 7.17 (2H, d., J 8.4 Hz, /7-3',5'); 6 c (75.42 MHz, 
C2h C 13) 12.83 (CH3CH2), 20.81 (CH3Ar), 44.85 (CH2), 127.06 (C-2 ',6 '), 130.14 
(C-3’,5'), 135.79 (C-4'), 140.58 (C-F), 154.73 (C=NOH); m/z (Cl) 194 ([M+H]+, 
100%)
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l-Piperidyl-2-hydroxyguanidine hydrochloride (139)
\
I/
N  OH
NHg C f
7/-Piperidylcyanamide (127) (2.20g, 20 mmol) and hydroxylamine hydrochloride (1.38 
g, 20 mmol) were stirred in dry methanol (40 cm^) and catalytic potassium hydroxide 
(0.2 g) added. The reaction was heated under reflux for 13 hours, cooled and poured 
onto diethyl ether (600 cm^). The white precipitate was collected by filtration and dried 
to give the product (1 3 9 )  as a white solid (2.03 g, 57%). A small amount was 
recrystallised from methanol/diethyl ether to give a white solid,m.p 200-202 °C 
(decomp.); Umax (nujol)/cm"^ 3450 and 3350 (NH2), 3100 (OH); Ôr (300 MHz, 2H2O)
1.5 (6H, s., C/72-3,4,5), 3.35 (4H, 2., C/72-2,6); ôc (75.42 MHz, 2H2O) 19.69 (CH2- 
4), 21.27 (CH2-3,5), 43.37 (CH2-2,6), 155.17 (C=NOH); m/z (Cl) 145 ([M-C1]+, 
20%)
203
l-Morpholino-2-hydroxyguanidine hydrochloride (140)
o I
N OH
NHg Cl
This compound was prepared in an identical manner to 1-piperidy 1-2-hydroxy guanidine 
hydrochloride (139) using A-morpholinocyanamide (128) (1.12 g, 10 mmol) to give 
the product (140) as a white solid (1.17 g, 64%). A small amount was recrystallised 
from methanol/diethyl ether to give the pure product as a white solid, m.p. 214-216 °C 
(decomp.); (Found: C, 32.83; H, 6.58; N, 22.81; Calc, for C5H 12N3O2CI: C, 33.06; H, 
6 .6 6 ; N, 23.13%); Dmax (nujol)/cm-l 3475 and 3400 (NH2), 3200 (OH); Sh (200 MHz, 
% 2 0 ) 3.37 (2H, t., J 5.0, C%N), 3.73 (2H, t., J  5.0, C % 0); 5c (50.31 MHz, % 2 0 ) 
41.82 (CH2N), 62.12 (CH2O), 155.92 (C=NOH); m/z (Cl) 147[ftf-Cl]+, 60%)
204
l-Benzyl-l-(2-phenylethyl)-2“hydroxyguanidine hydrochloride (136)
This compound was prepared in an identical manner to 1 -piperidyl-2-hydroxyguanidine 
hydrochloride (139) using 7/-benzyl-7/-(2-phenylethyl)cyanamide (118) (1.98 g, 10 
mmol) to give the product (136), after recrystallisation from methanol/diethyl ether as a 
white solid (8.1 g, 30%), m.p. 270-271 (Decomp.); Umax (nujol)/cm‘  ^ 3400 and 3300 
(NH2), 3100 (OH), 970, 830 (aromatics); Ôr (300 MHz, C^HsO^H) 2.90 (2H, t., 7 7.4, 
PhC772CH2), 3.56 (2H, t., 7 7.4, CH2C/72N), 4.39 (2H, s., PhCiÏ2N), 7.18-7.40 
(lOH, m., aromatics); ôc (75.43 MHz, C^HsO^H) 34.01 (PhCH2CH2), 50.93 and
52.90 (CH2CH2N and PhCH2N), 128.06, 128.44, 129.36, 129.94, 130.11 and 130.18 
(aromatics), 136.09 and 139.16 (quat. aromatics), 160.42 (C=NOH); m/z (Cl) 246 ([M- 
Cl]+, 45%)
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A,A-Dibenzylurea (154)
/  \__y
7/,/7-Dibenzylcyanamide (117) (2.22g, 10 mmol) was dissolved in ethanol (10 cm^) 
and sulfuric acid (2M, 10 cm^) was added. The solution was stirred overnight at room 
temperature and then concentrated under reduced pressure. The residue was paritioned 
between water (10 cm^) and ethyl acetate (10 cm^) and the aqueous layer was washed 
with ethyl acetate (2 x 10 cm^). The combined organic extracts were then washed with 
brine (20 cm^), dried (MgSO^), filtered and concentrated under reduced pressure to yield 
the crude product as an off-white solid (1.56 g, 65%). A small portion of this compound 
was recrystallised from ethanol to give the product (154) as a white crystalline solid, 
m.p. 122-124 °C (lit.,150 125 °C); Umax (nujol)/cm-l 3410 (NH2), 1630 (C=0), 900, 
730 (aromatics); Ôr (200 MHz, C^HCls) 4.5 (4H, s., CH2 ), 7.20-7.35 (lOH, m., 
aromatics); 5c (50.31 MHz, C^HClg) 50.65 (CH2), 127.56, 127.78 and 128.14 
(aromatics), 137.22 (quat. aromatics), 160.35 (C=0); m/z (El) 222 (M+, 14%), 131 (5, 
[M-CH2C6H5]+), 91 (100, [C6H5CH21+)
206
A-Benzyl-A-methylurea (155)
This compound was prepared in an identical manner to % iV-dibenzylurea (154) using 
At-benzyl-M-methylcyanamide (119) (1.46 g, 10 mmol) to give the crude product as a 
solid (0.56 g, 34%). A small portion was recrystallised from ethanol to afford the 
product (155) as a white solid, m.p. 132-134 “C (lit.,*/ 130-132 °C); (Found: C, 
65.60; H, 7.28; N, 16.81; Calc, for C9H 12N2O: C, 65.83; H, 7.37; N, 17.06 %); 
(nujol)/cm-l 3400 (NH2), 1600 (C=0), 950, 730 (aromatics); 8h (200 MHz, C^HCls) 
2.92 (3H, s., CH3), 4.5 (2H, s., ArCiÏ2), 7.23-7.73 (5H, m., aromatics); 8c (50.31 
MHz, C^HCb) 35.28 (CH3), 52.84 (CH2), 127.71, 127.98 and 129.27 (aromatics), 
137.71 (quat. aromatic), 159.83 (C=0); m/z (EX) 164 (Af+, 100%), 147 (9, [Af-OH]+), 
120 (49, [Af-C(=0)NH2]+), 106 (55, [CgH5CH2NH]+), 91 (87, [C6H5CH2]+), 77 (17, 
(C6H5]+), 65 (22 , [C5H51+)
207
A-Ethyl-A-(p-tolyl)urea (153)
H3C
5' 6' CH2CH3
This compound was prepared in an identical manner to 7/,7/-dibenzyIurea (154) using 
A^-ethyl-7/-(p-tolyl)cyanamide (121) (1.6 g, 10 mmol) to give the product (153) as an 
oil (0.7 g, 39%), Umax/cm-1 3350 (NH2), 1650 (C=0 ), 890, 700 (aromatics); ô r  (300 
MHz, C^HCls) 1.4 (3H, t., J  7.5, C/73CH2), 2.3 (3H, s., CH^Av), 3.6 (2H, q., J  7.5, 
CH3C/72), 6.9 (2H, d., J  8 , 77-2',6 '), 7.15 (2H, d., J 8.2, 77-3',5'); 5c (50.31 MHz, 
C % C l3) 12.49 (CH3CH2), 20.33 (CH3Ar), 44.14 (CH3CH2), 115.92 (C-2 '6 '), 130.12 
(C-3’,5’), 133.16 and 137.45 (quat. aromatics); m/z (El) 178 (M+, 7%), 160 (100, [M- 
OH2I+), 145 (39, [(M-0 H2)-CH 3]+), 132 (55, [(M-OH2)-CH2CH 3]+), 91 (67, 
[CH2C6H51+), 77 (24, [GeHsl^), 65 (22 , [C5H5]-*-), 51 (13, [C4H3I+)
208
A-Benzylthiourea (181)
Benzylamine (2.0 g, 18.6 mmol) was dissolved in dichloromethane (40 cm^) and added 
to a vigorously stirred suspension of thiophosgene (3.2 cm^, 42 mmol) in water (60 
cm3). The reaction was stirred for 2 hours at room temperature. The resulting 
suspension was separated and the organic layer washed with water (50 cm^), dried 
(MgS0 4 ) and concentrated under reduced pressure to give an orange oil. The orange oil 
was then dissolved in methanol (40 cm^), cooled to 0 °C and aqueous ammonia (1.6 cm^ 
of a 32% solution) slowly added. The reaction mixture was stirred at 0 °C for a further 3 
hours and then concentrated under reduced pressure to give a pale orange solid. This 
was recrystallised from ethanol to give the product (181) as a white solid (0.59 g, 20%), 
m.p. 159-161 °C (lit.,126 161-162 °C); (Found: C, 57.65; H, 5.88; N, 16.52. Calc, for 
CgHioNaS: C, 57.80; H, 6.06; N, 16.85%); Umax (nujol)/cm-l 3390 (NH), 3200 
(NH2 ), 1500 (C=S), 720, 700 (aromatics); Ôr (200 MHz, C^HsO^H) 4.7 (2H, s., 
PhC772), 7.21-7.34 (5H, m., aromatics); ôc (50.3 MHz, d^-DMSO) 47.79 (CH2 ), 
127.23, 127.63 and 128.59 (aromatics), 139.49 (quat. aromatics), 183.71 (C=S); m/z 
(El) 166 (M+, 100%), 149 (5, [PhCH2NCS]+), 106 (47, [PhCH2NH]+), 91 (85, 
[C6H5CH21+)
209
A^-(2-phenylethyl)thiourea (183)
This compound was prepared in an identical manner to XV,A-dibenzyIthiourea (181) 
using 2-phenethyIamine (24.2 g, 200 mmol) to give the product (183) as a white solid 
(18.5 g, 51%), m.p. 126-128 °C; (Found: C, 60.31; H, 6.72; N, 15.36. Calc, for 
C9H 12N2S: C, 59.97; H, 6.71; N, 15.54%); (nujol)/cm-l 3400 and 3350 (NH2), 
3100 (NH), 1340 (C=S) 730 (aromatic); 8h  (200 MHz, C^HaO^H), 2.87 (2H, t., J 7.4, 
PhCH2), 3.71 (2H, t., J  7.4, CH2NH), 7.14-7.34 (5H, m., aromatics), 7.6 (IH, s., 
NH); Sc (75.42 MHz, C^HaO^H) 35.03 (PhCH2), 45.57 (CH2NH), 126.50, 128.71 
and 128.98 (aromatics), 139.61 (quat. aromatics), 183.51 (C=S); m/z (El) 180 (A7+, 
74%), 120 (14, [M-H2NCS1+), 104 (100, [M-CeH5]+), 91 (32, [C6HsCH2]+)
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N,A-Dibenzylthiourea (184)
/  \ _ /
Chlorobenzene (45 cm^) was saturated with dry HCl gas. Dibenzylamine (12 g, 11.7 
cm2, 60 mmol) was then added to the resultant cloudy solution, followed by ammonium 
thiocyanate (4.62 g, 60 mmol). The resultant white suspension was heated under reflux 
for 8.5 hours then cooled. The white solid was filtered off, washed with water and dried 
to give the product (184) as a white solid (9.07 g, 59%), m.p. 134-135 °C (lit., 2^7 134. 
136 °C); Umax (nujol)/ cm'l 3250 (NH2), 1510 (C=S) 760, 700 and 640 (aromatics); Ôr 
(200 MHz, C2HC13) 4.9 (4H, s., PhC772 x2), 5.7 (2H, s., NH 2 ), 7.3 (lOH, m., 
aromatics); ôc (75.42 MHz, C2HCI3) 50.41 (CH2), 127.36, 127.56 and 128.83 
(aromatics), 137.14 (quat. aromatic), 182.84 (C=S); m/z (El) 256 (M+, 23%), 197 (28, 
[M-HNCS1+), 91 (100, [C6H5CH21+)
211
A-BenzyI-A-(2-phenylethyl)thiourea (185)
7/-Benzyl-2-pheiiylethylamine (4.2 g, 4.2 cm^, 20 mmol) was added an aqueous solution 
of HCl (2M, 50 cm2). Ammonium thiocyanate (0.76 g, 20 mmol) was added and the 
suspension heated under reflux for 7 hours. The solid was filtered giving the product 
(185) as a pale solid (4.08 g, 76%), m.p. 260-262 °C ;Umax (nujol)/cm-^ 3200 (NH2), 
1510 (C=S), 710 and 640 (aromatics); ô r  (300 MHz, C^HgO^H) 3.06 (2H, t., J  8.2, 
PhC772CH2), 4 .20  (2H, t., J 8.2, PhCH2C772N), 4.24  (2H, s., PhCH2N), 7.26-7.55 
(lOH, m., aromatics); 6c  (75.42 MHz, C^HgO^H) 3 3 .16  (PhC H 2C H 2), 49.69 and
52.33 (PhCH2CH2N and PhCH2N), 128.34, 129.86, 130.06, 130.36, 130.77 and 
131.18 (aromatics), 132.61 and 137.90 (quat. aromatic), 184.5 (C=S); m/z (El) 270 
(M + , 24%), 212 (9, [M -SCN ]+), 120 (100, [PhCH2C H 2N H ]+), 105 (16, 
[PhCH2CH2]+), 91 (94, [PhCH2]+)
212
N^,A^-Dicyclohexylthiourea (190)
This compound was prepared in an identical manner to A^,//-dibenzylthiourea (184) 
using dicyclohexylamine (3.63 g, 20 mmol). The reaction was heated under reflux for
6.5 hours. The product (190) was obtained as a white solid (3.71 g, 11%), m.p. 226- 
225 °C ; Dmax (nujol)/cm'l 3300 (NHi), 1490 (C=S); Ôh (300MHz, C^HgO^H) 1.2-1.7 
(6H, m., CH2-4 ,5 ,6), 1.80-1.95 (2H, m., C7Ï 2-3), 2.05-2.10 (2H, m., C772-2), 3.1- 
3.25 (IH, m., Ci7-5); 6c (75.42 MHz, C % 3 0 % ) 25.43 (C-3,5), 26.08 (C-4), 30.45 
(C-2,6), 54.45 (C-1), 182.1 (C=S); m/z (El) 240 (M+, 40%)
213
A^-Benzylaminoiminomethanesulfonic acid (193)
SO3H
N NH2
7/-Benzylthiourea (181) (8.3 g, 50 mmol) and sodium molybdate dihydrate (181 mg, 
0.75 mmol) were stirred in water (100 cm^). The resulting suspension was cooled to 0 
°C and hydrogen peroxide (100 vol, 16 cm^) added at such a rate that the temperature did 
not exceed 0 °C. After addition was complete the ice bath was removed and the reaction 
allowed to warm. Once exotherm was complete the reaction was recooled to 0 °C and the 
resulting white precipitate was filtered off and dried under vacuum to yield the product 
(193) as a white solid (9.13 g, 85%), m.p. 163-165 °C (decomp.) (lit.,^^1 168 °C 
(decomp.)); (Found: C, 45.26; H 4.85; N, 13.19; Calc, for C8H10N2SO3: C, 44.85; H, 
4.70; N, 13.08%); (nujol)/cm-l 3320 and 3300 (NH2), 1240 (RSO3 ), 740 and 690 
(aromatic); 6h (200 MHz, d^-DMSG) 4.51 (2H, s., PhCH^2), 7.31-7.40 (5H, m., 
aromatics), 9.4 (2H, s., NH2 ); ôc (50.31 MHz, d^-DMSG) 51.10 (PhCH2), 127.54, 
127.72 and 128.82 (aromatics), 136.75 (quat. aromatic), 165.96 (C-SG3H); m/z (ES‘) 
213 ([M-H]-, 100%)
214
A-Phenylethylaminoiminomethanesulfinic acid (194)
SO2H
This compound was prepared in an identica l manner to N -  
benzylaminoiminomethanesulfonic acid (193) using A-phenylethylthiourea (183) (5.41 
g, 30 mmol) to give the product (194) as a solid (2.18 g, 54%); m.p. 119-120 °C; Dmax 
(nujol)/cm-l 3200 (NH2), 1600 (C=N) 1050 (R-SO-OH) 810 and 680 (aromatics); Ôh 
(200 MHz, C^HsO^H) 2.95 (2H, t., J 7.4, PhCH2), 3.57 (2H, t., J 7.4, CH2 NU), 
7.20-7.36 (5H, m., aromatics); ôc (50.31 MHz, d^-DMSO) 33.70 (PhCH2), 43.27 
(CH2N), 126.77, 128.67 and 128.94, 129.09 (aromatics), 138.31 (quat. aromatic), 
177.59 (C-SO2H); m/z (ES") 211 ([M-H]-, 100%)
A-Phenethylaminoiminomethanesulfonic acid (195)
SO3H
N NH2
This com pound was prepared in an sim ilar m anner to N - 
benzylaminoiminomethanesulfonic acid (193) using N-phenethylthiourea (183) (30 
mmol, 5.41 g) and a greater excess of hydrogen peroxide (10.2 cm^) to give the product 
(195) as a solid (4.07 g, 59%), m.p. 135-137 °C; (Found: C, 47.69; H, 5.40; N,
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12.10. Calc, for C9H12N2SO3: C, 47.36; H, 5.30; N, 12.27%); Umax (nujol)/cm-l 3100 
(NH2) 1600 (C=N) 1250 (R-SO3-); 5h (200  MHz. C^HsOZR) 2.95 (2H. t., J  7.3, 
PhCH2), 3.58 (2H, t., J  7.4, CH2NH), 7.19-7.36 (5H, m., aromatics); 5c (50.31 
MHz, C^HsO^H) 34.02 (PI1CH2), 45.50 (CH2NH), 127.04, 128.65 and 128.86 
(aromatics), 138.00 (quat. aromatic), 185.03 (C-SO3H); m/z (ES") 227 ([M-H]', 100%)
A',Al-DibenzyIaminoiminomethanesulfonic acid (196)
/  \
This was prepared in an identical manner to 7/-benzylaminoiminomethanesulfonic acid 
(181) using MiV-dibenzylthiourea (184) (2.56 g, 10 mmol) to give the product (196) 
as a yellow solid (1.68 g, 55%), m.p. 118-119 °C (decomp.); (Found: C, 58.68; H, 
5.01; N, 9.01. Calc, for C15H 16N 2SO 3 : C, 59.19; H, 5.30; N, 9.20%); Dmax 
(nujol)/cm-l 3340, 3250 and 3200 (NH+NH2), 1240 (RSO3-), 800 and 700 (aromatic); 
ÔH (300 MHz, C % 3 0 ^H) 4.6 (2H, s., PhC/72), 5.2 (2H, s., ŸhCHi), 7.37 (lOH, s., 
aromatics); ôc (75.42 MHz, C^H3 0 % ) 52.34 (PhCH2), 56.00 (PhCH2), 127.97, 
129.53, 129.82, 129.96, 130.09 and 130.35 (aromatics), 133.32 and 135.22 (quat. 
aromatics), 167.89 (C=S0 3 H); m/z (ES-) 303 ([M-H]-, 100%)
216
A-Benzyl-A-(2-phenylethyl)aminoiminomethanesulfonic acid (197)
/  \ SO3H\
This com pound was prepared in an identical m anner to N -  
benzylam inoim inom ethanesulfon ic acid (181) using A -b e n z y l-N - (2 - 
phenylethyl)thiourea (185) (2.70 g, 10 mmol) to yield the product (197) as a solid 
(1.81 g, 57%), m.p. 254 °C (decomp.); Dmax (nujol)/cm’l 3250 (NH), 1600 (CN), 1250 
(SO3H), 880 and 770 (aromatics); ôy (300 MHz, € ^ 3 0 % ) 3.03 (2H, t., J  7.8, 
PhCH2CH2), 3.27 (2H, t., J  7.8, CH2C/72N), 4.25 (2H, s., P h % N ) ,  7.28-7.56 
(lOH, m., aromatics); Ôc (75.42 MHz, d^-DMSO) 31.99 (PhCH2CH2), 48.35 and
50.80 (CH2CH2N and PhCH2N), 127.58, 129.32, 129.41, 129.52, 129.81 and 130.63 
(aromatics), 132.43 and 137.68 (quat aromatics), 166.90 (C-SO3H); m/z (ES") 317 ([M-
H]-, 100%)
217
iV,A^-DicycIohexylaminoiminomethanesulfonic acid (198)
SO3H
This com pound was prepared in an identica l manner to N - 
benzylaminoiminomethanesulfonic acid (181) using A^,AT-dicyclohexylthiourea (190) 
(2.40 g, 10 mmol). The product (198) was obtained as a white solid (1.35 g, 47%), 
m.p. >290 °C; t)max (nujol)/cm-l 3200 (NH), 1260 (SO3H); Ôh (300MHz, C % 3 0 % ) 
1.2-1.7 (6H, m., C/72-3 ,4 ,5), 1.85 (2H, m., C7/ 2-2), 2.05 (2H, m., CH2 -6 ), 3.15 
(IH, m., C77-5); 6c  (75.42 MHz, C^HgO^H) 25.45 (C-3,5), 26.10 (C-4), 30.49 (C- 
2,5), 54.47 (C-1); (ES-) 287 ([M-H]-, 100%)
218
Pyridinium /;-toluenesulfonate (219)
2 ' 3 '
H
CHg
6 ' 5'
p-Toluenesulfonic acid monohydrate (22.8 g, 120 mmol) was added to pyridine (48.4 
cm3, 300 mmol) with stirring. After the exotherm had ceased, the excess pyridine was 
removed under reduced pressure to yield a white solid in quantitative yield. The white 
solid was then recrystallised from acetone to give the product (219) as a white solid 
(22.3 g, 74%), m.p. 117-118 °C (lit.,138 \20 °C); (Found: C, 57.44; H, 5.25; N, 
5.78%. Calc, for C12H13NSO3: C, 57.35; H, 5.27; N, 5.57%); t)max (nujol)/cm“l 3450 
(NH), 1200 (SO3H), 750 and 675 (aromatics); Ôh (300 MHz, C^HCb) 2.23 (3H, s., 
CH3 ), 7.15 (2H, d., /  5.4, CFf-3',5'), 7.78 (2H, d., J 5.4, CH~2',6'), 7.92 (2H, d.d., 
J 3.6 and 5.3, CH-3,5), 8.4 (IH, t., J 5.3, CH-4), 8.98 (2H, d., J 3.6, C/7-2,6); ôc 
(75.42 MHz, C % C l3) 21.33 (CH3), 126.00 (C-2',6'), 127.51 and 129.05 (C-3,5 and 
C-3'5'), 140.39 (C-4'), 142.04 (C-2,6), 142.35 (C-F), 146.32 (C-4)
219
O-Tetrahydropyranyl-A^-hydroxyphthalimide (218)
o
N  0 -
‘O'
A^-Hydroxyphthalimide (1.63 g, 10 mmol) was dissolved in dry dichloromethane (30 
cm^). Dihydropyran (1.26 g, 15 mmol) and pyridinium p-toluenesulfonate (219) (0.25 
g, 0.1 mmol) were then added. The reaction was stirred for 16 hours at room 
temperature under an atmosphere of nitrogen. The resultant solution was then diluted 
with diethyl ether (250 cm^) and washed with saturated brine solution (3 x 70 cm^). The 
organic layer was then dried, and concentrated under reduced pressure to yield a yellow 
solid (2.10 g, 97%). The yellow solid was recrystallised from ethyl acetate to give the 
product (219) as a white solid (0,85 g, 40%), m.p. 119-121 °C (lit.,139 123 °C),
(Found: C, 63.72; H, 5.34; N, 5.66%; Calc, for C13H 13NO4: C, 63.55; H, 5.34; N, 
5.66%); Dmax (nujol)/cm~l 1700 (C=0) 1010, 920 (O-C-O), 810 and 690 (aromatics); %  
(300 MHz, C2HCI3) 1.69-2.13 (6H, m., C ^ 2-2 ,3 ,4 ), 3.64-3.70 (IH, m., C/7-5), 4.47- 
4.52 (IH, m., C/7-5), 5.35 (IH, m., C/7-1), 7.73-7.83 (4H, m., aromatics); ôc (75.42 
MHz, C % C l3) 17.65, 24.9, 27.75 (C-2,3,4), 62.30 (C-5), 103.17 (C-1), 123.54, 
134.50 (aromatics), 129.34 (quat. aromatic), 163.98 (C=0); m/z (Cl) 248 ([M+H]+, 
21%), 148 (100, [C8H2NO2I+), 85 (100, [CsHgO]^)
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O-Tetrahydropyranylhydroxylamine (215)
HgN O'
'O '
C"Tetrahydropyranyl-7/-hydroxyphthalimide (218) (17.29 g, 70 mmol) was dissolved 
in ethanol (15 cm^) and hydrazine hydrate was added (3.68 g, 69 mmol). The reaction 
was heated under reflux for 4 hours and then cooled to room temperature. The by­
product was removed by filtration and the filtrate concentrated under reduced pressure to 
yield a yellow residue. The yellow residue was then distilled under reduced pressure 
using the Kugelrohr apparatus to give the product (215) as a white solid (5.41 g, 69%), 
m.p. 35-36 °C; 'Umax (nujol)/cm"l 3200 (NH2) 1020 and 950 (O-C-O); Ôr (300 MHz, 
C^HCls) 1.53-1.73 (6H, m, C/72-2 ,3 ,4), 3.58 (IH, m., C/7-5), 3.90 (IH, m., C/7-5), 
4.7 (IH, m., C/7-1), 5.47 (2H, s., N/72); ôc (75.42 MHz, C^HClg) 19.72, 25.39, 
28.96 (C-2,3,4), 62.66 (C-5), 102.73 (C-1); m/z (Cl) 118 ([M+H]+, 100%), 85 (60, 
[CsH9 0 ]+)
221
o - Acety 1-A^-hydroxyphthalimide (223)
0
\ N"— O
A^-Hydroxyphthalimide (1.63 g, 10 mmol) was dissolved in dry THF (10 cm^). Acetic 
anhydride (1.4 cm^, 15 mmol), A ,^A^-dimethyl—aminopyridine (DMAP) (0.12 g, 1 
mmol) and triethylamine (2.09 cm^, 15 mmol) were added. The reaction was stirred for 
18 hours at room temperature under an atmosphere of nitrogen. The reaction was then 
partioned between diethyl ether (20 cm^) and 2M HCl (20 cm^), separated and the 
aqueous layer was further extracted with diethyl ether (2 x 20 cm^). The combined 
organic layers were then washed with saturated sodium hydrogen carbonate solution (20 
cm3), dried (MgS0 4 ), filtered and concentrated under reduced pressure to give the 
product (223) as a white solid (1.21 g, 59%), m.p. 160-162 °C; Vmax (nujol)/cm‘ l 
1800, 1760 (C=0), 710, 580 (aromatics); Ôr (300 MHz, d^-DMSO) 1.27 (3H, s., 
C/73), 7.28-7.91 (4H, m., aromatics); 6c (50.3 MHz, d^-DMSO) 17.45 (CH3), 124.27 
and 135.79 (aromatics), 128.43 (quat. aromatic), 162.10 (CH3CO) and 167.60 (C=0); 
m/z (El) 205 (M+, 28%), 163 (56, [M-CH2COJ+)
222
o -Benzoyl acetohydroximic acid ethyl ester (229)
O
CHg
C2 H5 O
■ N O
Acetohydroximic acid ethyl ester (2.6 g, 25 mmol) was dissolved in dry diethyl ether (20 
cm3) and cooled in an ice bath. Pyridine (1.95 g, 25 mmol) was added before a solution 
of freshly distilled benzoyl chloride (3.5 g, 25 mmol) in diethyl ether (10 cm^) was added 
dropwise. The reaction was warmed to room temperature and stirred for 3 hours. The 
pyridinium chloride was removed by filtration and the filtrate was dried (MgS0 4 ), filtered 
and concentrated under reduced pressure to yield a white solid. Recrystallisation from 
petroluem ether (40-60 °C) gave the product (229) as a white solid (3.03 g, 58%), 
m.p. 72-74 °C (lit.,140 77^79 oq ). (pound: C, 63.77; H, 6.11; N, 6.71; Calc, for 
C11H 13NO3: C, 63.76; H, 6.32; N, 6.76%); Umax (nujol)/cm'l 1750 (C=0), 975 and 
725 (aromatics); Ôr (300 MHz, C^HCb) 1.35 (3H, m., C/73CH2O), 2.14 (3H, s., 
C/7 3 ), 4.27 (2H, q., J  7.2, CH3C/72O), 7.4 (2H, m., C/7-3,5), 7.6 (IH, m., C/7-4), 
8.0 (2H, m., C/7-2,6); 5c (75.42 MHz, C^HC^) 14.10 and 15.05 (CH3CH2O and 
CH3), 63.75 (CH3CH2O), 128.52, 129.44 (C-3',5' and C-4'), 129.3 (C-T), 133.13 
(C-2',6'), 164.01 (C=N), 169.66 (C=0); /n/k (Cl) 208 ([M+H]+, 96%)
223
0-BenzoyIhydroxylamine hydrochloride (228)
O
C f HgN-
0-Benzoylacetohydroximic acid ethyl ester (229) (1.05 g, 5 mmol) was stirred in 
dioxan (10 cm^) and water (0.9 cm^, 5 mmol) was added. Dry HCl gas was then 
bubbled through the solution and a white solid precipitated from solution. The 
suspension was stirred for 30 minutes before dry diethyl ether (10 cm^) was added. The 
solid was removed by filtration and and washed repeatedly with diethyl ether to give the 
product (228) as a white solid (0.72 g, 83%), m.p. 106-108 °C (Iit.,12 110-112 °C); 
Umax (nujol)/cm'l 3380 and 3370 (NH2), 1760 (C=0), 690 and 680 (aromatics); Ôr (200 
MHz, 2H2O) 7.43 (2H, m., C/7-3,5), 7.6 (IH, m., C/7-4), 8.0 (2H, m., C/7-2,6); Ôc 
(75.42 MHz, 2H2O) 125.94, 126.64 (C-2,6 and C-5,3), 130.67 (C-1), 132.12 (C-4),
162.27 (C=0); m/z (Cl) 138 ([M-C1]+, 82%)
224
C>-ButylcarbamyI-A-hydroxyphthaIimide (231)
A^-Hydroxyphthalimide (1.63 g, 10 mmol) was stirred in dry THF (10 cm^) and butyl 
isocyanate (0.9 g, 1.02 cm^, 10 mmol) was added. The reaction was monitored by tic 
(1:1 ethyl acetate/petroluem ether (40-60 °C)). After 45 minutes reaction was complete 
and the reaction mixture was concentrated under reduced pressure to yield a orange solid 
(231) (2.28 g, 87%), m.p. 154-155 °C; Umax (nujol)/cm-l 1750 (C=0), 1075, 975 (O- 
C-O), 825 and 700 (aromatics); Ôr (300 MHz, C^HsO^H) 0.96 (3H, t., 7 7.3, CH3), 
1.37 (2H, m., C/72-3), T53 (2H, m., C/7 2 -2 ), 3.2 (2H, t., 7 6 .6 , C/72- 1), 7.8 (4H, 
m., aromatics); ôc (75.42 MHz, C % 3 0 % ) 13.98 (CH3 ), 20.77 (C-3), 32.62 (C-2), 
42.39 (C-1), 124.18 and 124.81 (aromatics), 135.67 and 136.28 (quat. aromatics)
225
O-(Benzylcarbamyl) acetohydroximic acid ethyl ester (232)
CHs
C2H5O
:N O
Benzyl isocyanate (1.33 g, 1.23 cm^, 10 mmol) in dry ether (10 cm^) was added 
dropwise to a solution of acetohydroximic acid ethyl ester (1.03 g, 10 mmol) in ether (10 
cm3). The reaction was stirred at room temperature for 3 hours and then concentrated 
under reduced pressure to give the product (232) as an oil (1.25 g, 53%); ô r  (300 
MHz, C^HCls) 1.20 (3H, m., C/73CH 2O), 2.09 (3H, s., C/73), 3.98 (2H., m., 
C/72Ph), 4.30 (2H, q, J  7, CH3C/72O), 7.2 (5H., m., aromatics); ôc (75.42 MHz, 
C% C l3) 13.99 and 15.02 (CH3CH2O and CH3), 44.89 (CH2Ph), 63.29 (CH3CH2O), 
127.50, 127.57 and 128.73 (aromatics), 138.26 (quat. aromatic), 207.15 (C=N); m/z 
(Cl) 237 (9, [M+H]+)
0-(4-Methoxyphenylcarbamyl) acetohydroximic acid ethyl ester (235)
O
CH
C2H5
N O' \  / ■OCH3
Acetohydroximic acid ethyl ester (1.03 g, 10 mmol) was dissolved in sodium dried 
toluene (10 cm^) and p-methoxyphenyl isocyanate (1.49 g, 10 mmol) was added. The 
mixture was stirred under nitrogen at room temperature for an hour before it was heated
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at reflux for an hour and then stirred at room temperature for 12 hours. The resultant 
solution was concentrated under reduced pressure to yield a yellow oil with a trace of 
solid present. The oil was dissolved in ethyl acetate and the solid removed by filtration. 
The filtrate was concentrated under reduced pressure to give a yellow oil which became 
solid on standing. This solid was purified by silica column chromatography (elutant 3:1 
petroleum ether (40-60 °C)/ethyl acetate) to give the product (235) as a white solid (1.0 
g, 40 %), m.p. 76.5 °C; Umax (nujol)/cm-l 3180 (NH), 1680 (C=0), 950 and 790 
(aromatics); Ôr (200 MHz, C^HgO^H) 1.3 (3H, t., C/73CH 2O), 2.1 (2H, m., 
CH3CH2O), 2.3 (3H, s., OC/73), 4.2 (3H, m., C/73), 7.2 (4H, 2 x d., aromatics); ôc 
(75.42 MHz, C2H3Q2H) 10.93 (CH3CH2O), 17.55 (OCH3), 26.46 (CH3CH2), 60.33 
(OCH3), 126.43 and 126.50 (aromatics), 130.70 and 131.43 (quat. aromatics), 149.51 
(C=N) and 163.68 (C=0)
(9-(4-Methoxyphenylcarbamyl)hydroxyIamine (233)
HgN- -O
O
\  / OCH3
0-(Methoxyphenylcarbamyl)acetohydroximic acid ethyl ester (235) (3 mmol, 0.76g) 
was stirred in dioxan (10 cm^) and water (3 mmol, 0.06 cm^) added. The reaction was 
cooled to 0 °C and dry HCl gas was bubbled through the solution and a white precipitate 
was formed. After stirring at 0 °C for 30 minutes the suspension was diluted with dry 
diethyl ether (10 cm^) and filtered. The collected solid was repeatedly washed with 
diethyl ether to give the product (233) as a white solid (0.52 g, 95%); m.p. 119-120 °C; 
Umax (nujol)/cm-l 3180 (NH), 1740 (C=0), 900, 840 (aromatics); Ô r  (200 MHz,
227
C2HC13) 2.3 (2H, s., NH2), 3.34 (IH, s., NH), 4.98 (OCH3), 7.25 (4H, d.d., 
aromatics); 8c (75.42 MHz, C^HCls) 15.54 (OCH3), 120.51, 130.89 (aromatics), 
135.98 (quat. aromatic)
O-Trimethylsilylhydroxylaraine (236)
ÇH3
H,N— O— Si— CH,I
CH3
Powdered hydroxylamine hydrochloride (35 g, 0.5 mol) was added slowly (Care 
reaction is exothermic) to a stirred solution of ethylenediamine (30 g, 0.5 mol) in 
dichloromethane (150 cm^). This mixture was stirred at room temperature for 6 hours 
until 2 cleaiiy defined liquid phases were present. Chlorotrimethylsilane (65 cm^, 0.5 
mol) was then added dropwise over an hour. Once reflux was complete the reaction was 
stirred for 24 hours at room temperature. The resulting solid (ethylendiamine chloride) 
was filtered off and washed with portions of dichloromethane. The filtrate was then 
evaporated at reduced pressure and the residue distilled to give the product (236) as a 
colourless liquid, b.p. 98 -100 °C; Ôr (300 MHz, C^HCls) 0.1 (9H, s., Si(C7f3)3), 5.00 
(2H, s., ON/72)
228
2,3,4,6-Tetra-O-acetyI-l-brom o-a-D-gïucopyranose
(a-D-Acetobromoglucose) (242)
AcO
AcO
AcO
OAc
Br
D-Glucose (9 g, 50 mmol) was dissolved in acetic anhydride (35 cm^) and hydrobromic 
acid in acetic acid (45% w/v, 14 cm^, 77 mmol) was added dropwise. After complete 
addition the reaction was stirred at room temperature for an hour before further 
hydrobromic acid (42 cm^, 231 mmol) was added. The reaction was then stirred for 18 
hours at room temperature before being poured, carefully, onto ice-cold water (200 cm^). 
The homogenous solution was extracted with dichloromethane (2 x 200cm3). The 
combined organic extracts were then carefully poured onto ice cold saturated sodium 
hydrogen carbonate solution (200 cm^). The mixture was separated and the organic layer 
washed with sodium hydrogen carbonate solution (3 x 200 cm^), dried (MgSO^), filtered 
and concentrated under reduced pressure to give a thick oil. Crystallisation was induced 
by adding ether to the oil and leaving at -18 °C for a number of hours. The solid 
obtained was filtered and recrystallised to give the product as a solid (8.87 g, 40%), m.p. 
87-88 °C (lit.,151 88-89 °C); [a]o +196.3 ° (c 2.42 in CHCI3) (lit.,i52 +197.84 ° (c 
2.42 in CHCI3)); Dmax (nujol)/cm^l 1720 (CO); Ôh (200 MHz, C^HCb) 2.04 (12H, 4 x 
s., COOC773), 4.09 (IH, m., H-5), 4.29 (2H, m., H-6^,6^), 4.81 (IH, dd., J  1,2 4, 72,3 
10,H-2), 5.14 (IH, t., 7 3,4=74,5 10, 77-4), 5.53 (IH, t., 7 2,3=^3,4 10, 77-3), 6.59 (IH, 
d., 7 1,2 4, 77-1); ôc (75.42 MHz, C^HCb) 21.01 and 21.11 (CH3), 61.39 (C-6), 67.6 
(C-4), 70.59 (C-2), 71.00 (C-5), 72.57 (C-3), 86.56 (C-1), 169.91, 170.23, 170.29 
and 170.94 (C=0); m/z (Cl) 430 and 428 ([M+NH4]+, 18%)
229
Attempted preparation of 0-(2,3,4,6-Tetra-0-acetyl-a-D-gIucopyranose)-
A^-hydroxyphthalimide (241) from acetobromo-a-D-glucose (242)
N-Hydroxyphthaiimide (0.82 g, 5 mmol) was dissolved in dry THF (15 cm^) and then 
sodium hydride (0.2 g of a 60% suspension in oil) was added in small portions. To the 
resultant dark solution acetobromo-a-D-glucose (242) (2.06 g, 5 mmol) was added and 
the reaction stirred overnight at room temperature. After this period water was added 
carefully until evolution of gas ceased. The residue was then concentrated under reduced 
pressure and the resultant solid was partioned between ethyl acetate (20 cm^) and water 
(20 cm^). The aqueous layer was washed with ethyl acetate (2 x 20 cm^) and the 
combined organic extracts were washed with brine (2 x 20 cm^), dried (MgSO^), filtered 
and concentrated under reduced pressure to yield a white solid (1.32 g, 26%). Both the 
iR and NMR spectra of the product were consistent with the product being a mixture 
of starting materials.
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2,3,4,6-Tetra-O-acetyl-D-glucono-y-iactone (245)
AcO
AcO
AcO
OOAc
Zinc chloride (8.91 g, 65 mmol) was dissolved in acetic anhydride (90 cm^) and stirred 
under nitrogen. To the suspension D-glucono-y-lactone (17.83 g, 100 mmol) was added 
slowly. The reaction was stirred at room temperature for 40 minutes and then poured 
onto crushed ice (300 cm^). After shaking, the homogenous solution was extracted with 
dichloromethane (2 x 250 cm^). The combined organic extracts were washed with ice- 
cold water (2 x 250 cm^), dried (MgS0 4 ) and concentrated under reduced pressure to 
give the product (245) as a gold oil (34.6 g, 100%); [a]o 77.2° (c 2.0 in CHCI3) 
(lit.,153 +79.7° (c 2.0 in CHCI3); Dmax (nujol)Zcm-l 2950 (CH), 1730 (CO); Ôh (300 
MHz, C % C l3) 1.99-2.08 (12H, 4s., 4 x CH3 ), 4.18 (IH, d.d., 7 5 ,6 a 2.6, 76a,6b 12.8, 
^ - 6a), 4.32 (IH, d.d., 7 5 ,6 b 3.8, 76a,6b 12.8, H-6 h), 4.53-4.58 (IH, m., H-5), 5.07 
(IH, d., 72,3 9.0, H-2), 5.3 (IH, t., 73,4=74,5 9.0, H-4), 5.48 (IH, t., 72,3=73,4 9.0, H- 
3); ÔC (75.42 MHz, C^HCb) 20.11, 20.18, 20.24 and 21.80 (4 x CH3), 61.18 (C-6),
66.27 (C-4), 69.99 (C-3), 70.10 (C-5), 75.60 (C-2), 164.59 (C-1), 169.13, 169.34, 
169.84 and 170.20 (4 x C=0); m/z (El) 347 (M+, 22%)
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2,3,4,6-Tetra-O-acetyI-a/p-D-gIucopyranose (243)
AcO
AcO
AcO
OHOAc
2,3,4,6-Tetra-(9-acetyl-D-glucono-Y-lactone (245) (100 mmol, 34.6 g) was dissolved in 
THF (150 cm^) and cooled to 0 °C. Sodium borohydride (50 mmol, 1.91 g) in ice-cold 
water (30 cm^) was then added dropwise to the resultant solution. The reaction mixture 
was stirred at 0 °C for 3 hours before DOWEX 50W H+ resin (15 g) was added. The 
suspension was filtered and the filtrate concentrated under reduced pressure to give an 
oily solid which was washed with methanol to yield the product (243) as a colourless 
syrup. (20.16 g, 58 %), M d  +11.1 ° (c 1.0 in CHCI3) (lit.,154 +9 .8° (c 0.816 in 
CHCI3); Dmax (nujol)/cm-l 3300 (OH) and 1750 (CO); ôy (200 MHz, C^HCb) 2.00- 
2.15 (12H, 4s., 4 X CH3 ), 3.7 (IH, m., H-5), 4.10 (2H, m., /7-6a,6b), 4.75-5.70 (4H, 
m., 77-1,2,3,4); ôc (75.42 MHz, C^HCb) 20.47 and 20.58 (CH3 ), 61.41 (C-6 p), 
61.91 (C-6a), 67.17 (C-4a), 67.71 (C-4P), 68.46 (C-2a), 69.82 (C-5a), 70.19 (C~ 
2P), 71.04 (C-3a), 72.03 (C-5P), 72.19 (C-3p), 90.15 (C-1 a), 95.54 (C-ip), 169.80, 
170.33, 170.40 and 170.99 (4 x C=0); m/z (Cl) 366 ([M+NH4]+, 95%), 331 (100, [M- 
OH]+), 271 (8, [M-C2H503]+), 211 (3, [M-C4H90s]+)
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Attempted preparation of 0-(2,3,4,6-Tetra-0-acetyl-a-D-glucopyranose)- 
A-hydroxyphthalimide (241) from 2,3,4,6-Tetra-O-acetyl-a/p-D- 
glucopyranose (243)
O
O
AcO
2,3,4,6-Tetra-0-acetyl-a/|3-D -glucopyranose (243) (1.42 g, 4.1 mmol), N-  
hydroxypthalimide (0.69 g, 4.2 mmol) and triphenylphosphine (1.1 g, 4.2 mmol) were 
stirred in dry THF (15 cm^) under a nitrogen atmosphere. To this suspension diethyl 
azodicarboxylate (DEAD) (0.73 g, 4.2 mmol) was added. The reaction was stirred for 20 
hours at room temperature. After this time the reaction was concentrated under reduced 
pressure to yield a yellow oil. Pufification of the crude oil was attempted by column 
chromatography (silica, toluene: ether, 9:1), however the NMR spectrum of the 
isolated fractions showed them to be starting materials.
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Attempted preparation of 0-(2,3,4,6-tetra-0-benzyl-D-glucopyranose-A^-
hydroxyphthalimlde
2,3,4,6-Tetra-O-benzyI-D-glucopyranose (2.7 g, 5 mmol), A^-hydroxyphthalimide (0.82 
g, 5 mmol) and triphenylphosphine (1.31 g, 5 mmol) were dissolved in THF (15 cm^). 
To the resultant solution DEAD (0.96 g, 0.87 cm^, 5.5. mmol) was added, the reaction 
was slightly exothermic. The reaction was stirred at room temperature for 46 hours and 
then concentrated under reduced pressure to yield an oil. Methanol was added to the oil 
and a solid precipitate was obtained, which was filtered off and dried. An attempt to 
purify this white solid by column chromatography (silica, ethyl acetate: petroleum ether, 
1:3) yielded A-hydroxyphthalimde and 2,3,4,6-tetra-D-benzyl-D-glucopyranose. The 
filtrate was concentrated under reduced pressure to yield an oil. An attempt to purify the 
oil by column chromatography (silica, ethyl acetate : petroleum ether, 1:1) yielded no 
target compound.
234
2,3,4,6-Tetra-0-acetyl-p“D-gIucopyranosyI trichloroacetimidate (247)
AcO
AcO
AcO
OAc
NH
O ' ' C C I 3
2,3,4,6-Tetra-O -acetyl-a/p-D -gliicopyranose (243) (58 mmol, 20.19 g) and 
trichloroacetonitrile (29 cm^) were stirred together in dry dichloromethane (100 cm^). To 
this solution was added hot potassium carbonate (22.5 g). The reaction was stirred at 
room temperature for 25 hours. The reaction mixture was then filtered to remove the 
inorganic salts and the filtrate concentrated under reduced pressure to yield an oil. 
Purification by column chromatography (silica, 2:3 ethyl acetate/petroluem ether ) gave 
the product (247) as a white solid (11.89 g, 43%), m.p. 69-71 °C (lit. (a), oil, 
(P),155 154-155 °C); [a]D +44.7 ° (c 1.0 in CHCI3) (lit. (a),i55 +61.5 ° (c 1.0 in 
CHCI3), (P),155 +8 .3  (c 1.0 in CHCI3)); ÔH (200 MHz, C^HCh) 2.10 (12H, 4s., 4 x 
C7/3), 4.05-4.30 (3H, m., /7-5,6a,6b), 5.10-5.20 (2H, m., 77-3,4), 5.60 (IH, t., J , H- 
2), 6.55 (IH, d., J  8.0, 77-1), 8.7 (IH, s., N77); ôc (75.42 MHz, C2HCI3) 14.03 
(CCI3), 20.27, 20.41, 20.50 and 20.87 (4 x CH3), 60.28, 61.29 (C-5,6), 67.72 (C-4),
69.80 (C-3), 69.96 (C-2), 92.88 (C-1), 160.87 (C=NH), 169.58, 169.92, 170.07 and 
170.63 (4 X C=0)
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0-(Tetra-0-acetyl-a-D-glucopyranose)-A^-hydroxyphthalimide (241)
O
AcO
AcO OAc
N OAc
O
A/-Hydroxyphthalimi(le (1.86 g, 3.8 mmol) and 2,3,4,6-tetra-O-acetyl-p-D- 
glucopyranosyl trichloroacetimidate (247) (0.62 g, 3.8 mmol) were stirred in DCM (10 
cm^) and cooled to -15 °C. Boron trifliioride diethyl etherate (0.76 cm^, 15.2 mmol) 
was added and the reaction stirred for 75 minutes. After this time the reaction was 
recooled to -15 °C and further boron trifluoride diethyl etherate (0.76 cm^) was added to 
the solution. The reaction was then stirred overnight at room temperature. The resultant 
solution was added to saturated bicarbonate solution (15 cm^) and ethyl acetate (15 cm^). 
The aqueous layer was washed with ethyl acetate (2 x 20 cm^). The combined organic 
extracts were washed with brine (2 x 20 cm^), dried (MgSO^), filtered and concentrated 
under reduced pressure to yield an oil. This oil was stirred in methanol and the solid 
obtained was filtered and dried to give the product (241) as a white solid (0.53 g, 29%), 
m.p. 168-170 °C; Dmax (nujol)/cm~l 1870 (CO), 710 and 690 (aromatics); ôh (200 MHz, 
d6-DMS0) 1.94-2.47 (12H, 4s., CH3 ), 3.94-4.02 (2H, m., H-6 a and H-5), 4.22 (IH, 
d.d., 75,6b 4.8, 76a,6b 12.2, //-6b), 5.03 (2H, m., H-2 and H-A), 5.38 (2H, m., H-3 
and //-I), 7.86 (4H, s., aromatics); ôc (75.42 MHz, d^-DMSG) 19.74, 19.81 and 19.91 
(CH3), 61.04 (C-6), 67.39 (C-4), 68.87 (C-2), 70.56 (C-5), 71.12 (C-3), 103.91 (C-
1), 123.09 and 134.67 (aromatics), 127.98 (quat. aromatics), 161.98 (aromatic C=0), 
168.88, 169.25 and 169.60 (C=0); m/z (ES+) 516 ([M+Na]+, 100%)
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3,4,5,6-Tetrachloro-iV-hydroxyphthalimide (248)
Cl
CI
N OH
Tetrachlorophthalic anhydride (5.71 g, 20 mmol) was stirred in 2M sodium hydroxide 
solution (20 cm^) and hydroxylamine hydrochloride (1.39g, 20 mmol) added. The 
reaction was heated at reflux for 8 hours and then stirred overnight at room temperature. 
Partial concentration under reduced pressure of the reaction solution yielded a solid which 
was removed by filtration and dried under vacuum to yield the product as a solid (2.21 g, 
37%), m.p >300; Dmax (nujol)/cm"l 3300 (OH), 1570 (CO), 650, 605 (aromatics); Ôc 
(75.42 MHz, % 0 ) ,  109.87, 128.25 and 133.84 (aromatics), 168.58 (C=0)
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0-(Tetra-0-acetyl-D-gIucopyranose)hydroxyIamine (250)
AcO
AcO
AcO
OAc
O  NH2
A^-(Tetra-(9-acetyl-a-D-glucopyranose)phthalimide (241) (0.49 g, 1 mmol) was stirred 
in THF (10 cm^) and hydrazine hydrate added (0.1 cm^). The reaction mixture was 
heated under reflux for 10 minutes and then cooled to room temperature, when the by­
product phthalizine precipitated from the solution. The suspension was diluted with 
aqueous sodium bicarbonate solution (5%, 10 cm^) and washed with diethyl ether (3 x 
15 cm^). The combined organic extracts were washed with water ( 2x15  cm^), dried 
(MgS0 4 ), filtered and concentrated under reduced pressure to yield an off-white solid 
(250) (0.25g, 69 %); D^ax (nujol)/cm“l 3450 and 3400 (N%), 1670 (C=0); by (300 
MHz, C^HCls) 1.99-2.08 (12H, 4s., 4 x CTfg), 3.72 (IH, m., H-5), 4.15 (IH, d.d., 
75,6a 2, 76a,6b 12.4, 7f-6a), 4.30 (IH, d.d,, 7g 6b 4.3, 76a,6b 12.4, i7-6b), 4.70 (IH, d., 
7 8.2,77-1), 5.02-5.27 (3H, m., 77-2,3,4); 8c  (75.42 MHz, C ^ C lg )  21.05, 21.09, 
21.17 and 21.22 (CH3), 62.21 (C-6), 68.61 (C-4), 70.06 (C-3), 72.23 (C-5), 73.35 (C-
2), 103.88 (C-1), 169.77, 170.02, 170.70 and 171.20 (C=0); m/z (ES+) 386 
([M+Na]+, 100%)
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Attempted preparation of 0-(4-nitrophenyl)-A-hydroxyphthallmide (254)
O
o
•o- \  / N02
A^-Hydroxyphthalimide (1.63 g, 10 mmol), 4-nitrofluorobenzene (1.38 g, 10 mmol) and 
pyridine (0.79 g, 10 mmol) were stirred together in dry DCM (15 cm^) for sixteen hours. 
After this time tic indicated that reaction had not occurred and the reaction was then heated 
at between 40 and 60 °C for twelve hours and then stirred at room temperature for seven 
days. The reaction was concentrated under reduced pressure and the residue partioned 
between water (15 cm^) and ethyl acetate (15 cm^). The aqueous layer was washed with 
ethyl acetate (2 x 15 cm^) and the combined organic extracts were washed with brine (15 
cm^), dried (MgS0 4 ), filtered and concentrated under reduced pressure to yield an orange 
solid. The NMR spectrum of this compound showed that it was a mixture of compounds 
but that the major product was starting material.
Attempted preparation of 0-(2,4-dinitrophenyl)-A -hydroxyphthaIim ide  
(255)
O OgN
\  / •NO2
N-Hydroxyphthalimde (1.63 g, 10 mmol), 2,4-dinitrofluorobenzene (1.86 g, 10 mmol),
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DMAP (0.12 g, 1 mmol) and triethylamine (2.09 cm^, 15 mmol) were stirred together in 
THF (10 cm3). The reaction was stirred at room temperature for 24 hours and then 
partioned between diethyl ether (15 cm^) and 2M HCl (15 cm^). The aqueous layer was 
washed with diethyl ether (2 x 1 5  cm^) and the combined organic layers were washed 
with saturated hydrogen carbonate solution (15 cm^), dried (MgS0 4 ), filtered and 
concentrated under reduced pressure to yield a yellow solid. The NMR spectrum 
indicated that the desired product had not been obtained.
Attempted preparation of C?-(2,4-dinitrophenyl)-A-hydroxyphthalimide 
(255)
O
O
O2N,
N O- \  / NO2
A-Hydroxyphthalimde (2.45 g, 15 mmol) was stirred in dry DCM (15 cm^) and sodium 
hydride (0.6 g) was added. Once gas evolution had ceased 2,4-dinitrofluorobenzene 
(2.79 g, 15 mmol) was added and the solution heated under reflux for 5 hours and then 
the solid residue was removed by filtration. Concentration of the filtrate under reduced 
pressure yielded an orange solid. The NMR spectrum of this solid indicated that the 
compound was a mixture of compounds with some of the desired product present. 
However all attempts to purify this compound failed.
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Attempted preparation of (?-(2,4-dinitrophenyl)-A-hydroxyphthaIim ide
(255)
O
O
O2N
\  / NO2
2,4-Dinitrophenol (0.93 g, 5 mmol) was stirred in dry THF (15 cm^) at 0 °C and N- 
hydroxyphthalimide (0.82 g, 5 mmol) and triphenylphosphine (1.46 g, 5.7 mmol) 
added. Diethyl azodicarboxylate (0.89 cm^, 5.7 mmol) was added to the suspension over 
a period of 10 minutes. The reaction was then stirred at room temperature for 30 minutes 
and then concentrated under reduced pressure to yield a dark oil. Subsequent column 
chromatography (silica, 3/1 ethyl acetate/ diethyl ether) yielded a number of products. 
The NMR spectrum of these products showed that there was none of the desired 
compound present.
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D-Benzyl-l-benzyl-2-hydroxyguanidine (258)
N  OCHgCgHg
Potassium carbonate (2.76 g, 20 mmol) was added to water (30 cm^), followed by 0~ 
b enzy lhydroxy  lam ine h y d ro ch lo r id e  (1 .60g , 10 m m o l). N -
Benzylaminoiminomethanesulfonic acid (193) (2.14 g, 10 mmol) was added to the 
solution in small quantities. Once addition was complete the reaction was stirred at room 
temperature for 8 hours. The resultant suspension was filtered and the solid dried under 
vacuum to give the product (258) as a white solid (1.22 g, 48%), m.p. 84-86 °C; 
(Found: C, 70.35; H, 6.95; N, 16.63. Calc, for C15H 17N3O: C, 70.57; H, 6.71; N, 
16.46%); Dmax (nujol)/cm'l 3450 (NH) 3100, 3060 (NH2), 760 and 700 (aromatics); ôh 
(200 MHz, d6-DMSO) 4.1 (2H, s., PhC7f2NH), 4.7 (2H, s., OCFf2Ph), 5.0 (2H, s., 
NH2 ), 7.2 (lOH, m., aromatics); 6c (50.3 MHz, d^-DMSO) 44.57 (PhCH2NH), 74.27 
(OCH2Ph), 127.74, 128.16, 128.74, 129.09, 129.17 and 129.48 (aromatics), 140.74 
(quat. aromatic), 154.95 (C=N); m/z (El) 255 (M+, 11%), 164 (38, [M-PhCH2]+), 133 
(79, [M-NH0CH2Ph]+, 79), 91 (99, [PhCH2]+), 77 (26, [GeHsl^)
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O-Benzyl-l-phenylethyl-2-hydroxyguanidine (259)
 OCH2C6H5
This was prepared in a manner identical to O-benzyl-l-benzyl-2-hydroxyguanidine 
(258) using A^-phenylethylaminoiminomethanesulfonic acid (195) (10 mmol, 2.28 g) 
to give the product (259) as an oil (1.23 g, 46%); Dmax (nujol)/cm"l 3450, 3020 and 
3010 (NH+NH2), 740 and 690 (aromatics); 6h (300 MHz, C^HCls) 2.65 (2H, m., 
PhC/72CH2), 3.10 (2H, m, CH2C7/2NH), 4.70 (2H, s., OC%Ph), 7.10 (lOH, m., 
aromatics); 6c (75.42 MHz, C^HClg) 32.99 (PhCH2CH2), 39.89 (CH2CH2NH), 72.17 
(0 CH2Ph), 124.36, 124.57, 124.94, 125.17, 125.28 and 125.77 (aromatics), 135.24 
(quat. aromatic), 152.13 (C=N); m/z (El) 269 (M+, 29%), 178 (39, [M-CH2C6H5I+), 
147 (96, [M-NOCH2C6H5J+), 105 (93, [C6H5CH2CH21+), 91 (100, [C6H5CH2]+), 77 
(25, [C6H51+)
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0-BenzyI-l,l-dibenzyl-2-hydroxyguanidine (260)
N  OCHpPh
/  \_ y
This was prepared in an identical manner to 0-benzyl-l-benzyl-2-hydroxyguanidine 
(258) using A/jA'-dibenzylaminoiminomethanesulfonic acid (196) (3.04 g, 10 mmol) to 
give the product (260) as a solid (3.08 g, 89%), m.p. 63-64 °C, (Found: C, 76.73; H, 
6.79; N, 12.09; Calc, for C22H 17N 3O: C, 76.49; H, 6.71; N, 12.16%); 
(nujol)/cm‘l 3030 and 3000 (NH2), 750 and 670 (aromatics); ôh (200 MHz, C% C l3)
4.3 (6H, m., 2 x PhC772 and NHj),  5.0 (2H, s., OC/72Ph), 7.4 (15H, m., aromatics); 
6c (50.3 MHz, C^HCb) 51.05 (PhCH2), 75.97 (OCH2Ph), 127.74, 128.16, 128.74, 
129.09, 129.17 and 129.84 (aromatics), 138.57 and 139.02 (quat. aromatics), 157.63 
(C=N); m/z (El) 345 (M+, 17%), 254 (38, [M-CH2CôH 5 ]+), 223 (56, [M- 
NHOCH2C6H51+), 196 (49, [(C6H5CH2)2N]+), 106 (79, [C6HsCH2NH]+), 91 (100, 
[C6H5CH21+)
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O-BenzyI-l-benzyl-l-methyl-2-hydroxyguanidm e
N  OCH2C6H5
N' NH2
CHg
This compound was prepared in an identical manner to 0-benzyl-l-benzyl-2- 
hydroxyguanidine using A/TV-benzylmethylaminoiminomethanesulfonic acid (0.91 g, 4 
mmol) to give the the crude product as a pale yellow oil. This oil was purified by column 
chromatography (silica, 3/1 ethyl acetate/petroleum ether (40-60 °C)) to give the product 
as an oil (0.24g, 11.2 %); Dmax (nujol)/cm“l 3450 (NH2), 970 and 890 (aromatics); 6h 
(200 MHz, C^HCls) 2.78 (3H, s., CH3 ), 4.34 (2H, s., P h ^ N ) ,  4.38 (2H, s., NH2 ), 
4.94 (2H, s., OC7/2Ph), 7.3 (lOH, m., aromatics); ôc (75.42 MHz, C^HClg) 35.58 
(CH3), 54.07 (PhCH2N), (OCH2Ph), 127.22, 127.63, 128.04, 128.22, 128.41 and 
128.61 (aromatics), 138.16 and 138.39 (quat. aromatics), 157.30 (C=NO); m/z (El) 269 
(M+, 100%)
General Hydrogenation Procedure
The 0-benzyl A^-hydroxyguanidine was dissolved in solvent (ethanol, methanol, ethyl 
acetate or trifluroethanol). If required acetic acid was added to the reaction mixture. The 
catalyst (10% palladium on carbon) was then added to the reaction flask. The flask was 
fitted with a septum, purged with hydrogen gas and stirred under an atmosphere of 
hydrogen for 16 to 29 hours. The reaction was then filtered through celite to remove the 
catalyst and the filtrate concentrated under reduced pressure to yield the product.
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1-Benzylguanidine (265)
Potassium carbonate (2.06 g, 15 mmol) was added to water (30 cm^) followed by 
a q u e o u s  a m m o n i a  ( 32% s o l u t i o n ,  100 m m o l ,  6 cm^ ). N -  
Benzylaminoiminomethanesulfonic acid (193) (3.21 g, 15 mmol) was then added to the 
solution in small quantities. After addition was complete the reaction was stirred at room 
temperature for 24 hours. The solvent was then removed under reduced pressure to yield 
a yellow solid. This solid was stirred in ethanol and the inorganic salts were removed by 
filtration. The solvent was removed at reduced pressure to give the product (265) as a 
white solid (1.83 g, 82%), m.p. 159-161 °C; 6h (200 MHz, % 20) 4.3 (2H, s., CH2 ),
7.2 (5H, m., aromatics); ôc (75.42 MHz, ^ O )  43.58 (CH2 ), 127.18, 127.26 and
128.57 (aromatics), 138.21 (quat. aromatic), 157.93 (C=NH); m/z (El) 149 (M+, 35%), 
148 (40, [M-H]+), 106 ( 100, [M-C(=NH)NH2]+), 91 (50, [C6H5CH2]-*-), 77 (27, 
[C6H 5]+)
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0-Tetrahydropyranyl-l,l“dibenzyI-2-hydroxyguanidine (268)
/  \ N O- ‘O
NH2
0-Tetrahydropyranyl“hydroxylamine (0.59 g, 5 mmol) and potassium carbonate (4.15 g, 
30 mmol) were dissolved in water (30 cm^). To the resulting solution N,N- 
dibenzylaminoiminomethanesulfonic acid (196) (1.52 g, 5 mmol) was added. The 
reaction was stirred for 18 hours at room temperature and filtered. The crude product 
was obtained as an off-white solid. This solid was dissolved in hot diethyl ether and the 
insoluble residue removed by filtration. The filtrate was cooled and the solid collected by 
filtration to yield the product (268) as a white solid (0.45 g, 28%), m.p. 99-101 °C; 
(Found: C, 70.77; H, 7.22; N, 12.06; Calc, for C20H25N3O2: C, 70.77; H, 7.42; N, 
12.38%); Umax (nujol)/cm-l 3390 and 3380 (NH2), 1010, 960 (O-C-0), 850, 830 and 
680 (aromatics); Ôh (200 MHz, C^R^Cl) 1.57-1.84 (6H, m., CH2-2 ,3 ,4 ), 3.56-3.64 
(IH, m., CH2 -5 ) 3.92-4.00 (IH, m., C/72-5), 4.37 (4H, pair of d., J  10, AVCH2 ), 
4.46 (2H, s., NH2 ), 5.00-5.02 (IH, m., C/7-1), 7.21-7.36 (lOH, m., aromatics); ôc 
(50.31 MHz, C2H3CI) 21.30, 25.85 and 30.11 (C-2,3,4), 51.23 (ArCH2), 64.20 (C-5),
101.57 (C-1), 127.723, 128.01 and 129.03 (aromatics), 138.54 (quat. aromatics), 
158.05 (C=NOH); m/z (Cl) 340 (M+, 12%), 249 (59, [M-C6H5CH2]+), 223 (17, [M- 
C5HiiN02]+), 118 (45, [C5Hi2N02]+)
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0-(Tetra-0-acetyl-D -glucopyranose)-l,l-dibenzyl-2-hydroxyguanidine
(272)
OAc
AcO OAc
OAc\
N NH2/
0-(Tetra“0-acetyl-D-glucopyranosyl)hydroxylamine (250) (0.22 g, 0.6 mmol) and 
potassium carbonate (0.21 g, 1.5 mmol) were stirred in water (5 cm^). To this solution 
A^,A^-dibenzylaminoiminomethanesulfonic acid (196) (0.18 g, 0.6 mmol) was added 
and the reaction stirred overnight at room temperature. The aqueous layer was diluted 
with water (15 cm^) and then covered with dichloromethane (15 cm^). The aqueous 
layer was washed further with dichloromethane ( 2x15  cm^). The combined organic 
extracts were washed with brine (2x15 cm^), dried (MgSO^), filtered and concentrated 
under reduced pressure to yield an oil (272) (0.09 g, 25%); ôh (300 MHz, C^HsCl)
1.90-2.14 (12H, 4s., 4 x CH3 ), 3.70 (IH, m., H-5), 4.03-4.50 (5H, m., H-2,3,4,6), 
5.00-5.24 (5H, m., H -l and CH2  x2), 7.10-7.38 (lOH, m., aromatics); ôc (75.42 
MHz, C%3C1) 20.43, 20.47 and 20.54 (CH3), 50.37 (ArCH2), 61.73 (C-6), 68.11 (C- 
4), 69.59 (C-2), 72.33 (C-5), 72.40 (C-3), 105.13 (C-1), 127.17, 127.64, 128.71, 
128.90, 129.00, 129.22 (aromatics), 134.40 (quat aromatic), 159.45 (C=NOH), 
169.44, 169.68, 170.26 and 170.76 (C=0); m/z (ES+) 618 ([M+Na]+, 100%)
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5.3 CHEMICAL OXIDATION REACTIONS
6.3.1 Griess Reagent
The two solutions were prepared as follows/^ Sulfanilamide (2.5 g) was dissolved in 
water (500 cm^) containing 2% v/v concentrated hydrochloric acid. A-(l-Naphthyi)- 
ethylenediamine dihydrochloride (1.5 g) was dissolved in water (500 cm^) containing 1% 
v/v concentrated hydrochloric acid. The two solutions were stored separately and used as 
required.
6.3.2 Nitrite Calibration Curve
The stock nitrite solution was prepared by dissolving sodium nitrite (0.0038 g, 0.055 
mmol) in water (500 cm^). This solution was then diluted to the required concentrations. 
The Griess test was carried out by withdrawing a sample of the nitrite solution (1 cm^) 
and adding the sulfanilamide solution (0.5 cm^) followed, 5 minutes later, by the N-( 1 - 
naphthyl)ethylenediamine dihydrochloride solution (0.5 cm^). The solution was shaken 
thoroughly and the optical density was measured at 550 nm after 15 minutes (Table 18) 
(Graph 8).
Table 18:- Nitrite Calibration Data
Concentration/ 10"^  mol dm“3 Absorbance
1.1 2.8052
0.55 1.5115
0.22 0.6270
0.011 0.3208
0.0055 0.1629
0.0011 0.0254
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G raph 8:- Nitrite Calibration Curve
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6.4 DECOMPOSITION STUDIES OF 0 - T H F - l , l - D I B E N Z Y L - 2 -  
HYDROXYGUANIDINE (268)
6.4.1 HPLC Analysis
The HPLC analysis was carried out using a Phenomenex LUNA column and 60/40 
acetonitrile/water with 1% triethylamine as the eluant. Each HPLC was run for 10 
minutes using a flow rate of 1 cm^ min'^ and UV detection was employed at a 
wavelength of 240 nm. All organic solvents used were HPLC grade and water used was 
purified as described . The organic solvents were filtered and then the solvent system 
was degassed by placing in a sonic bath for 20 minutes.
6.4.2 Reactions at pH 0
A IM volumetric solution of hydrochloric acid was obtained from concentrated 
hydrochloric acid (3 cm^ in 100 cm^ of distilled water). A small portion (25 cm^) was 
placed in a round bottom flask and incubated at 37 °C (+ 0.1 °C) in a water bath. O- 
THP-1,1 -dibenzy 1-2-hydroxy guanidine (268) (0.0454 g, 0.125 mmol) was dissoved in 
acetonitrile (1 cm^) and added to the solution. After various periods of time a small 
aliquot (0.2 cm^) of the reaction mixture was removed and quenched with IM sodium 
hydroxide (0.2 cm^) solution. The aliqouts were then diluted with acetonitrile (0.2 cm^) 
and analysed by HPLC as described (Section 6.4.1). The peak due to the 0-THP-
1,1 -dibenzy 1-2-hydroxyguaninde (268) had a retention time of 7 minutes 50 seconds 
and was seen to totally disappear over a twenty minute period. The area of the peak was 
calculated using the computer software (Table 19)
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Table 1 9 : -  R e s u l t s  o f  a c i d  c a t a l y s e d  h y d r o l y s i s  o f  ( 2 6 8 )  a t  p H  0 .
Time /  s Area of peak
0 3991000
30 2859000
60 2513000
90 1900000
120 1738000
150 1441000
180 1254000
210 1053000
240 859700
270 1000000
300 616100
360 500600
420 350200
480 315400
540 269500
600 226800
1200 0
6.4.2 Reaction at pH 0.5
The hydrolysis was carried out using the same procedure as described for the hydrolysis 
of (268) at pH 0. The reaction was carried out in 0.32M hydrochloric acid (32 cm^ of 
IM hydrochloric acid in 100 cm^). Again the reaction was quenched by adding an equal 
volume of IM sodium hydroxide solution and then diluting with acetonitrile. The areas 
of the peak at 8.50 minutes are given (Table 20).
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Table 20:- R e s u l t s  o f  a c i d  c a t a l y s e d  h y d r o l y s i s  o f  (268) a t  p H  0 .5
Time /  s Peak af#a
0 6484000
60 6169000
120 6460000
180 5319000
240 4467000
300 3771000
480 3166000
540 3100000
600 3159000
720 3128000
840 2187000
960 2181000
1080 1951000
1200 1541000
1800 792000
2400 0
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6.3.3 Reaction at pH 1
The hydroylsis was carried out as previously described using a potassium 
chloride/hydrochloric acid buffer, The buffer was made up from 200 mmol dm^ 
potassium chloride solution (25 cm^) and 200 mmol dm^ hydrochloric acid (67 cm^). 
The pH was adjusted to pH 1 and then the solution was diluted (100 cm^). The aliquots 
were quenched using an equal volume of IM sodium hydroxide. The HPLC analysis 
was earned out as before and the area of the peak at 8.25 minutes was calculated (Table 
2 1 )
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Table 21:- R e s u l t s  o f  t h e  a c i d  c a t a l y s e d  h y d r o l y s i s  o f  (268) a t  p H  1
' . m m i i A ....... , Area of # a k
0 7871000
200 6783000
420 5594000
480 5308000
600 4778000
720 4302000
840 3873000
1200 3100000
1500 2754000
1800 2320000
2100 1832000
2400 1561000
2700 1356000
3000 1144000
3300 1012000
3600 919000
3900 762100
4200 542000
4500 0
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6.3.4 Reaction at pH 1.5
The hydrolysis was carried out as previously described using a potassium chloride/ 
hydrochloric acid buffer. The buffer was made up from 200 mmol dm^ potassium 
chloride solution (25 cm^) and 200 mmol dm^ hydrochloric acid (20.7 cm^). The pH 
was adjusted to pH 1.5 and then the solution was diluted (100 cm^). The reaction was 
run and aliquots removed and quenched with an equal volume of triethylamine. The 
HPLC analysis was then carried out before and the area of the peak at 8.30 minutes 
calculated (Table 22).
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T a b l e  2 2 ; -  R e s u l t s  f r o m  t h e  a c i d  h y d r o l y s i s  o f  ( 2 6 8 )  a t  p H  1 .5
Time / s # # k a r m
0 7066000
600 6599000
2280 5927000
2400 3848000
3000 5202000
3600 4922000
3900 4880000
4200 4528000
4800 4027000
5400 3845000
6000 3346000
6600 3098122
7200 2871000
7800 2639000
8400 2401000
9000 2287000
10800 1674000
14400 482300
15000 0
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6.3,5 Reactions at pH 2
The hydrolysis was carried out as described previously using a potassium chloride/ 
hydrochloric acid buffer. The buffer was made up from 200 mmol dm^ potassium 
chloride solution (25 cm^) and 200 mmol dm^ hydrochloric acid (6.5 cm^). The pH was 
adjusted to pH 2 and then the solution was diluted (100 cm^). The reaction was run and 
aliquots were removed and quenched with and equal volume of tiethylamine. The HPLC 
analysis were run as before and the areas of the peak at 8:30 minutes was calculated 
(Table 23)
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Table 23:- R e s u l t s  o f  t h e  a c i d  c a t a l y s e d  h y d r o l y s i s  o f  (268) a t  p H  2
Time (  s 'Jeak  area
0 8103000
600 7926000
1200 7906000
1800 7712000
2400 7456000
3600 7416000
4800 7829000
6000 7797000
7200 6997000
8400 7266000
12600 6159000
14400 6474000
21600 5046000
23400 5483000
27000 5421000
30600 4140000
102600 2591000
115200 2294000
216000 0
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6.5 BIOLOGICAL TESTING OF l - B E N Z Y L - l - M E T H Y L - 2 -  
HYDROXYGUANIDINE (137)
Isolated segments of a rat tail artery (male Wistar, 325-355 g, terminated by cervical 
dislocation) were perfused internally with oxygenated Krebs solution (composition, mM: 
NaCl 118, KCl 4.7, NaHCOg 25, NaH2PÛ4 1.15, CaCh 2.5, MgClz 1.1, glucose 5.6, 
gassed with 95% 02/5% CO2 to maintain pH7.4, at 32 °C), initially at low flow rate 
which was increased gradually over the next 10-20 mins to reach a maximum final rate of 
2 cm^ mimk The preparation was allowed to stabilise for 20 to 30 mins after which it 
was precontracted with Krebs solution and phenylephrine HCl (5 x 10'^ M) (agonist- 
induced pressure = 70 mmHg). A solution of 1-benzyl-l-methyl-2-hydroxyguanidine 
(137) was then prepared using the internal perfusate as the solvent. This solution was 
then internally perfused for 10 minutes during which time the pressure dropped to 20 
mmHg indicating a 70% artery dilation.
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Experimental
Data Collection
A colorless plate crystal o f C 9 H 1 3 N3 O having approximate dimensions of 0.40 x  0.20 x  0.10 m m  was 
mounted on a glass fiber. All measurements were made on a Rigaku AFC7S diffractometer with graphite 
monochromated M o-K a radiation.
Cell constants and an orientation m atrix for data collection , obtained from a least-squares refinement 
using the setting angles of 18 carefully centered reflections in the range 6.38 <  2$ <  12.53® corresponded to  
a primitive orthorhombic cell w ith dimensions:
a =  11.367(6) A 
b =  7.728(7) A 
c =  22.651(6) A 
V  = 1989(1) A=
For Z =  8  and F .W . =  179.22, the calculated density is 1.20 g/cm®. Based on the system atic absences of:
Okl: 1 ^  2n 
hOl: h ^  2n
packing considerations, a statistical analysis o f intensity distribution, and the successful solution and refine­
ment o f the structure, the space group was determined to be:
Pca2i (# 2 9 )
The data were collected at a temperature o f 20 ±  1®C using the co-26 scan technique to a m axim um  
26 value o f 50.0®. Omega scans o f several intense reflections, made prior to data collection, had an average 
width at half-height of 0.32® w ith a take-off angle o f 6.0®. Scans o f (1.78 -f 0.35 tan O f  were m ade at a 
speed o f 16.0®/min (in om ega). The weak reflections (I <  15.0<r(I)) were rescanned (m axim um  of 4 scans) 
and the counts were accumulated to ensure good counting statistics. Stationary background counts were 
recorded on each side o f the reflection. The ratio o f peak counting time to background counting tim e was 
2:1. The diameter of the incident beam collimator was 1.0 mm and the crystal to detector distance was 235 
mm. The computer-controlled slits were set to 9.0 mm (horizontal) and 13.0 mm (vertical).
D ata Reduction
Of the 2055 reflections which were collected, 2054 were unique (Rj„t =  0.266). T he intensities o f three 
representative reflection were measured after every 150 reflections. No decay correction was applied.
The linear absorption coefficient, /i, for M o-Ko radiation is 0.8 cm ” .^ An empirical absorption correction 
based on azimuthal scans o f several reflections was applied which resulted in transmission factors ranging 
from 0.94 to 1.00. The data were corrected for Lorentz and polarization effects.
Structure Solution and Refinement
The structure was solved by direct methods^ and expanded using Fourier techniques^. The non-hydrogen 
atom s were refined isotropically. Hydrogen atoms were included but not refined. The final cycle o f full-m atrix  
least-squares refinement® was based on 661 observed reflections (I >  3.00<r(I)) and 104 variable parameters 
and converged (largest parameter shift was 0.04 tim es its esd) with unweighted and weighted agreement 
factors of:
R  =  ^ \F o \  -  \F c \\ /^ F o\  =  0.091
R«, =  a/ ( S « ; ( | F o |  -  |F c |)V E «;Fo2)] =  0.054
The standard deviation o f an observation o f unit weight^ was 3.90. The weighting scheme was based  
on counting statistics and included a factor (p =  0.001) to  downweight the intense reflections. P lots o f  
E w (|F o | — |Fc|)^ versus |F o |, reflection order in data collection, sin 6/X and various classes o f indices showed 
no unusual trends. The m axim um  and minimum peaks on the final difference Fourier map corresponded to  
0.33 and -0.26 e“ /A®, respectively.
Neutral atom  scattering factors were taken from Cromer and Waber® . Anom alous dispersion effects 
were included in Fcalc®; the values for Af* and A f ’ were those o f Creagh and McAuley^. The values for the 
mass attenuation coefficients are those o f Creagh and Hubbel®. All calculations were performed using the 
teXsan® crystallographic software package o f Molecular Structure Corporation.
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EXPERIM ENTAL D ETAILS
A. Crystal D ata
Empirical Formula 
Formula Weight 
Crystal Color, Habit 
Crystal Dimensions 
Crystal System  
Lattice Type
No. o f Reflections Used for Unit 
Cell Determination (2^ range)
Omega Scan Peak W idth  
at Half-height 
Lattice Parameters
C9 H 1 3 N3 O
179.22
colorless, plate 
0.40 X 0.20 X 0.10 mm  
orthorhombic 
Primitive
18 ( 6.4 - 12.5® )
0.32®
a =  11.367(6)1  
b =  7.728(7) A 
c =  22.651(6) A
Space Group 
Z value 
D ca/c  
Fooo
//(M oK a)
V =  1989(1) A®
Pca2i (# 2 9 )
8
1.196 g/cm® 
768.00
0.82 cm~^
B. Intensity Measurements
Diffractometer
Radiation
Rigaku AFC7S 
M oKa (A =  0.71069 A)
Attenuator 
Take-off Angle 
Detector Aperture
Crystal to Detector Distance
Temperature
Scan Type
Scan Rate
Scan W idth
2^m aaf
No. o f Reflections Measured 
Corrections
graphite monochromated  
Zr foil (factor =  8.53)
6 .0®
9.0 m m  horizontal
13.0 m m  vertical
235 mm
20.0®C
w-2g
16.0®/min (in w) (up to 4 scans) 
(1.78 +  0.35 tan e)®
60.0®
Total: 2055
Unique: 2054 (Ri„t =  0.266)
Lorentz-polarization
Absorption
(trans. factors: 0.9382 - 1.0000)
Structure Solution  
Refinement 
Function Minimized 
Least Squares Weights 
p-factor
Anomalous Dispersion
No. Observations (I>3.00tr(I))
No. Variables
Reflection/Param eter Ratio 
Residuals: R; Rw 
Goodness o f F it Indicator
C. Structure Solution and Refinement
Direct Methods (SIR92) 
Full-matrix least-squares 
Ew(|Fo| -  lFc|)2
1 __ AFo^a-^(Fo)  —  a-^(Fo^)
0.0010
All non-hydrogen atoms 
661 
104 
6.36
0.091 ; 0.054 
3.90
M ax Shift/Error in Final Cycle 0.04
M aximum peak in Final Diff. Map 0.33 e"/A®
M inimum peak in Final Diff. Map -0.26 e“ /A®
Table 1. Atomic coordinates and eq
atom X y z Beç
0(1) 0.731(1) 0.661(2) 0.2258 5.3(3)
0(2) 0.523(1) -0.156(2) 0.1587(5) 4.7(3)
N (l) 0.704(2) 0.359(2) 0.1084(10) 5.5(4)
N (2) 0.814(1) 0.361(2) 0.1956(9) 5.5(4)
N(3) 0.679(2) 0.592(2) 0.1722(9) 6.3(5)
N(4) 0.543(1) 0.144(2) 0.2740(9) 5.1(4)
N (5) 0.440(1) 0.139(2) 0.1853(9) 5.5(4)
N (6 ) 0.568(1) -0.089(2) 0.2130(8) 3.7(4)
C (l) 0.790(2) 0 .1 0 1 (2 ) 0.060(1) 4.0(5)
0 (2 ) 0.800(2) -0.055(3) 0.049(1) 5.8(6)
0 (3 ) 0.873(3) -0.151(4) 0.015(1) 1 1 ( 1 )
0 (4 ) 0.943(2) -0.050(3) - 0 .0 1 1 ( 1 ) 6 .6(7)
0 (5 ) 0.966(3) 0.151(4) -0.007(1) 9.2(8)
0 (6 ) 0.871(2) 0.209(2) 0.031(1) 4.1(5)
0 (7 ) 0.712(2) 0.173(3) 0 .1 0 1 ( 1 ) 5.7(5)
0 (8 ) 0.612(2) 0.445(3) 0.071(1) 7.7(7)
0 (9 ) 0.737(2) 0.447(3) 0.161(1) 6 .1 ( 6 )
0 ( 1 0 ) 0.448(2) 0.393(2) 0.325(1) 4.1(5)
0 ( 1 1 ) 0.449(3) 0.599(4) 0.341(2) 1 1 .1 ( 1 0 )
0 ( 1 2 ) 0.355(2) 0.626(4) 0.383(1) 8.7(8)
0 (1 3 ) 0.278(2) 0.516(3) 0.404(1) 6.0(7)
0 (14 ) 0.292(3) 0.364(4) 0.391(1) 9.3(8)
0 (15 ) 0.372(2) 0.278(3) 0.350(1) 8.5(7)
0 (1 6 ) 0.545(2) 0.331(3) 0.278(1) 5.7(5)
Table 1. Atomic coordinates and (continued)
atom X y z Be,
C(17) 0.622(2) 0.057(3) 0.315(1) 7.8(7)
C(18) 0.522(2) 0.063(3) 0 .2 2 2 0 ( 1 0 ) 2.7(4)
H (l) 0.7440 -0.1244 0.0697 7.0766
H(2) 0.8717 -0.2744 0 . 0 1 0 2 13.5265
H(3) 0.9937 -0,1064 -0.0382 7.8944
H(4) 1.0261 0.2163 -0.0256 10.6809
H(5) 0.8639 0.3294 0.0374 4.9473
H(6 ) 0.7326 0.1260 0.1385 6.8775
H(7) 0.6353 0.1333 0.0905 6.8775
H(8 ) 0.6158 0.5663 0.0766 9.2521
H(9) 0.6235 0.4163 0.0312 9.2521
H(10) 0.5357 0.4050 0.0835 9.2521
H ( ll) 0.5010 0.6832 0.3269 13.1952
H(12) 0.3488 0.7405 0.3972 10.3451
H(13) 0.2141 0.5521 0.4281 7.2062
H(14) 0.2404 0.2867 0.4106 11.3105
H(15) 0.3708 0.1586 0.3417 10.0631
H(16) 0.6211 0.3672 0.2920 6.7870
H(17) 0.5297 0.3807 0.2414 6.7870
H(18) 0.5898 -0.0523 0.3263 9.1286
H(19) 0.6967 0.0374 0.2967 9.1286
H(20) 0.6334 0.1254 0.3494 9.1286
H(21) 0.8227 0.4216 0.2319 6.6606
H(22) 0.7860 0.2473 0.2033 6.6606
Table 1. Atomic coordinates and Bi,<,/Bcg (continued)
atom X y z Beg
H(23) 0.4420 0.0850 0.1477 6.6240
H(24) 0.4566 0.2582 0.1815 6.6240
Beg =  (f/ii((%a*) +  1/22(66*) +1/33(00*) +  2£/i2un*65* cos 7 +  2l7i3aa*00* cos/? +  21/2306*00* cos O')
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Table 2. Bond Lengths(A)
atom atom distance atom atom distance
0 ( 1 ) N (3) 1.45(2) 0 (2 ) . N (8 ) 1.43(2)
N (l) 0 (7 ) 1.45(2) N (l) 0 (8 ) 1.50(3)
N (l) 0 (9 ) 1.42(3) N (2) 0 (9 ) 1.35(2)
N (3) 0 (9 ) 1.32(3) N(4) 0 (1 6 ) 1.45(2)
N (4) 0 (1 7 ) 1.46(3) N (4) 0 (1 8 ) 1.36(2)
N (5) 0 (1 8 ) 1.38(2) N (6 ) 0 (1 8 ) 1.30(2)
C (l) 0 (2 ) 1.24(3) 0 ( 1 ) 0 (6 ) 1.40(3)
0 ( 1 ) 0 (7 ) 1.41(3) 0 (2 ) 0 (3 ) 1.35(3)
0 (3 ) 0 (4 ) 1.27(3) 0 (4 ) 0 (5 ) 1.57(3)
0 (5 ) 0 (6 ) 1.46(4) 0 ( 1 0 ) 0 ( 1 1 ) 1.63(4)
0 ( 1 0 ) 0 (1 5 ) 1.36(3) 0 ( 1 0 ) 0 (1 6 ) 1.60(3)
0 ( 1 1 ) 0 ( 1 2 ) 1.43(4) 0 ( 1 2 ) 0 (1 3 ) 1.31(3)
0 (1 3 ) 0 (1 4 ) 1.22(3) 0 (14 ) 0 (1 5 ) 1.45(4)
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Table 3. Bond Lengths(A)
atom atom distance atom atom distance
N(2) H(21) 0.95 N (2) H(22) 0.95
N(5) H(23) 0.95 N(5) H(24) 0.95
C(2) H (l) 0.96 0 (3 ) H(2) 0.96
C (4) H(3) 0.95 0 (5 ) H(4) 0.95
C(6 ) H(5) 0.95 0 (7 ) H(6 ) 0.96
C(7) H(7) 0.95 0 (8 ) H (8 ) 0.94
0 (8 ) H(9) 0.94 0 (8 ) H(10) 0.96
0 ( 1 1 ) H ( l l ) 0.94 0 ( 1 2 ) H(12) 0.95
0 (1 3 ) H(13) 0.95 0 (1 4 ) H(14) 0.95
0 (1 5 ) H(15) 0.94 0 (1 6 ) H(16) 0.96
0 (1 6 ) H(17) 0.94 0 (17 ) H(18) 0.95
0 (1 7 ) H(19) 0.96 0 (17 ) H(20) 0.95
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Table 4. Bond Angles(®)
atom atom atom angle atom atom atom angle
C(7) N (l) 0 ( 8 ) 114(1) 0 (7 ) N (l) 0 (9 ) 123(1)
C (8 ) N (l) 0 (9 ) 116(1) 0 ( 1 ) N(3) 0 (9 ) 106(1)
C(16) N (4) 0 (1 7 ) 114(1) 0 (1 6 ) N(4) 0 (1 8 ) 1 2 1 ( 1 )
C(17) N(4) 0 (1 8 ) 116(1) 0 (2 ) N (6 ) 0 (1 8 ) 108(1)
C (2) C (l) 0 (6 ) 115(1) 0 (2 ) 0 ( 1 ) 0 (7 ) 124(2)
0 (6 ) C (l) 0 (7 ) 119(1) 0 ( 1 ) 0 (2 ) 0 (3 ) 134(2)
0 (2 ) C(3) 0 (4 ) 108(2) 0 (3 ) 0 (4 ) 0 (5 ) 133(2)
0 (4 ) 0 (6 ) 1 0 2 (2 ) 0 ( 1 ) 0 (6 ) 0 (5 ) 125(1)
N (l) C(7) 0 ( 1 ) 1 2 0 (2 ) N (l) 0 (9 ) N (2) 115(2)
N (l) C(9) N (3) 116(2) N(2) 0 (9 ) N (3) 128(2)
0 ( 1 1 ) (3(10) 0 (1 6 ) 123(2) 0 ( 1 1 ) 0 ( 1 0 ) 0 (1 6 ) 115(1)
0 (1 5 ) C (1 0 ) 0 (1 6 ) 1 2 1 (2 ) 0 ( 1 0 ) 0 ( 1 1 ) 0 ( 1 2 ) 106(2)
0 ( 1 1 ) C (1 2 ) 0 (1 3 ) 129(2) 0 ( 1 2 ) 0 (13 ) 0 (14 ) 116(2)
0 (13 ) (3(14) 0 (1 5 ) 132(2) 0 ( 1 0 ) 0 (1 5 ) 0 (1 4 ) 111(2)
N (4) (3(16) 0 ( 1 0 ) 109(1) N (4) 0 (18 ) N (6 ) 116(1)
N(4) c a s ) N(6 ) 118(1) N (5) 0 (18 ) N (6 ) 123(1)-^
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Table 5. Bond Angles(®)
atom atom atom angle atom atom atom angle
C(9) N (2) H(21) 109.3 0 (9 ) N(2) H(22) 1 1 0 . 1
H(21) N(2) H(22) 109.5 0 (1 8 ) N (5) H(23) 109.9
0 (1 8 ) N(6 ) 11(24) 109.5 18(23) N (5) H(24) 1 1 0 . 0
0 ( 1 ) 0 (2 ) H (l) 113.0 0 (3 ) 0 (2 ) H (l) 112.4
0 (2 ) 0 (3 ) H(2) 127.0 0 (4 ) 0 (3 ) H(2) 125.0
0 (3 ) 0 (4 ) 11(3) 113.3 0 (5 ) 0 (4 ) H(3) 112.9
0 (4 ) 0 (5 ) H(4) 128.6 0 (6 ) 0 (5 ) H(4) 129.0
0 ( 1 ) 0 (6 ) H(5) 117.5 0 (5 ) 0 (6 ) H(5) 117.2
N (l) 0 (7 ) H (6 ) 106.6 N (l) 0 (7 ) H(7) 107.0
0 ( 1 ) 0 (7 ) H (6 ) 106,4 0 ( 1 ) 0 (7 ) H(7) 106.9
H(6 ) 0 (7 ) H(7) 109.0 N (l) 0 (8 ) H (8 ) 109.4
N (l) 0 (8 ) H(9) 109.5 N (l) 0 (8 ) H(10) 108.7
H(8 ) 0 (8 ) H(9) 1 1 0 . 6 H(8 ) 0 (8 ) 11(10) 109.2
H(9) 0 (8 ) 1 1 ( 1 0 ) 109.3 0 ( 1 0 ) 0 ( 1 1 ) H ( l l ) 127.0
0 ( 1 2 ) 0 ( 1 1 ) H ( l l ) 126.5 0 ( 1 1 ) 0 ( 1 2 ) 11(12) 114.8
0 (1 3 ) 0 ( 1 2 ) 11(12) 115.3 0 ( 1 2 ) 0 (1 3 ) 11(13) 1 2 2 . 1
0 (14 ) 0 (1 3 ) 11(13) 1 2 1 . 6 0(13 ) 0 (1 4 ) 11(14) 113.8
0 (15 ) 0 (14 ) H(14) 113.5 0 ( 1 0 ) 0 (15 ) 11(16) 124.2
0 (1 4 ) 0 (15 ) H(15) 124.7 N(4) 0 (16 ) 11(16) 109.0
N(4) 0 (1 6 ) 11(17) 109.9 0 ( 1 0 ) 0 (16 ) 11(16) 108.8
0 ( 1 0 ) 0 (1 6 ) 11(17) 109.9 H(16) 0 (16 ) 11(17) 109.7
N(4) 0 (17 ) 11(18) 1 1 0 . 0 N(4) 0 (1 7 ) 11(19) 109.3
N(4) 0 (17 ) 1 1 (2 0 ) 110.3 H(18) 0 (1 7 ) 11(19) 108.7
11(18) 0 (17 ) 1 1(2 0 ) 109.7 H(19) 0 (1 7 ) H(20) 108.9
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Table 5. Bond Angles(®) (continued)
atom  atom  atom angle atom  atom  atom  angle
15
Table 6 . Torsion Angles(^) 
atom  atom  atom atom angle atom atom atom atom angle
0 ( 1 ) N (3) 0 (9 ) N (l) -177(1) 0 ( 1 ) N (3) 0 (9 ) N (2) 10(3)
0 (2 ) N (6 ) 0 (1 8 ) N (4) 173(1) 0 (2 ) N(6 ) 0 (1 8 ) N(5) 2 (2 )
N ( l) 0 (7 ) 0 ( 1 ) 0 ( 2 ) -177(1) N (l) 0 (7 ) 0 ( 1 ) 0 (6 ) 7(3)
N (2) 0 (9 ) N (l) 0 (7 ) 22(3) N (2) 0 (9 ) N (l) 0 (8 ) 175(1)
N(3) 0 (9 ) N (l) 0 (7 ) -150(2) N (3) 0 (9 ) N (l) 0 (8 ) 2(3)
N (4) 0 (1 6 ) 0 ( 1 0 ) 0 ( 1 1 ) 173(1) N (4) 0 (16 ) 0 ( 1 0 ) 0 (1 5 ) -5(3)
N(5) 0 (1 8 ) N (4) 0 (1 6 ) -37(2) N (5) 0 (18 ) N (4) 0 (1 7 ) 174(1)
N (6 ) 0 (1 8 ) N (4) 0 (1 6 ) 151(1) N (6 ) 0 (18 ) N (4) 0 (1 7 ) 2 (2 )
C (l) 0 ( 2 ) 0 (3 ) 0 (4 ) 0(4) 0 ( 1 ) 0 (6 ) 0 (5 ) 0 (4 ) 4(3)
C (I) 0 (7 ) N (l) 0 (8 ) 92(2) 0 ( 1 ) 0 (7 ) N (l) 0 (9 ) -114(2)
C (2) 0 ( 1 ) 0 (6 ) 0 (5 ) -2(3) 0 (2 ) 0 (3 ) 0 (4 ) 0 (5 ) 4(4)
0 (3 ) 0 (2 ) 0 ( 1 ) 0 (6 ) 0(4) 0 (3 ) 0 (2 ) 0 ( 1 ) 0 (7 ) -175(3)
0 (3 ) 0 (4 ) 0 (5 ) 0 (6 ) -6(4) 0 (5 ) 0 (6 ) 0 ( 1 ) 0 (7 ) 172(2)
0 ( 1 0 ) 0 ( 1 1 ) 0 ( 1 2 ) 0 (1 3 ) -3(4) 0 ( 1 0 ) 0 (15 ) 0 (1 4 ) 0 (1 3 ) 3(4)
0 ( 1 0 ) 0 (1 6 ) N (4) 0 (1 7 ) -89(2) 0 ( 1 0 ) 0 (16 ) N(4) 0 (1 8 ) 1 2 1 ( 1 )
0 ( 1 1 ) 0 ( 1 0 ) 0 (1 5 ) 0 (1 4 ) 1(3) 0 ( 1 1 ) 0 ( 1 2 ) 0 (1 3 ) 0 (1 4 ) 7 ( 4
0 ( 1 2 ) 0 ( 1 1 ) 0 ( 1 0 ) 0 (1 5 ) -1(3) 0 ( 1 2 ) 0 ( 1 1 ) 0 ( 1 0 ) 0 (1 6 ) 179(2)
0 ( 1 2 ) 0 (1 3 ) 0 (14 ) 0 (1 5 ) -7(4) 0 (1 4 ) 0 (1 5 ) 0 ( 1 0 ) 0 (1 6 ) -179(1)
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Table 7. Non-bonded Contacts out to 3.30 A
atom atom distance ADC atom atom distance A D C
0 ( 1 ) N (6 ) 2.69(2) 56501 0 ( 1 ) N (5) 2.98(2) 56504
0 ( 1 ) 0 (2 ) 3.14(1) 56501 0 ( 1 ) C(15) 3.27(3) 56504
0 (2 ) N (3) 2 .6 6 ( 2 ) 54501 0 (2 ) N(2) 2.98(2) 45504
N (3) N (6 ) 2.92(2) 56501
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The A D C  (atom  designator code) specifies the position of an atom  in a crystal. The 5-digit number 
shown in the table is a com posite o f three one-digit numbers and one two-digit number: TA (first digit) 
d- T B  (second digit) -|- TC  (third digit) +  SN (last two digits). TA, T B  and TC  are the crystal lattice 
translation digits along cell edges a, b and c. A translation digit o f 5 indicates the origin unit cell. If TA  =  4, 
this indicates a translation o f one unit cell length along the a^axis in the negative direction. Each translation  
digit can range in value from 1 to 9 and thus ^ 4  lattice translations from the origin (T A =5, T B = 5 , T C = 5)  
can be represented.
The SN, or sym metry operator number, refers to the number o f the sym m etry operator used to generate 
the coordinates o f the target atom . A list o f symmetry operators relevant to this structure are given below.
For a given intermolecular contact, the first atom  (origin atom) is located in the origin unit cell and its 
position can be generated using the identity operator (S N = 1 ). Thus, the ADC for an origin atom  is always 
55501. The position o f the second atom  (target atom) can be generated using the A D C  and the coordinates 
of the atom  in the parameter table. For example, an ADC o f 47502 refers to the target atom  moved through  
sym m etry operator two, then translated - 1  cell translations along the a axis, + 2  cell translations along the 
b axis, and 0  cell translations along the c axis.
An ADC o f 1 indicates an intermolecular contact between two fragments (eg. cation and anion)-that 
reside in the same asymmetric unit.
Symmetry Operators:
(1) X, Y, Z (2) -X , -Y , 1/2-fZ
(3) 1 /2-X , Y, 1/2-fZ  (4) 1 /2 + X , -Y, Z
18

